<!DOCTYPE html><!--[if lt IE 7]> <html lang='en' class='no-js lt-ie10 lt-ie9 lt-ie8 lt-ie7'> <![endif]--><!--[if IE 7]>    <html lang='en' class='no-js lt-ie10 lt-ie9 lt-ie8'> <![endif]--><!--[if IE 8]>    <html lang='en' class='no-js lt-ie10 lt-ie9'> <![endif]--><!--[if IE 9]>    <html lang='en' class='no-js lt-ie10'> <![endif]--><!--[if (gt IE 9)|!(IE)]><!--><html xmlns="http://www.w3.org/1999/xhtml" lang="en" class=" js flexbox flexboxlegacy canvas canvastext webgl no-touch geolocation postmessage websqldatabase indexeddb hashchange history draganddrop websockets rgba hsla multiplebgs backgroundsize borderimage borderradius boxshadow textshadow opacity cssanimations csscolumns cssgradients cssreflections csstransforms csstransforms3d csstransitions fontface generatedcontent video audio localstorage sessionstorage webworkers applicationcache svg inlinesvg smil svgclippaths" style=""><!--<![endif]--><head><script type="text/javascript" src="https://bam.nr-data.net/1/27b438aa5b?a=77504&amp;v=1184.ab39b52&amp;to=cV9cEEdeCA5cExpaX19VQgVSVEsLVwVQSg%3D%3D&amp;rst=3150&amp;ck=1&amp;ref=https://www.jci.org/&amp;ap=356&amp;be=944&amp;fe=3106&amp;dc=1837&amp;perf=%7B%22timing%22:%7B%22of%22:1606992591663,%22n%22:0,%22f%22:189,%22dn%22:189,%22dne%22:198,%22c%22:198,%22s%22:280,%22ce%22:458,%22rq%22:458,%22rp%22:934,%22rpe%22:1019,%22dl%22:939,%22di%22:1837,%22ds%22:1837,%22de%22:1850,%22dc%22:3105,%22l%22:3105,%22le%22:3130%7D,%22navigation%22:%7B%7D%7D&amp;fp=1444&amp;fcp=1444&amp;jsonp=NREUM.setToken"></script><script type="text/javascript" src="https://m.addthis.com/live/red_lojson/300lo.json?si=5fc8c2d11a195492&amp;bkl=0&amp;bl=1&amp;pdt=1025&amp;sid=5fc8c2d11a195492&amp;pub=ra-4d8389db4b0bb592&amp;rev=v8.28.8-wp&amp;ln=en&amp;pc=men&amp;cb=0&amp;ab=-&amp;dp=www.jci.org&amp;fp=&amp;fr=&amp;of=0&amp;pd=0&amp;irt=0&amp;vcl=0&amp;md=0&amp;ct=1&amp;tct=0&amp;abt=0&amp;cdn=0&amp;pi=1&amp;rb=0&amp;gen=100&amp;chr=UTF-8&amp;colc=1606992594787&amp;jsl=1&amp;uvs=5fc8c2d102c5793e000&amp;skipb=1&amp;callback=addthis.cbs.jsonp__7493847246763070"></script><script type="text/javascript" src="https://v1.addthisedge.com/live/boost/ra-4d8389db4b0bb592/_ate.track.config_resp"></script><script src="https://js-agent.newrelic.com/nr-1184.min.js"></script><script type="text/javascript" async="" src="https://www.google-analytics.com/analytics.js"></script><script type="text/javascript" src="https://z.moatads.com/addthismoatframe568911941483/moatframe.js"></script><meta class="foundation-mq-small" /><meta class="foundation-mq-small-only" /><meta class="foundation-mq-medium" /><meta class="foundation-mq-medium-only" /><meta class="foundation-mq-large" /><meta class="foundation-mq-large-only" /><meta class="foundation-mq-xlarge" /><meta class="foundation-mq-xlarge-only" /><meta class="foundation-mq-xxlarge" /><meta class="foundation-data-attribute-namespace" />
<meta charset="utf-8" />
<script async="" src="https://www.googletagmanager.com/gtm.js?id=GTM-WTNK8H9"></script><script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js"></script><script>window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","errorBeacon":"bam.nr-data.net","licenseKey":"27b438aa5b","applicationID":"77504","transactionName":"cV9cEEdeCA5cExpaX19VQgVSVEsLVwVQSg==","queueTime":0,"applicationTime":356,"agent":""}</script>
<script>(window.NREUM||(NREUM={})).loader_config={licenseKey:"27b438aa5b",applicationID:"77504"};window.NREUM||(NREUM={}),__nr_require=function(e,t,n){function r(n){if(!t[n]){var i=t[n]={exports:{}};e[n][0].call(i.exports,function(t){var i=e[n][1][t];return r(i||t)},i,i.exports)}return t[n].exports}if("function"==typeof __nr_require)return __nr_require;for(var i=0;i&lt;n.length;i++)r(n[i]);return r}({1:[function(e,t,n){function r(){}function i(e,t,n){return function(){return o(e,[u.now()].concat(c(arguments)),t?null:this,n),t?void 0:this}}var o=e("handle"),a=e(6),c=e(7),f=e("ee").get("tracer"),u=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&amp;&amp;(newrelic=s);var d=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],p="api-",l=p+"ixn-";a(d,function(e,t){s[t]=i(p+t,!0,"api")}),s.addPageAction=i(p+"addPageAction",!0),s.setCurrentRouteName=i(p+"routeName",!0),t.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,t){var n={},r=this,i="function"==typeof t;return o(l+"tracer",[u.now(),e,n],r),function(){if(f.emit((i?"":"no-")+"fn-start",[u.now(),r,i],n),i)try{return t.apply(this,arguments)}catch(e){throw f.emit("fn-err",[arguments,this,e],n),e}finally{f.emit("fn-end",[u.now()],n)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,t){m[t]=i(l+t)}),newrelic.noticeError=function(e,t){"string"==typeof e&amp;&amp;(e=new Error(e)),o("err",[e,u.now(),!1,t])}},{}],2:[function(e,t,n){function r(){return c.exists&amp;&amp;performance.now?Math.round(performance.now()):(o=Math.max((new Date).getTime(),o))-a}function i(){return o}var o=(new Date).getTime(),a=o,c=e(8);t.exports=r,t.exports.offset=a,t.exports.getLastTimestamp=i},{}],3:[function(e,t,n){function r(e,t){var n=e.getEntries();n.forEach(function(e){"first-paint"===e.name?d("timing",["fp",Math.floor(e.startTime)]):"first-contentful-paint"===e.name&amp;&amp;d("timing",["fcp",Math.floor(e.startTime)])})}function i(e,t){var n=e.getEntries();n.length&gt;0&amp;&amp;d("lcp",[n[n.length-1]])}function o(e){e.getEntries().forEach(function(e){e.hadRecentInput||d("cls",[e])})}function a(e){if(e instanceof m&amp;&amp;!g){var t=Math.round(e.timeStamp),n={type:e.type};t&lt;=p.now()?n.fid=p.now()-t:t&gt;p.offset&amp;&amp;t&lt;=Date.now()?(t-=p.offset,n.fid=p.now()-t):t=p.now(),g=!0,d("timing",["fi",t,n])}}function c(e){d("pageHide",[p.now(),e])}if(!("init"in NREUM&amp;&amp;"page_view_timing"in NREUM.init&amp;&amp;"enabled"in NREUM.init.page_view_timing&amp;&amp;NREUM.init.page_view_timing.enabled===!1)){var f,u,s,d=e("handle"),p=e("loader"),l=e(5),m=NREUM.o.EV;if("PerformanceObserver"in window&amp;&amp;"function"==typeof window.PerformanceObserver){f=new PerformanceObserver(r);try{f.observe({entryTypes:["paint"]})}catch(v){}u=new PerformanceObserver(i);try{u.observe({entryTypes:["largest-contentful-paint"]})}catch(v){}s=new PerformanceObserver(o);try{s.observe({type:"layout-shift",buffered:!0})}catch(v){}}if("addEventListener"in document){var g=!1,y=["click","keydown","mousedown","pointerdown","touchstart"];y.forEach(function(e){document.addEventListener(e,a,!1)})}l(c)}},{}],4:[function(e,t,n){function r(e,t){if(!i)return!1;if(e!==i)return!1;if(!t)return!0;if(!o)return!1;for(var n=o.split("."),r=t.split("."),a=0;a&lt;r.length;a++)if(r[a]!==n[a])return!1;return!0}var i=null,o=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var c=navigator.userAgent,f=c.match(a);f&amp;&amp;c.indexOf("Chrome")===-1&amp;&amp;c.indexOf("Chromium")===-1&amp;&amp;(i="Safari",o=f[1])}t.exports={agent:i,version:o,match:r}},{}],5:[function(e,t,n){function r(e){function t(){e(a&amp;&amp;document[a]?document[a]:document[i]?"hidden":"visible")}"addEventListener"in document&amp;&amp;o&amp;&amp;document.addEventListener(o,t,!1)}t.exports=r;var i,o,a;"undefined"!=typeof document.hidden?(i="hidden",o="visibilitychange",a="visibilityState"):"undefined"!=typeof document.msHidden?(i="msHidden",o="msvisibilitychange"):"undefined"!=typeof document.webkitHidden&amp;&amp;(i="webkitHidden",o="webkitvisibilitychange",a="webkitVisibilityState")},{}],6:[function(e,t,n){function r(e,t){var n=[],r="",o=0;for(r in e)i.call(e,r)&amp;&amp;(n[o]=t(r,e[r]),o+=1);return n}var i=Object.prototype.hasOwnProperty;t.exports=r},{}],7:[function(e,t,n){function r(e,t,n){t||(t=0),"undefined"==typeof n&amp;&amp;(n=e?e.length:0);for(var r=-1,i=n-t||0,o=Array(i&lt;0?0:i);++r&lt;i;)o[r]=e[t+r];return o}t.exports=r},{}],8:[function(e,t,n){t.exports={exists:"undefined"!=typeof window.performance&amp;&amp;window.performance.timing&amp;&amp;"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,t,n){function r(){}function i(e){function t(e){return e&amp;&amp;e instanceof r?e:e?f(e,c,o):o()}function n(n,r,i,o){if(!p.aborted||o){e&amp;&amp;e(n,r,i);for(var a=t(i),c=v(n),f=c.length,u=0;u&lt;f;u++)c[u].apply(a,r);var d=s[w[n]];return d&amp;&amp;d.push([b,n,r,a]),a}}function l(e,t){h[e]=v(e).concat(t)}function m(e,t){var n=h[e];if(n)for(var r=0;r&lt;n.length;r++)n[r]===t&amp;&amp;n.splice(r,1)}function v(e){return h[e]||[]}function g(e){return d[e]=d[e]||i(n)}function y(e,t){u(e,function(e,n){t=t||"feature",w[n]=t,t in s||(s[t]=[])})}var h={},w={},b={on:l,addEventListener:l,removeEventListener:m,emit:n,get:g,listeners:v,context:t,buffer:y,abort:a,aborted:!1};return b}function o(){return new r}function a(){(s.api||s.feature)&amp;&amp;(p.aborted=!0,s=p.backlog={})}var c="nr@context",f=e("gos"),u=e(6),s={},d={},p=t.exports=i();p.backlog=s},{}],gos:[function(e,t,n){function r(e,t,n){if(i.call(e,t))return e[t];var r=n();if(Object.defineProperty&amp;&amp;Object.keys)try{return Object.defineProperty(e,t,{value:r,writable:!0,enumerable:!1}),r}catch(o){}return e[t]=r,r}var i=Object.prototype.hasOwnProperty;t.exports=r},{}],handle:[function(e,t,n){function r(e,t,n,r){i.buffer([e],r),i.emit(e,t,n)}var i=e("ee").get("handle");t.exports=r,r.ee=i},{}],id:[function(e,t,n){function r(e){var t=typeof e;return!e||"object"!==t&amp;&amp;"function"!==t?-1:e===window?0:a(e,o,function(){return i++})}var i=1,o="nr@id",a=e("gos");t.exports=r},{}],loader:[function(e,t,n){function r(){if(!E++){var e=b.info=NREUM.info,t=p.getElementsByTagName("script")[0];if(setTimeout(u.abort,3e4),!(e&amp;&amp;e.licenseKey&amp;&amp;e.applicationID&amp;&amp;t))return u.abort();f(h,function(t,n){e[t]||(e[t]=n)});var n=a();c("mark",["onload",n+b.offset],null,"api"),c("timing",["load",n]);var r=p.createElement("script");r.src="https://"+e.agent,t.parentNode.insertBefore(r,t)}}function i(){"complete"===p.readyState&amp;&amp;o()}function o(){c("mark",["domContent",a()+b.offset],null,"api")}var a=e(2),c=e("handle"),f=e(6),u=e("ee"),s=e(4),d=window,p=d.document,l="addEventListener",m="attachEvent",v=d.XMLHttpRequest,g=v&amp;&amp;v.prototype;NREUM.o={ST:setTimeout,SI:d.setImmediate,CT:clearTimeout,XHR:v,REQ:d.Request,EV:d.Event,PR:d.Promise,MO:d.MutationObserver};var y=""+location,h={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1184.min.js"},w=v&amp;&amp;g&amp;&amp;g[l]&amp;&amp;!/CriOS/.test(navigator.userAgent),b=t.exports={offset:a.getLastTimestamp(),now:a,origin:y,features:{},xhrWrappable:w,userAgent:s};e(1),e(3),p[l]?(p[l]("DOMContentLoaded",o,!1),d[l]("load",r,!1)):(p[m]("onreadystatechange",i),d[m]("onload",r)),c("mark",["firstbyte",a.getLastTimestamp()],null,"api");var E=0},{}],"wrap-function":[function(e,t,n){function r(e){return!(e&amp;&amp;e instanceof Function&amp;&amp;e.apply&amp;&amp;!e[a])}var i=e("ee"),o=e(7),a="nr@original",c=Object.prototype.hasOwnProperty,f=!1;t.exports=function(e,t){function n(e,t,n,i){function nrWrapper(){var r,a,c,f;try{a=this,r=o(arguments),c="function"==typeof n?n(r,a):n||{}}catch(u){p([u,"",[r,a,i],c])}s(t+"start",[r,a,i],c);try{return f=e.apply(a,r)}catch(d){throw s(t+"err",[r,a,d],c),d}finally{s(t+"end",[r,a,f],c)}}return r(e)?e:(t||(t=""),nrWrapper[a]=e,d(e,nrWrapper),nrWrapper)}function u(e,t,i,o){i||(i="");var a,c,f,u="-"===i.charAt(0);for(f=0;f&lt;t.length;f++)c=t[f],a=e[c],r(a)||(e[c]=n(a,u?c+i:i,o,c))}function s(n,r,i){if(!f||t){var o=f;f=!0;try{e.emit(n,r,i,t)}catch(a){p([a,n,r,i])}f=o}}function d(e,t){if(Object.defineProperty&amp;&amp;Object.keys)try{var n=Object.keys(e);return n.forEach(function(n){Object.defineProperty(t,n,{get:function(){return e[n]},set:function(t){return e[n]=t,t}})}),t}catch(r){p([r])}for(var i in e)c.call(e,i)&amp;&amp;(t[i]=e[i]);return t}function p(t){try{e.emit("internal-error",t)}catch(n){}}return e||(e=i),n.inPlace=u,n.flag=a,n}},{}]},{},["loader"]);</script>
<meta content="text/html; charset=UTF-8" http-equiv="Content-Type" />
<meta content="The Journal of Clinical Investigation" name="AUTHOR" />
<!-- Set the viewport width to device width for mobile -->
<meta content="width=device-width, initial-scale=1.0" name="viewport" />
<link href="/rss" rel="alternate" title="JCI New Article RSS" type="application/rss+xml" />
<meta name="csrf-param" content="authenticity_token" />
<meta name="csrf-token" content="9G19Dj0Q7ehkN6anjX8Jlmb43gjwg2+cMrOeDyVK23xXg0QugQtofkii+hAcYEv4YV1qUNO4Lh9GieYEKjLluA==" />
<link rel="shortcut icon" type="image/x-icon" href="/assets/jci-favicon-b6f74d2a3ee91ddde987c4dcc25a92d19a3f49aaf2cc6f8b58190cf1e34e3785.ico" />
<title>
JCI -
Welcome
</title>

<!--[if gt IE 8]><!--><link rel="stylesheet" media="all" href="/assets/application-35f039dfdaa72883cf636e1848ce546cf36a1bb8dc337aa0aaf2944cc0efe73f.css" /><!--<![endif]-->
<!--[if (lt IE 9)]>
<link rel="stylesheet" media="all" href="/assets/ie8/application-8344233743ad5fae6328b0a08482b9778961dfa02c8f980574689a50e97c13cb.css" />
<script src="/assets/ie8/ie8-head-bfd8231ba171b62724ed7348c9f7aef3cb95e7c031381a8875b6b0769bb2cd66.js"></script>
<![endif]-->

<style>
  @font-face {
    font-family: "klavika-bold";
    src: url("//dm5migu4zj3pb.cloudfront.net/fonts/klavika/eot/KlavikaWebBasicBold.eot");
    src:
      url("//dm5migu4zj3pb.cloudfront.net/fonts/klavika/eot/KlavikaWebBasicBold.eot?#iefix") format("embedded-opentype"),
      url("//dm5migu4zj3pb.cloudfront.net/fonts/klavika/woff/KlavikaWebBasicBold.woff") format("woff");
  }
  @font-face {
    font-family: "klavika-regular";
    src: url("//dm5migu4zj3pb.cloudfront.net/fonts/klavika/eot/KlavikaWebBasicRegular.eot");
    src:
      url("//dm5migu4zj3pb.cloudfront.net/fonts/klavika/eot/KlavikaWebBasicRegular.eot?#iefix") format("embedded-opentype"),
      url("//dm5migu4zj3pb.cloudfront.net/fonts/klavika/woff/KlavikaWebBasicRegular.woff") format("woff");
  }
  @font-face {
    font-family: "foundation-icons";
    src: url("//dm5migu4zj3pb.cloudfront.net/fonts/foundation-icons-3/foundation-icons.eot");
    src: url("//dm5migu4zj3pb.cloudfront.net/fonts/foundation-icons-3/foundation-icons.eot?#iefix") format("embedded-opentype"),
         url("//dm5migu4zj3pb.cloudfront.net/fonts/foundation-icons-3/foundation-icons.woff") format("woff"),
         url("//dm5migu4zj3pb.cloudfront.net/fonts/foundation-icons-3/foundation-icons.ttf") format("truetype"),
         url("//dm5migu4zj3pb.cloudfront.net/fonts/foundation-icons-3/foundation-icons.svg#fontcustom") format("svg");
    font-weight: normal;
    font-style: normal;
  }
</style>

<script>
  //Google Tag Manager Data Layer
  //Values must be set before GTM tags are triggered
  window.dataLayer = window.dataLayer || [];
  window.dataLayer.push({
    'siteName': 'content-jci',
    'ipAddress': '169.235.26.103',
    'environment': 'production',
  });
</script>
<script src="/assets/vendor/modernizr-34068bbe55efaed404fc5f26a12641757e9f4e5ba63d46a472021f167c4e66c4.js"></script>
<script type="text/javascript">
	var googletag = googletag || {};
	googletag.cmd = googletag.cmd || [];
	(function () {
		var gads = document.createElement('script');
		gads.async = true;
		gads.type = 'text/javascript';
		var useSSL = 'https:' == document.location.protocol;
		gads.src = (useSSL ? 'https:' : 'http:') + '//www.googletagservices.com/tag/js/gpt.js';
		var node = document.getElementsByTagName('script')[0];
		node.parentNode.insertBefore(gads, node);
	})();

	googletag.cmd.push(function () {

		// NOTE: This script manages google ads, more info at doc/GoogleAds.md

		var mapping = googletag.sizeMapping().addSize([800, 600], [300, 250]).addSize([640, 480], [260, 217]).build();
		var mapping2 = googletag.sizeMapping()
		   .addSize([1920, 1080], [728, 90])//All desktop like resolutions are set to 728x90
		   .addSize([800, 600], [728, 90])
		   .addSize([640, 480], [728, 90])
		   .addSize([0, 0], [320, 50]) //Smaller than 640x480 screens
		   .build();
			
		googletag.defineSlot('/82117132/jci-homepage-med-rectangle-left-col-top', [[300, 250],[260, 217]], 'jci-homepage-med-rectangle-left-col-top').defineSizeMapping(mapping).addService(googletag.pubads());

		googletag.defineSlot('/82117132/jci-article-interior-leaderboard-top', [[728, 90],[320, 50]], 'jci-article-interior-leaderboard-top').defineSizeMapping(mapping2).addService(googletag.pubads());
		googletag.defineSlot('/82117132/jci-article-interior-leaderboard-bottom', [728, 90], 'jci-article-interior-leaderboard-bottom').addService(googletag.pubads());
		googletag.defineSlot('/82117132/jci-article-interior-skyscraper-right-col', [160, 600], 'jci-article-interior-skyscraper-right-col').addService(googletag.pubads());
		googletag.defineSlot('/82117132/jci-interior-skyscraper-right-col', [160, 600], 'jci-interior-skyscraper-right-col').addService(googletag.pubads());

		// collapseEmptyDivs requires all slots be defined above.
		googletag.pubads().collapseEmptyDivs(true);
		googletag.enableServices();
	});
</script>

<script src="https://securepubads.g.doubleclick.net/gpt/pubads_impl_2020111901.js" async=""></script><style></style><style>.cke{visibility:hidden;}</style><meta class="foundation-mq-topbar" /><link rel="preload" href="https://adservice.google.com/adsid/integrator.js?domain=www.jci.org" as="script" /><script type="text/javascript" src="https://adservice.google.com/adsid/integrator.js?domain=www.jci.org"></script><link rel="prefetch" href="https://9d343ab2503a705a92a55156c147db76.safeframe.googlesyndication.com/safeframe/1-0-37/html/container.html" /><style type="text/css">.at-icon{fill:#fff;border:0}.at-icon-wrapper{display:inline-block;overflow:hidden}a .at-icon-wrapper{cursor:pointer}.at-rounded,.at-rounded-element .at-icon-wrapper{border-radius:12%}.at-circular,.at-circular-element .at-icon-wrapper{border-radius:50%}.addthis_32x32_style .at-icon{width:2pc;height:2pc}.addthis_24x24_style .at-icon{width:24px;height:24px}.addthis_20x20_style .at-icon{width:20px;height:20px}.addthis_16x16_style .at-icon{width:1pc;height:1pc}#at16lb{display:none;position:absolute;top:0;left:0;width:100%;height:100%;z-index:1001;background-color:#000;opacity:.001}#at_complete,#at_error,#at_share,#at_success{position:static!important}.at15dn{display:none}#at15s,#at16p,#at16p form input,#at16p label,#at16p textarea,#at_share .at_item{font-family:arial,helvetica,tahoma,verdana,sans-serif!important;font-size:9pt!important;outline-style:none;outline-width:0;line-height:1em}* html #at15s.mmborder{position:absolute!important}#at15s.mmborder{position:fixed!important;width:250px!important}#at15s{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);float:none;line-height:1em;margin:0;overflow:visible;padding:5px;text-align:left;position:absolute}#at15s a,#at15s span{outline:0;direction:ltr;text-transform:none}#at15s .at-label{margin-left:5px}#at15s .at-icon-wrapper{width:1pc;height:1pc;vertical-align:middle}#at15s .at-icon{width:1pc;height:1pc}.at4-icon{display:inline-block;background-repeat:no-repeat;background-position:top left;margin:0;overflow:hidden;cursor:pointer}.addthis_16x16_style .at4-icon,.addthis_default_style .at4-icon,.at4-icon,.at-16x16{width:1pc;height:1pc;line-height:1pc;background-size:1pc!important}.addthis_32x32_style .at4-icon,.at-32x32{width:2pc;height:2pc;line-height:2pc;background-size:2pc!important}.addthis_24x24_style .at4-icon,.at-24x24{width:24px;height:24px;line-height:24px;background-size:24px!important}.addthis_20x20_style .at4-icon,.at-20x20{width:20px;height:20px;line-height:20px;background-size:20px!important}.at4-icon.circular,.circular .at4-icon,.circular.aticon{border-radius:50%}.at4-icon.rounded,.rounded .at4-icon{border-radius:4px}.at4-icon-left{float:left}#at15s .at4-icon{text-indent:20px;padding:0;overflow:visible;white-space:nowrap;background-size:1pc;width:1pc;height:1pc;background-position:top left;display:inline-block;line-height:1pc}.addthis_vertical_style .at4-icon,.at4-follow-container .at4-icon{margin-right:5px}html&gt;body #at15s{width:250px!important}#at15s.atm{background:none!important;padding:0!important;width:10pc!important}#at15s_inner{background:#fff;border:1px solid #fff;margin:0}#at15s_head{position:relative;background:#f2f2f2;padding:4px;cursor:default;border-bottom:1px solid #e5e5e5}.at15s_head_success{background:#cafd99!important;border-bottom:1px solid #a9d582!important}.at15s_head_success a,.at15s_head_success span{color:#000!important;text-decoration:none}#at15s_brand,#at15sptx,#at16_brand{position:absolute}#at15s_brand{top:4px;right:4px}.at15s_brandx{right:20px!important}a#at15sptx{top:4px;right:4px;text-decoration:none;color:#4c4c4c;font-weight:700}#at15sptx:hover{text-decoration:underline}#at16_brand{top:5px;right:30px;cursor:default}#at_hover{padding:4px}#at_hover .at_item,#at_share .at_item{background:#fff!important;float:left!important;color:#4c4c4c!important}#at_share .at_item .at-icon-wrapper{margin-right:5px}#at_hover .at_bold{font-weight:700;color:#000!important}#at_hover .at_item{width:7pc!important;padding:2px 3px!important;margin:1px;text-decoration:none!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover{margin:0!important}#at_hover .at_item.athov,#at_hover .at_item:focus,#at_hover .at_item:hover,#at_share .at_item.athov,#at_share .at_item:hover{background:#f2f2f2!important;border:1px solid #e5e5e5;color:#000!important;text-decoration:none}.ipad #at_hover .at_item:focus{background:#fff!important;border:1px solid #fff}.at15t{display:block!important;height:1pc!important;line-height:1pc!important;padding-left:20px!important;background-position:0 0;text-align:left}.addthis_button,.at15t{cursor:pointer}.addthis_toolbox a.at300b,.addthis_toolbox a.at300m{width:auto}.addthis_toolbox a{margin-bottom:5px;line-height:initial}.addthis_toolbox.addthis_vertical_style{width:200px}.addthis_button_facebook_like .fb_iframe_widget{line-height:100%}.addthis_button_facebook_like iframe.fb_iframe_widget_lift{max-width:none}.addthis_toolbox a.addthis_button_counter,.addthis_toolbox a.addthis_button_facebook_like,.addthis_toolbox a.addthis_button_facebook_send,.addthis_toolbox a.addthis_button_facebook_share,.addthis_toolbox a.addthis_button_foursquare,.addthis_toolbox a.addthis_button_linkedin_counter,.addthis_toolbox a.addthis_button_pinterest_pinit,.addthis_toolbox a.addthis_button_tweet{display:inline-block}.addthis_toolbox span.addthis_follow_label{display:none}.addthis_toolbox.addthis_vertical_style span.addthis_follow_label{display:block;white-space:nowrap}.addthis_toolbox.addthis_vertical_style a{display:block}.addthis_toolbox.addthis_vertical_style.addthis_32x32_style a{line-height:2pc;height:2pc}.addthis_toolbox.addthis_vertical_style .at300bs{margin-right:4px;float:left}.addthis_toolbox.addthis_20x20_style span{line-height:20px}.addthis_toolbox.addthis_32x32_style span{line-height:2pc}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact,.addthis_toolbox.addthis_pill_combo_style a{float:left}.addthis_toolbox.addthis_pill_combo_style a.addthis_button_tweet{margin-top:-2px}.addthis_toolbox.addthis_pill_combo_style .addthis_button_compact .at15t_compact{margin-right:4px}.addthis_default_style .addthis_separator{margin:0 5px;display:inline}div.atclear{clear:both}.addthis_default_style .addthis_separator,.addthis_default_style .at4-icon,.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300bs,.addthis_default_style .at300m{float:left}.at300b img,.at300bo img{border:0}a.at300b .at4-icon,a.at300m .at4-icon{display:block}.addthis_default_style .at300b,.addthis_default_style .at300bo,.addthis_default_style .at300m{padding:0 2px}.at300b,.at300bo,.at300bs,.at300m{cursor:pointer}.addthis_button_facebook_like.at300b:hover,.addthis_button_facebook_like.at300bs:hover,.addthis_button_facebook_send.at300b:hover,.addthis_button_facebook_send.at300bs:hover{opacity:1}.addthis_20x20_style .at15t,.addthis_20x20_style .at300bs{overflow:hidden;display:block;height:20px!important;width:20px!important;line-height:20px!important}.addthis_32x32_style .at15t,.addthis_32x32_style .at300bs{overflow:hidden;display:block;height:2pc!important;width:2pc!important;line-height:2pc!important}.at300bs{overflow:hidden;display:block;background-position:0 0;height:1pc;width:1pc;line-height:1pc!important}.addthis_default_style .at15t_compact,.addthis_default_style .at15t_expanded{margin-right:4px}#at_share .at_item{width:123px!important;padding:4px;margin-right:2px;border:1px solid #fff}#at16p{background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);z-index:10000001;position:absolute;top:50%;left:50%;width:300px;padding:10px;margin:0 auto;margin-top:-185px;margin-left:-155px;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#5e5e5e}#at_share{margin:0;padding:0}#at16pt{position:relative;background:#f2f2f2;height:13px;padding:5px 10px}#at16pt a,#at16pt h4{font-weight:700}#at16pt h4{display:inline;margin:0;padding:0;font-size:9pt;color:#4c4c4c;cursor:default}#at16pt a{position:absolute;top:5px;right:10px;color:#4c4c4c;text-decoration:none;padding:2px}#at15sptx:focus,#at16pt a:focus{outline:thin dotted}#at15s #at16pf a{top:1px}#_atssh{width:1px!important;height:1px!important;border:0!important}.atm{width:10pc!important;padding:0;margin:0;line-height:9pt;letter-spacing:normal;font-family:arial,helvetica,tahoma,verdana,sans-serif;font-size:9pt;color:#444;background:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgaGAgAjAxEAlGFVJHIUCAAQDcngCUgqGMqwAAAABJRU5ErkJggg==);padding:4px}.atm-f{text-align:right;border-top:1px solid #ddd;padding:5px 8px}.atm-i{background:#fff;border:1px solid #d5d6d6;padding:0;margin:0;box-shadow:1px 1px 5px rgba(0,0,0,.15)}.atm-s{margin:0!important;padding:0!important}.atm-s a:focus{border:transparent;outline:0;transition:none}#at_hover.atm-s a,.atm-s a{display:block;text-decoration:none;padding:4px 10px;color:#235dab!important;font-weight:400;font-style:normal;transition:none}#at_hover.atm-s .at_bold{color:#235dab!important}#at_hover.atm-s a:hover,.atm-s a:hover{background:#2095f0;text-decoration:none;color:#fff!important}#at_hover.atm-s .at_bold{font-weight:700}#at_hover.atm-s a:hover .at_bold{color:#fff!important}.atm-s a .at-label{vertical-align:middle;margin-left:5px;direction:ltr}.at_PinItButton{display:block;width:40px;height:20px;padding:0;margin:0;background-image:url(//s7.addthis.com/static/t00/pinit00.png);background-repeat:no-repeat}.at_PinItButton:hover{background-position:0 -20px}.addthis_toolbox .addthis_button_pinterest_pinit{position:relative}.at-share-tbx-element .fb_iframe_widget span{vertical-align:baseline!important}#at16pf{height:auto;text-align:right;padding:4px 8px}.at-privacy-info{position:absolute;left:7px;bottom:7px;cursor:pointer;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:10px;line-height:9pt;letter-spacing:.2px;color:#666}.at-privacy-info:hover{color:#000}.body .wsb-social-share .wsb-social-share-button-vert{padding-top:0;padding-bottom:0}.body .wsb-social-share.addthis_counter_style .addthis_button_tweet.wsb-social-share-button{padding-top:40px}.body .wsb-social-share.addthis_counter_style .addthis_button_facebook_like.wsb-social-share-button{padding-top:21px}@media print{#at4-follow,#at4-share,#at4-thankyou,#at4-whatsnext,#at4m-mobile,#at15s,.at4,.at4-recommended{display:none!important}}@media screen and (max-width:400px){.at4win{width:100%}}@media screen and (max-height:700px) and (max-width:400px){.at4-thankyou-inner .at4-recommended-container{height:122px;overflow:hidden}.at4-thankyou-inner .at4-recommended .at4-recommended-item:first-child{border-bottom:1px solid #c5c5c5}}</style><style type="text/css">.at-branding-logo{font-family:helvetica,arial,sans-serif;text-decoration:none;font-size:10px;display:inline-block;margin:2px 0;letter-spacing:.2px}.at-branding-logo .at-branding-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAMAAAC67D+PAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAAZQTFRF////+GlNUkcc1QAAAB1JREFUeNpiYIQDBjQmAwMmkwEM0JnY1WIxFyDAABGeAFEudiZsAAAAAElFTkSuQmCC")}.at-branding-logo .at-branding-icon,.at-branding-logo .at-privacy-icon{display:inline-block;height:10px;width:10px;margin-left:4px;margin-right:3px;margin-bottom:-1px;background-repeat:no-repeat}.at-branding-logo .at-privacy-icon{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAkAAAAKCAMAAABR24SMAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABhQTFRF8fr9ot/xXcfn2/P5AKva////////AKTWodjhjAAAAAd0Uk5T////////ABpLA0YAAAA6SURBVHjaJMzBDQAwCAJAQaj7b9xifV0kUKJ9ciWxlzWEWI5gMF65KUTv0VKkjVeTerqE/x7+9BVgAEXbAWI8QDcfAAAAAElFTkSuQmCC")}.at-branding-logo span{text-decoration:none}.at-branding-logo .at-branding-addthis,.at-branding-logo .at-branding-powered-by{color:#666}.at-branding-logo .at-branding-addthis:hover{color:#333}.at-cv-with-image .at-branding-addthis,.at-cv-with-image .at-branding-addthis:hover{color:#fff}a.at-branding-logo:visited{color:initial}.at-branding-info{display:inline-block;padding:0 5px;color:#666;border:1px solid #666;border-radius:50%;font-size:10px;line-height:9pt;opacity:.7;transition:all .3s ease;text-decoration:none}.at-branding-info span{border:0;clip:rect(0 0 0 0);height:1px;margin:-1px;overflow:hidden;padding:0;position:absolute;width:1px}.at-branding-info:before{content:'i';font-family:Times New Roman}.at-branding-info:hover{color:#0780df;border-color:#0780df}</style><script id="altmetric-embed-js" src="https://d1bxh8uas1mnw7.cloudfront.net/assets/altmetric_badges-dae2a658e53c442cd84f4390def938db5569f7911cfa1aa78d8970054ec2f48f.js"></script><link id="altmetric-embed-css" rel="stylesheet" type="text/css" href="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed-31802d5163e7112bb932c6b069663a78644b40bdeb2e6ca3a53456853965d98d.css" /><script type="text/javascript" charset="utf-8" async="" src="https://s7.addthis.com/static/layers.fa6cd1947ce26e890d3d.js"></script><style type="text/css">.at-share-dock.atss{top:auto;left:0;right:0;bottom:0;width:100%;max-width:100%;z-index:1000200;box-shadow:0 0 1px 1px #e2dfe2}.at-share-dock.at-share-dock-zindex-hide{z-index:-1!important}.at-share-dock.atss-top{bottom:auto;top:0}.at-share-dock a{width:auto;transition:none;color:#fff;text-decoration:none;box-sizing:content-box;-webkit-box-sizing:content-box;-moz-box-sizing:content-box}.at-share-dock a:hover{width:auto}.at-share-dock .at4-count{height:43px;padding:5px 0 0;line-height:20px;background:#fff;font-family:Helvetica neue,arial}.at-share-dock .at4-count span{width:100%}.at-share-dock .at4-count .at4-share-label{color:#848484;font-size:10px;letter-spacing:1px}.at-share-dock .at4-count .at4-counter{top:2px;position:relative;display:block;color:#222;font-size:22px}.at-share-dock.at-shfs-medium .at4-count{height:36px;line-height:1pc;padding-top:4px}.at-share-dock.at-shfs-medium .at4-count .at4-counter{font-size:18px}.at-share-dock.at-shfs-medium .at-share-btn .at-icon-wrapper,.at-share-dock.at-shfs-medium a .at-icon-wrapper{padding:6px 0}.at-share-dock.at-shfs-small .at4-count{height:26px;line-height:1;padding-top:3px}.at-share-dock.at-shfs-small .at4-count .at4-share-label{font-size:8px}.at-share-dock.at-shfs-small .at4-count .at4-counter{font-size:14px}.at-share-dock.at-shfs-small .at-share-btn .at-icon-wrapper,.at-share-dock.at-shfs-small a .at-icon-wrapper{padding:4px 0}</style><style type="text/css">div.at-share-close-control.ats-dark,div.at-share-open-control-left.ats-dark,div.at-share-open-control-right.ats-dark{background:#262b30}div.at-share-close-control.ats-light,div.at-share-open-control-left.ats-light,div.at-share-open-control-right.ats-light{background:#fff}div.at-share-close-control.ats-gray,div.at-share-open-control-left.ats-gray,div.at-share-open-control-right.ats-gray{background:#f2f2f2}.atss{position:fixed;top:20%;width:3pc;z-index:100020;background:none}.at-share-close-control{position:relative;width:3pc;overflow:auto}.at-share-open-control-left{position:fixed;top:20%;z-index:100020;left:0;width:22px}.at-share-close-control .at4-arrow.at-left{float:right}.atss-left{left:0;float:left;right:auto}.atss-right{left:auto;float:right;right:0}.atss-right.at-share-close-control .at4-arrow.at-right{position:relative;right:0;overflow:auto}.atss-right.at-share-close-control .at4-arrow{float:left}.at-share-open-control-right{position:fixed;top:20%;z-index:100020;right:0;width:22px;float:right}.atss-right .at-share-close-control .at4-arrow{float:left}.atss.atss-right a{float:right}.atss.atss-right .at4-share-title{float:right;overflow:hidden}.atss .at-share-btn,.atss a{position:relative;display:block;width:3pc;margin:0;outline-offset:-1px;text-align:center;float:left;transition:width .15s ease-in-out;overflow:hidden;background:#e8e8e8;z-index:100030;cursor:pointer}.at-share-btn::-moz-focus-inner{border:0;padding:0}.atss-right .at-share-btn{float:right}.atss .at-share-btn{border:0;padding:0}.atss .at-share-btn:focus,.atss .at-share-btn:hover,.atss a:focus,.atss a:hover{width:4pc}.atss .at-share-btn .at-icon-wrapper,.atss a .at-icon-wrapper{display:block;padding:8px 0}.atss .at-share-btn:last-child,.atss a:last-child{border:none}.atss .at-share-btn span .at-icon,.atss a span .at-icon{position:relative;top:0;left:0;display:block;background-repeat:no-repeat;background-position:50% 50%;width:2pc;height:2pc;line-height:2pc;border:none;padding:0;margin:0 auto;overflow:hidden;cursor:pointer;cursor:hand}.at4-share .at-custom-sidebar-counter{font-family:Helvetica neue,arial;vertical-align:top;margin-right:4px;display:inline-block;text-align:center}.at4-share .at-custom-sidebar-count{font-size:17px;line-height:1.25em;color:#222}.at4-share .at-custom-sidebar-text{font-size:9px;line-height:1.25em;color:#888;letter-spacing:1px}.at4-share .at4-share-count-container{position:absolute;left:0;right:auto;top:auto;bottom:0;width:100%;color:#fff;background:inherit}.at4-share .at4-share-count,.at4-share .at4-share-count-container{line-height:1pc;font-size:10px}.at4-share .at4-share-count{text-indent:0;font-family:Arial,Helvetica Neue,Helvetica,sans-serif;font-weight:200;width:100%;height:1pc}.at4-share .at4-share-count-anchor{padding-bottom:8px;text-decoration:none;transition:padding .15s ease-in-out .15s,width .15s ease-in-out}</style><style type="text/css">#at4-drawer-outer-container{top:0;width:20pc;position:fixed}#at4-drawer-outer-container.at4-drawer-inline{position:relative}#at4-drawer-outer-container.at4-drawer-inline.at4-drawer-right{float:right;right:0;left:auto}#at4-drawer-outer-container.at4-drawer-inline.at4-drawer-left{float:left;left:0;right:auto}#at4-drawer-outer-container.at4-drawer-shown,#at4-drawer-outer-container.at4-drawer-shown *{z-index:999999}#at4-drawer-outer-container,#at4-drawer-outer-container .at4-drawer-outer,#at-drawer{height:100%;overflow-y:auto;overflow-x:hidden}.at4-drawer-push-content-right-back{position:relative;right:0}.at4-drawer-push-content-right{position:relative;left:20pc!important}.at4-drawer-push-content-left-back{position:relative;left:0}.at4-drawer-push-content-left{position:relative;right:20pc!important}#at4-drawer-outer-container.at4-drawer-right{left:auto;right:-20pc}#at4-drawer-outer-container.at4-drawer-left{right:auto;left:-20pc}#at4-drawer-outer-container.at4-drawer-shown.at4-drawer-right{left:auto;right:0}#at4-drawer-outer-container.at4-drawer-shown.at4-drawer-left{right:auto;left:0}#at-drawer{top:0;z-index:9999999;height:100%;animation-duration:.4s}#at-drawer.drawer-push.at-right{right:-20pc}#at-drawer.drawer-push.at-left{left:-20pc}#at-drawer .at-recommended-label{padding:0 0 0 20px;color:#999;line-height:3pc;font-size:18px;font-weight:300;cursor:default}#at-drawer-arrow{width:30px;height:5pc}#at-drawer-arrow.ats-dark{background:#262b30}#at-drawer-arrow.ats-gray{background:#f2f2f2}#at-drawer-open-arrow{background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAA0AAABcCAYAAAC1OT8uAAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAAyNpVFh0WE1MOmNvbS5hZG9iZS54bXAAAAAAADw/eHBhY2tldCBiZWdpbj0i77u/IiBpZD0iVzVNME1wQ2VoaUh6cmVTek5UY3prYzlkIj8+IDx4OnhtcG1ldGEgeG1sbnM6eD0iYWRvYmU6bnM6bWV0YS8iIHg6eG1wdGs9IkFkb2JlIFhNUCBDb3JlIDUuNS1jMDE0IDc5LjE1MTQ4MSwgMjAxMy8wMy8xMy0xMjowOToxNSAgICAgICAgIj4gPHJkZjpSREYgeG1sbnM6cmRmPSJodHRwOi8vd3d3LnczLm9yZy8xOTk5LzAyLzIyLXJkZi1zeW50YXgtbnMjIj4gPHJkZjpEZXNjcmlwdGlvbiByZGY6YWJvdXQ9IiIgeG1sbnM6eG1wPSJodHRwOi8vbnMuYWRvYmUuY29tL3hhcC8xLjAvIiB4bWxuczp4bXBNTT0iaHR0cDovL25zLmFkb2JlLmNvbS94YXAvMS4wL21tLyIgeG1sbnM6c3RSZWY9Imh0dHA6Ly9ucy5hZG9iZS5jb20veGFwLzEuMC9zVHlwZS9SZXNvdXJjZVJlZiMiIHhtcDpDcmVhdG9yVG9vbD0iQWRvYmUgUGhvdG9zaG9wIENDIChNYWNpbnRvc2gpIiB4bXBNTTpJbnN0YW5jZUlEPSJ4bXAuaWlkOjk3ODNCQjdERUQ3QjExRTM5NjFGRUZBODc3MTIwMTNCIiB4bXBNTTpEb2N1bWVudElEPSJ4bXAuZGlkOjk3ODNCQjdFRUQ3QjExRTM5NjFGRUZBODc3MTIwMTNCIj4gPHhtcE1NOkRlcml2ZWRGcm9tIHN0UmVmOmluc3RhbmNlSUQ9InhtcC5paWQ6OTc4M0JCN0JFRDdCMTFFMzk2MUZFRkE4NzcxMjAxM0IiIHN0UmVmOmRvY3VtZW50SUQ9InhtcC5kaWQ6OTc4M0JCN0NFRDdCMTFFMzk2MUZFRkE4NzcxMjAxM0IiLz4gPC9yZGY6RGVzY3JpcHRpb24+IDwvcmRmOlJERj4gPC94OnhtcG1ldGE+IDw/eHBhY2tldCBlbmQ9InIiPz7kstzCAAAB4ElEQVR42uyWv0oDQRDGb9dYimgVjliID2Ca9AGfwtZob2Grja1PIFj7EhGCYK99VPBPOkVMp8X5rc6FeN7dfjOksMjAxwXZ3667OzvfLKRr682l5ZV9aDh+fxsnRHhoDzqGLjFBi4XOoFtoAxowoB893o/w7WpAl/+QgQMBwwRdTPhUC2lAV/wDA7qy5WOgq9psHejqTqkKdLE7KYCv0JZjMgBgB58raBG6mP1K6j2pT099T+qMUOeeOss1wDcEIA1PnQXy576rAUI0oFMoC7VCnn40Gs8Pd4lAiXNUKmJ0lh1mPzGEWiyUCqAGW3Pwv4IvUJsFO9CHgP3Zr6Te0xwgAf3LxaAjS241pbikCRkOg+nSJdV4p8HOPl3vvRYI5dtrgVDvvcWovcWovcWovcWovcWovcWovQChWNywNpqvdAKtQp/QNmPUIQ6kwwqt2Xmsxf6GMPM1Pptsbz45CPmXqKb+15Gz4J/LZcDSNIqBlQlbB0afe1mmUDWiCNKFZRq0VKMeXY1CTDq2sJLWsCmoaBBRqNRR6qBKC6qCaj2rDIqaXBGiXHEaom00h1S+K3fVlr6HNuqgvgCh0+owt21bybQn8+mZ78mcEebcM2e5+T2ZX24ZqCph0qn1vgQYAJ/KDpLQr2tPAAAAAElFTkSuQmCC);background-repeat:no-repeat;width:13px;height:23px;margin:28px 0 0 8px}.at-left #at-drawer-open-arrow{background-position:0 -46px}.ats-dark #at-drawer-open-arrow{background-position:0 -23px}.ats-dark.at-left #at-drawer-open-arrow{background-position:0 -69px}#at-drawer-arrow.at4-drawer-modern-browsers{position:fixed;top:40%;background-repeat:no-repeat;background-position:0 0!important;z-index:9999999}.at4-drawer-inline #at-drawer-arrow{position:absolute}#at-drawer-arrow.at4-drawer-modern-browsers.at-right{right:0}#at-drawer-arrow.at4-drawer-modern-browsers.at-left{left:0}.at4-drawer-push-animation-left{transition:left .4s ease-in-out .15s}.at4-drawer-push-animation-right{transition:right .4s ease-in-out .15s}#at-drawer.drawer-push.at4-drawer-push-animation-right{right:0}#at-drawer.drawer-push.at4-drawer-push-animation-right-back{right:-20pc!important}#at-drawer.drawer-push.at4-drawer-push-animation-left{left:0}#at-drawer.drawer-push.at4-drawer-push-animation-left-back{left:-20pc!important}#at-drawer .at4-closebutton.drawer-close{content:'X';color:#999;display:block;position:absolute;margin:0;top:0;right:0;width:3pc;height:45px;line-height:45px;overflow:hidden;opacity:.5}#at-drawer.ats-dark .at4-closebutton.drawer-close{color:#fff}#at-drawer .at4-closebutton.drawer-close:hover{opacity:1}#at-drawer.ats-dark.at4-recommended .at4-logo-container a{color:#666}#at-drawer.at4-recommended .at4-recommended-vertical{padding:0}#at-drawer.at4-recommended .at4-recommended-item .sponsored-label{margin:2px 0 0 21px;color:#ddd}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item{position:relative;padding:0;width:20pc;height:180px;margin:0}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img a:after{content:'';position:absolute;top:0;left:0;right:0;bottom:0;background:rgba(0,0,0,.65);z-index:1000000;transition:all .2s ease-in-out}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item.at-hover .at4-recommended-item-img a:after{background:rgba(0,0,0,.8)}#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img,#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img a,#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img img{width:20pc;height:180px;float:none}#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption{width:100%;position:absolute;bottom:0;left:0;height:70px}#at-drawer .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4{color:#fff;position:absolute;height:52px;top:0;left:20px;right:20px;margin:0;padding:0;line-height:25px;font-size:20px;font-weight:600;z-index:1000001;text-decoration:none;text-transform:none}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4 a:hover{text-decoration:none}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4 a:link{color:#fff}#at-drawer.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption small{position:absolute;top:auto;bottom:10px;left:20px;width:auto;color:#ccc}#at-drawer.at4-recommended .at4-logo-container{margin-left:20px}#at-drawer.ats-dark.at4-recommended .at4-logo-container a:hover{color:#fff}#at-drawer.at4-recommended .at-logo{margin:0}</style><style type="text/css">.at4-follow.at-mobile{display:none!important}.at4-follow{position:fixed;top:0;right:0;font-weight:400;color:#666;cursor:default;z-index:10001}.at4-follow .at4-follow-inner{position:relative;padding:10px 24px 10px 15px}.at4-follow-inner,.at-follow-open-control{border:0 solid #c5c5c5;border-width:1px 0 1px 1px;margin-top:-1px}.at4-follow .at4-follow-container{margin-left:9pt}.at4-follow.at4-follow-24 .at4-follow-container{height:24px;line-height:23px;font-size:13px}.at4-follow.at4-follow-32 .at4-follow-container{width:15pc;height:2pc;line-height:2pc;font-size:14px}.at4-follow .at4-follow-container .at-follow-label{display:inline-block;height:24px;line-height:24px;margin-right:10px;padding:0;cursor:default;float:left}.at4-follow .at4-follow-container .at-icon-wrapper{height:24px;width:24px}.at4-follow.ats-transparent .at4-follow-inner,.at-follow-open-control.ats-transparent{border-color:transparent}.at4-follow.ats-dark .at4-follow-inner,.at-follow-open-control.ats-dark{background:#262b30;border-color:#000;color:#fff}.at4-follow.ats-dark .at-follow-close-control{background-color:#262b30}.at4-follow.ats-light .at4-follow-inner{background:#fff;border-color:#c5c5c5}.at4-follow.ats-gray .at4-follow-inner,.at-follow-open-control.ats-gray{background:#f2f2f2;border-color:#c5c5c5}.at4-follow.ats-light .at4-follow-close-control,.at-follow-open-control.ats-light{background:#e5e5e5}.at4-follow .at4-follow-inner .at4-follow-close-control{position:absolute;top:0;bottom:0;left:0;width:20px;cursor:pointer;display:none}.at4-follow .at4-follow-inner .at4-follow-close-control div{display:block;line-height:20px;text-indent:-9999em;margin-top:calc(50% + 1px);overflow:hidden}.at-follow-open-control div.at4-arrow.at-left{background-position:0 -2px}.at-follow-open-control{position:fixed;height:35px;top:0;right:0;padding-top:10px;z-index:10002}.at-follow-btn{margin:0 5px 5px 0;padding:0;outline-offset:-1px;display:inline-block;box-sizing:content-box;transition:all .2s ease-in-out}.at-follow-btn:focus,.at-follow-btn:hover{transform:translateY(-4px)}.at4-follow-24 .at-follow-btn{height:25px;line-height:0;width:25px}</style><style type="text/css">.at-follow-tbx-element .at300b,.at-follow-tbx-element .at300m{display:inline-block;width:auto;padding:0;margin:0 2px 5px;outline-offset:-1px;transition:all .2s ease-in-out}.at-follow-tbx-element .at300b:focus,.at-follow-tbx-element .at300b:hover,.at-follow-tbx-element .at300m:focus,.at-follow-tbx-element .at300m:hover{transform:translateY(-4px)}.at-follow-tbx-element .addthis_vertical_style .at300b,.at-follow-tbx-element .addthis_vertical_style .at300m{display:block}.at-follow-tbx-element .addthis_vertical_style .at300b .addthis_follow_label,.at-follow-tbx-element .addthis_vertical_style .at300b .at-icon-wrapper,.at-follow-tbx-element .addthis_vertical_style .at300m .addthis_follow_label,.at-follow-tbx-element .addthis_vertical_style .at300m .at-icon-wrapper{display:inline-block;vertical-align:middle;margin-right:5px}.at-follow-tbx-element .addthis_vertical_style .at300b:focus,.at-follow-tbx-element .addthis_vertical_style .at300b:hover,.at-follow-tbx-element .addthis_vertical_style .at300m:focus,.at-follow-tbx-element .addthis_vertical_style .at300m:hover{transform:none}</style><style type="text/css">.at4-jumboshare .at-share-btn{display:inline-block;margin-right:13px;margin-top:13px}.at4-jumboshare .at-share-btn .at-icon{float:left}.at4-jumboshare .at-share-btn .at300bs{display:inline-block;float:left;cursor:pointer}.at4-jumboshare .at4-mobile .at-share-btn .at-icon,.at4-jumboshare .at4-mobile .at-share-btn .at-icon-wrapper{margin:0;padding:0}.at4-jumboshare .at4-mobile .at-share-btn{padding:0}.at4-jumboshare .at4-mobile .at-share-btn .at-label{display:none}.at4-jumboshare .at4-count{font-size:60px;line-height:60px;font-family:Helvetica neue,arial;font-weight:700}.at4-jumboshare .at4-count-container{display:table-cell;text-align:center;min-width:200px;vertical-align:middle;border-right:1px solid #ccc;padding-right:20px}.at4-jumboshare .at4-share-container{display:table-cell;vertical-align:middle;padding-left:20px}.at4-jumboshare .at4-share-container.at-share-tbx-element{padding-top:0}.at4-jumboshare .at4-title{position:relative;font-size:18px;line-height:18px;bottom:2px}.at4-jumboshare .at4-spacer{height:1px;display:block;visibility:hidden;opacity:0}.at4-jumboshare .at-share-btn{display:inline-block;margin:0 2px;line-height:0;padding:0;overflow:hidden;text-decoration:none;text-transform:none;color:#fff;cursor:pointer;transition:all .2s ease-in-out;border:0;background-color:transparent}.at4-jumboshare .at-share-btn:focus,.at4-jumboshare .at-share-btn:hover{transform:translateY(-4px);color:#fff;text-decoration:none}.at4-jumboshare .at-label{font-family:helvetica neue,helvetica,arial,sans-serif;font-size:9pt;padding:0 15px 0 0;margin:0;height:2pc;line-height:2pc;background:none}.at4-jumboshare .at-share-btn:hover,.at4-jumboshare .at-share-btn:link{text-decoration:none}.at4-jumboshare .at-share-btn::-moz-focus-inner{border:0;padding:0}.at4-jumboshare.at-mobile .at-label{display:none}</style><style type="text/css">.at4-recommendedbox-outer-container{display:inline}.at4-recommended-outer{position:static}.at4-recommended{top:20%;margin:0;text-align:center;font-weight:400;font-size:13px;line-height:17px;color:#666}.at4-recommended.at-inline .at4-recommended-horizontal{text-align:left}.at4-recommended-recommendedbox{padding:0;z-index:inherit}.at4-recommended-recommended{padding:40px 0}.at4-recommended-horizontal{max-height:340px}.at4-recommended.at-medium .at4-recommended-horizontal{max-height:15pc}.at4-recommended.at4-minimal.at-medium .at4-recommended-horizontal{padding-top:10px;max-height:230px}.at4-recommended-text-only .at4-recommended-horizontal{max-height:130px}.at4-recommended-horizontal{padding-top:5px;overflow-y:hidden}.at4-minimal{background:none;color:#000;border:none!important;box-shadow:none!important}@media screen and (max-width:900px){.at4-recommended-horizontal .at4-recommended-item,.at4-recommended-horizontal .at4-recommended-item .at4-recommended-item-img{width:15pc}}.at4-recommended.at4-minimal .at4-recommended-horizontal .at4-recommended-item .at4-recommended-item-caption{padding:0 0 10px}.at4-recommended.at4-minimal .at4-recommended-horizontal .at4-recommended-item-caption{padding:20px 0 0!important}.addthis-smartlayers .at4-recommended .at-h3.at-recommended-label{margin:0;padding:0;font-weight:300;font-size:18px;line-height:24px;color:#464646;width:100%;display:inline-block;zoom:1}.addthis-smartlayers .at4-recommended.at-inline .at-h3.at-recommended-label{text-align:left}#at4-thankyou .addthis-smartlayers .at4-recommended.at-inline .at-h3.at-recommended-label{text-align:center}.at4-recommended .at4-recommended-item{display:inline-block;zoom:1;position:relative;background:#fff;border:1px solid #c5c5c5;width:200px;margin:10px}.addthis_recommended_horizontal .at4-recommended-item{border:none}.at4-recommended .at4-recommended-item .sponsored-label{color:#666;font-size:9px;position:absolute;top:-20px}.at4-recommended .at4-recommended-item-img .at-tli,.at4-recommended .at4-recommended-item-img a{position:absolute;left:0}.at4-recommended.at-inline .at4-recommended-horizontal .at4-recommended-item{margin:10px 20px 0 0}.at4-recommended.at-medium .at4-recommended-horizontal .at4-recommended-item{margin:10px 10px 0 0}.at4-recommended.at-medium .at4-recommended-item{width:140px;overflow:hidden}.at4-recommended .at4-recommended-item .at4-recommended-item-img{position:relative;text-align:center;width:100%;height:200px;line-height:0;overflow:hidden}.at4-recommended .at4-recommended-item .at4-recommended-item-img a{display:block;width:100%;height:200px}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-img,.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-img a{height:140px}.at4-recommended .at4-recommended-item .at4-recommended-item-img img{position:absolute;top:0;left:0;min-height:0;min-width:0;max-height:none;max-width:none;margin:0;padding:0}.at4-recommended .at4-recommended-item .at4-recommended-item-caption{height:74px;overflow:hidden;padding:20px;text-align:left;-ms-box-sizing:content-box;-o-box-sizing:content-box;box-sizing:content-box}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-caption{height:50px;padding:15px}.at4-recommended .at4-recommended-item .at4-recommended-item-caption .at-h4{height:54px;margin:0 0 5px;padding:0;overflow:hidden;word-wrap:break-word;font-size:14px;font-weight:400;line-height:18px;text-align:left}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-caption .at-h4{font-size:9pt;line-height:1pc;height:33px}.at4-recommended .at4-recommended-item:hover .at4-recommended-item-caption .at-h4{text-decoration:underline}.at4-recommended a:link,.at4-recommended a:visited{text-decoration:none;color:#464646}.at4-recommended .at4-recommended-item .at4-recommended-item-caption .at-h4 a:hover{text-decoration:underline;color:#000}.at4-recommended .at4-recommended-item .at4-recommended-item-caption small{display:block;white-space:nowrap;overflow:hidden;text-overflow:ellipsis;font-size:11px;color:#666}.at4-recommended.at-medium .at4-recommended-item .at4-recommended-item-caption small{font-size:9px}.at4-recommended .at4-recommended-vertical{padding:15px 0 0}.at4-recommended .at4-recommended-vertical .at4-recommended-item{display:block;width:auto;max-width:100%;height:60px;border:none;margin:0 0 15px;box-shadow:none;background:none}.at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img,.at4-recommended-vertical .at4-recommended-item .at4-recommended-item-img img{width:60px;height:60px;float:left}.at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption{border-top:none;margin:0;height:60px;padding:3px 5px}.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption .at-h4{height:38px;margin:0}.at4-recommended .at4-recommended-vertical .at4-recommended-item .at4-recommended-item-caption small{position:absolute;bottom:0}.at4-recommended .at-recommended-label.at-vertical{text-align:left}.at4-no-image-light-recommended,.at4-no-image-minimal-recommended{background-color:#f2f2f2!important}.at4-no-image-gray-recommended{background-color:#e6e6e5!important}.at4-no-image-dark-recommended{background-color:#4e555e!important}.at4-recommended .at4-recommended-item-placeholder-img{background-repeat:no-repeat!important;background-position:center!important;width:100%!important;height:100%!important}.at4-recommended-horizontal .at4-no-image-dark-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}.at4-recommended-vertical .at4-no-image-dark-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}.at4-recommended-horizontal .at4-no-image-gray-recommended .at4-recommended-item-placeholder-img,.at4-recommended-horizontal .at4-no-image-light-recommended .at4-recommended-item-placeholder-img,.at4-recommended-horizontal .at4-no-image-minimal-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}.at4-recommended-vertical .at4-no-image-gray-recommended .at4-recommended-item-placeholder-img,.at4-recommended-vertical .at4-no-image-light-recommended .at4-recommended-item-placeholder-img,.at4-recommended-vertical .at4-no-image-minimal-recommended .at4-recommended-item-placeholder-img{background-image:url(data:image/png;base64,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)!important}#at-drawer.ats-dark,.at4-recommended.ats-dark .at4-recommended-horizontal .at4-recommended-item-caption,.at4-recommended.ats-dark .at4-recommended-vertical .at4-recommended-item-caption{background:#262b30}#at-drawer.ats-gray,.at4-recommended.ats-gray .at4-recommended-horizontal .at4-recommended-item-caption{background:#f2f2f2}#at-drawer.ats-light,.at4-recommended.ats-light .at4-recommended-horizontal .at4-recommended-item-caption{background:#fff}.at4-recommended.ats-dark .at4-recommended-vertical .at4-recommended-item{background:none}.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption a:hover,.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption a:link,.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption a:visited,.at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption small,.at4-recommended.ats-dark .at4-recommended-item-caption,.at4-recommended.ats-dark .at-logo a:hover,.at4-recommended.ats-dark .at-recommended-label.at-vertical{color:#fff}.at4-recommended-vertical-logo{padding-top:0;text-align:left}.at4-recommended-vertical-logo .at4-logo-container{line-height:10px}.at4-recommended-horizontal-logo{text-align:center}.at4-recommended.at-inline .at4-recommended-horizontal-logo{text-align:left}#at4-thankyou .at4-recommended.at-inline .at4-recommended-horizontal{text-align:center}.at4-recommended .at-logo{margin:10px 0 0;padding:0;height:25px;overflow:auto;-ms-box-sizing:content-box;-o-box-sizing:content-box;box-sizing:content-box}.at4-recommended.at-inline .at4-recommended-horizontal .at-logo{text-align:left}.at4-recommended .at4-logo-container a.at-sponsored-link{color:#666}.at4-recommended-class .at4-logo-container a:hover,.at4-recommendedbox-outer-container .at4-recommended-recommendedbox .at4-logo-container a:hover{color:#000}</style><style type="text/css">.at-recommendedjumbo-outer-container{margin:0;padding:0;border:0;background:none;color:#000}.at-recommendedjumbo-footer{position:relative;width:100%;height:510px;overflow:hidden;transition:all .3s ease-in-out}.at-mobile .at-recommendedjumbo-footer{height:250px}.at-recommendedjumbo-footer #bg-link:after{content:'';position:absolute;top:0;left:0;right:0;bottom:0;background:rgba(0,0,0,.75)}.at-recommendedjumbo-footer:hover #bg-link:after{background:rgba(0,0,0,.85)}.at-recommendedjumbo-footer *,.at-recommendedjumbo-footer :after,.at-recommendedjumbo-footer :before{box-sizing:border-box}.at-recommendedjumbo-footer:hover #at-recommendedjumbo-footer-bg{animation:atRecommendedJumboAnimatedBackground 1s ease-in-out 1;animation-fill-mode:forwards}.at-recommendedjumbo-footer #at-recommendedjumbo-top-holder{position:absolute;top:0;padding:0 40px;width:100%}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-top-holder{padding:0 20px}.at-recommendedjumbo-footer .at-recommendedjumbo-footer-inner{position:relative;text-align:center;font-family:helvetica,arial,sans-serif;z-index:2;width:100%}.at-recommendedjumbo-footer #at-recommendedjumbo-label-holder{margin:40px 0 0;max-height:30px}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-label-holder{margin:20px 0 0;max-height:20px}.at-recommendedjumbo-footer #at-recommendedjumbo-label{font-weight:300;font-size:24px;line-height:24px;color:#fff;margin:0}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-label{font-weight:150;font-size:14px;line-height:14px}.at-recommendedjumbo-footer #at-recommendedjumbo-title-holder{margin:20px 0 0;min-height:3pc;max-height:78pt}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-title-holder{margin:10px 0 0;min-height:24px;max-height:54px}.at-recommendedjumbo-footer #at-recommendedjumbo-content-title{font-size:3pc;line-height:52px;font-weight:700;margin:0}.at-mobile .at-recommendedjumbo-footer #at-recommendedjumbo-content-title{font-size:24px;line-height:27px}.at-recommendedjumbo-footer a{text-decoration:none;color:#fff}.at-recommendedjumbo-footer a:visited{color:#fff}.at-recommendedjumbo-footer small{margin:20px 0 0;display:inline-block;height:2pc;line-height:2pc;font-size:14px;color:#ccc;cursor:default}.at-mobile .at-recommendedjumbo-footer small{margin:10px 0 0;height:14px;line-height:14px;font-size:9pt}.at-recommendedjumbo-footer .at-logo-container{position:absolute;bottom:20px;margin:auto;left:0;right:0}.at-mobile .at-recommendedjumbo-footer .at-logo-container{bottom:10px}.at-recommendedjumbo-footer a.at-sponsored-link{color:#ccc}.at-recommendedjumbo-footer div #at-recommendedjumbo-logo-link{padding:2px 0 0 11px;text-decoration:none;line-height:20px;font-family:helvetica,arial,sans-serif;font-size:9px;color:#ccc}@keyframes atRecommendedJumboAnimatedBackground{0%{transform:scale(1,1)}to{transform:scale(1.1,1.1)}}</style><style type="text/css">.at-resp-share-element{position:relative;padding:0;margin:0;font-size:0;line-height:0}.at-resp-share-element:after,.at-resp-share-element:before{content:" ";display:table}.at-resp-share-element.at-mobile .at4-share-count-container,.at-resp-share-element.at-mobile .at-label{display:none}.at-resp-share-element .at-share-btn{display:inline-block;*display:inline;*zoom:1;margin:0 2px 5px;padding:0;overflow:hidden;line-height:0;text-decoration:none;text-transform:none;color:#fff;cursor:pointer;transition:all .2s ease-in-out;border:0;font-family:helvetica neue,helvetica,arial,sans-serif;background-color:transparent}.at-resp-share-element .at-share-btn::-moz-focus-inner{border:0;padding:0}.at-resp-share-element .at-share-btn:focus,.at-resp-share-element .at-share-btn:hover{transform:translateY(-4px);color:#fff;text-decoration:none}.at-resp-share-element .at-share-btn .at-icon-wrapper{float:left}.at-resp-share-element .at-share-btn.at-share-btn.at-svc-compact:hover{transform:none}.at-resp-share-element .at-share-btn .at-label{font-family:helvetica neue,helvetica,arial,sans-serif;font-size:9pt;padding:0 15px 0 0;margin:0 0 0 5px;height:2pc;line-height:2pc;background:none}.at-resp-share-element .at-icon,.at-resp-share-element .at-label{cursor:pointer}.at-resp-share-element .at4-share-count-container{text-decoration:none;float:right;padding-right:15px;font-size:9pt}.at-mobile .at-resp-share-element .at-label{display:none}.at-resp-share-element.at-mobile .at-share-btn{margin-right:5px}.at-mobile .at-resp-share-element .at-share-btn{padding:5px;margin-right:5px}</style><style type="text/css">.at-share-tbx-element{position:relative;margin:0;color:#fff;font-size:0}.at-share-tbx-element,.at-share-tbx-element .at-share-btn{font-family:helvetica neue,helvetica,arial,sans-serif;padding:0;line-height:0}.at-share-tbx-element .at-share-btn{cursor:pointer;margin:0 5px 5px 0;display:inline-block;overflow:hidden;border:0;text-decoration:none;text-transform:none;background-color:transparent;color:inherit;transition:all .2s ease-in-out}.at-share-tbx-element .at-share-btn:focus,.at-share-tbx-element .at-share-btn:hover{transform:translateY(-4px);outline-offset:-1px;color:inherit}.at-share-tbx-element .at-share-btn::-moz-focus-inner{border:0;padding:0}.at-share-tbx-element .at-share-btn.at-share-btn.at-svc-compact:hover{transform:none}.at-share-tbx-element .at-icon-wrapper{vertical-align:middle}.at-share-tbx-element .at4-share-count,.at-share-tbx-element .at-label{margin:0 7.5px 0 2.5px;text-decoration:none;vertical-align:middle;display:inline-block;background:none;height:0;font-size:inherit;line-height:inherit;color:inherit}.at-share-tbx-element.at-mobile .at4-share-count,.at-share-tbx-element.at-mobile .at-label{display:none}.at-share-tbx-element .at_native_button{vertical-align:middle}.at-share-tbx-element .addthis_counter.addthis_bubble_style{margin:0 2px;vertical-align:middle;display:inline-block}.at-share-tbx-element .fb_iframe_widget{display:block}.at-share-tbx-element.at-share-tbx-native .at300b{vertical-align:middle}.at-style-responsive .at-share-btn{padding:5px}.at-style-jumbo{display:table}.at-style-jumbo .at4-spacer{height:1px;display:block;visibility:hidden;opacity:0}.at-style-jumbo .at4-count-container{display:table-cell;text-align:center;min-width:200px;vertical-align:middle;border-right:1px solid #ccc;padding-right:20px}.at-style-jumbo .at4-count{font-size:60px;line-height:60px;font-weight:700}.at-style-jumbo .at4-count-title{position:relative;font-size:18px;line-height:18px;bottom:2px}.at-style-jumbo .at-share-btn-elements{display:table-cell;vertical-align:middle;padding-left:20px}.at_flat_counter{cursor:pointer;font-family:helvetica,arial,sans-serif;font-weight:700;text-transform:uppercase;display:inline-block;position:relative;vertical-align:top;height:auto;margin:0 5px;padding:0 6px;left:-1px;background:#ebebeb;color:#32363b;transition:all .2s ease}.at_flat_counter:after{top:30%;left:-4px;content:"";position:absolute;border-width:5px 8px 5px 0;border-style:solid;border-color:transparent #ebebeb transparent transparent;display:block;width:0;height:0;transform:translateY(360deg)}.at_flat_counter:hover{background:#e1e2e2}</style><style type="text/css">.at4-thankyou-background{top:0;right:0;left:0;bottom:0;-webkit-overflow-scrolling:touch;z-index:9999999;background-image:url(data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpizCuu/sRABGBiIBKMKqSOQoAAAwC8KgJipENhxwAAAABJRU5ErkJggg==);background:hsla(217,6%,46%,.95)}.at4-thankyou-background.at-thankyou-shown{position:fixed}.at4-thankyou-inner{position:absolute;width:100%;top:10%;left:50%;margin-left:-50%;text-align:center}.at4-thankyou-mobile .at4-thankyou-inner{top:5%}.thankyou-description{font-weight:400}.at4-thankyou-background .at4lb-inner{position:relative;width:100%;height:100%}.at4-thankyou-background .at4lb-inner .at4x{position:absolute;top:15px;right:15px;display:block;width:20px;height:20px;padding:20px;margin:0;cursor:pointer;transition:opacity .25s ease-in;opacity:.4;background:url("data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAUCAYAAACNiR0NAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAABx0RVh0U29mdHdhcmUAQWRvYmUgRmlyZXdvcmtzIENTNui8sowAAAAWdEVYdENyZWF0aW9uIFRpbWUAMTEvMTMvMTKswDp5AAAAd0lEQVQ4jb2VQRLAIAgDE///Z3qqY1FAhalHMCsCIkVEAIAkkVgvp2lDBgYAnAyHkWotLccNrEd4A7X2TqIdqLfnWBAdaF5rJdyJfjtPH5GT37CaGhoVq3nOm/XflUuLUto2pY1d+vRKh0Pp+MrAVtDe2JkvYNQ+jVSEEFmOkggAAAAASUVORK5CYII=") no-repeat center center;overflow:hidden;text-indent:-99999em;border:1px solid transparent}.at4-thankyou-background .at4lb-inner .at4x:focus,.at4-thankyou-background .at4lb-inner .at4x:hover{border:1px solid #fff;border-radius:50%;outline:0}.at4-thankyou-background .at4lb-inner #at4-palogo{position:absolute;bottom:10px;display:inline-block;text-decoration:none;font-family:helvetica,arial,sans-serif;font-size:11px;cursor:pointer;-webkit-transition:opacity .25s ease-in;moz-transition:opacity .25s ease-in;transition:opacity .25s ease-in;opacity:.5;z-index:100020;color:#fff;padding:2px 0 0 13px}.at4-thankyou-background .at4lb-inner #at4-palogo .at-branding-addthis,.at4-thankyou-background .at4lb-inner #at4-palogo .at-branding-info{color:#fff}.at4-thankyou-background .at4lb-inner #at4-palogo:hover,.at4-thankyou-background.ats-dark .at4lb-inner a#at4-palogo:hover{text-decoration:none;color:#fff;opacity:1}.at4-thankyou-background.ats-dark{background-image:url("data:image/png;base64,iVBORw0KGgoAAAANSUhEUgAAAAoAAAAKCAYAAACNMs+9AAAAGXRFWHRTb2Z0d2FyZQBBZG9iZSBJbWFnZVJlYWR5ccllPAAAABtJREFUeNpiZGBgeMZABGBiIBKMKqSOQoAAAwB+cQD6hqlbCwAAAABJRU5ErkJggg==");background:rgba(0,0,0,.85)}.at4-thankyou-background .thankyou-title{color:#fff;font-size:38.5px;margin:10px 20px;line-height:38.5px;font-family:helvetica neue,helvetica,arial,sans-serif;font-weight:300}.at4-thankyou-background.ats-dark .thankyou-description,.at4-thankyou-background.ats-dark .thankyou-title{color:#fff}.at4-thankyou-background .thankyou-description{color:#fff;font-size:18px;margin:10px 0;line-height:24px;padding:0;font-family:helvetica neue,helvetica,arial,sans-serif;font-weight:300}.at4-thankyou-background .at4-thanks-icons{padding-top:10px}.at4-thankyou-mobile *{-webkit-overflow-scrolling:touch}#at4-thankyou .at4-recommended-recommendedbox .at-logo{display:none}.at4-thankyou .at-h3{height:49px;line-height:49px;margin:0 50px 0 20px;padding:1px 0 0;font-family:helvetica neue,helvetica,arial,sans-serif;font-size:1pc;font-weight:700;color:#fff;text-shadow:0 1px #000}.at4-thanks{padding-top:50px;text-align:center}.at4-thanks label{display:block;margin:0 0 15px;font-size:1pc;line-height:1pc}.at4-thanks .at4-h2{background:none;border:none;margin:0 0 10px;padding:0;font-family:helvetica neue,helvetica,arial,sans-serif;font-size:28px;font-weight:300;color:#000}.at4-thanks .at4-thanks-icons{position:relative;height:2pc}.at4-thanks .at4-thanks-icons .at-thankyou-label{display:block;padding-bottom:10px;font-size:14px;color:#666}.at4-thankyou-layer .at-follow .at-icon-wrapper{width:2pc;height:2pc}</style><style type="text/css">.at4-recommended-toaster{position:fixed;top:auto;bottom:0;right:0;z-index:100021}.at4-recommended-toaster.ats-light{border:1px solid #c5c5c5;background:#fff}.at4-recommended-toaster.ats-gray{border:1px solid #c5c5c5;background:#f2f2f2}.at4-recommended-toaster.ats-dark{background:#262b30;color:#fff}.at4-recommended-toaster .at4-recommended-container{padding-top:0;margin:0}.at4-recommended.at4-recommended-toaster div.at-recommended-label{line-height:1pc;font-size:1pc;text-align:left;padding:20px 0 0 20px}.at4-toaster-outer .at4-recommended .at4-recommended-item .at4-recommended-item-caption .at-h4{font-size:11px;line-height:11px;margin:10px 0 6px;height:30px}.at4-recommended.at4-recommended-toaster div.at-recommended-label.ats-gray,.at4-recommended.at4-recommended-toaster div.at-recommended-label.ats-light{color:#464646}.at4-recommended.at4-recommended-toaster div.at-recommended-label.ats-dark{color:#fff}.at4-toaster-close-control{position:absolute;top:0;right:0;display:block;width:20px;height:20px;line-height:20px;margin:5px 5px 0 0;padding:0;text-indent:-9999em}.at4-toaster-open-control{position:fixed;right:0;bottom:0;z-index:100020}.at4-toaster-outer .at4-recommended-item{width:90pt;border:0;margin:9px 10px 0}.at4-toaster-outer .at4-recommended-item:first-child{margin-left:20px}.at4-toaster-outer .at4-recommended-item:last-child{margin-right:20px}.at4-toaster-outer .at4-recommended-item .at4-recommended-item-img{max-height:90pt;max-width:90pt}.at4-toaster-outer .at4-recommended-item .at4-recommended-item-img img{height:90pt;width:90pt}.at4-toaster-outer .at4-recommended-item .at4-recommended-item-caption{height:30px;padding:0;margin:0;height:initial}.at4-toaster-outer .ats-dark .at4-recommended-item .at4-recommended-item-caption{background:#262b30}.at4-toaster-outer .at4-recommended .at4-recommended-item .at4-recommended-item-caption small{width:auto;line-height:14px;margin:0}.at4-toaster-outer .at4-recommended.ats-dark .at4-recommended-item .at4-recommended-item-caption small{color:#fff}.at4-recommended-toaster .at-logo{margin:0 0 3px 20px;text-align:left}.at4-recommended-toaster .at-logo .at4-logo-container.at-sponsored-logo{position:relative}.at4-toaster-outer .at4-recommended-item .sponsored-label{text-align:right;font-size:10px;color:#666;float:right;position:fixed;bottom:6px;right:20px;top:initial;z-index:99999}</style><style type="text/css">.at4-whatsnext{position:fixed;bottom:0!important;right:0;background:#fff;border:1px solid #c5c5c5;margin:-1px;width:390px;height:90pt;overflow:hidden;font-size:9pt;font-weight:400;color:#000;z-index:1800000000}.at4-whatsnext a{color:#666}.at4-whatsnext .at-whatsnext-content{height:90pt;position:relative}.at4-whatsnext .at-whatsnext-content .at-branding{position:absolute;bottom:15px;right:10px;padding-left:9px;text-decoration:none;line-height:10px;font-family:helvetica,arial,sans-serif;font-size:10px;color:#666}.at4-whatsnext .at-whatsnext-content .at-whatsnext-content-inner{position:absolute;top:15px;right:20px;bottom:15px;left:140px;text-align:left;height:105px}.at4-whatsnext .at-whatsnext-content-inner a{display:inline-block}.at4-whatsnext .at-whatsnext-content-inner div.at-h6{text-align:left;margin:0;padding:0 0 3px;font-size:11px;color:#666;cursor:default}.at4-whatsnext .at-whatsnext-content .at-h3{text-align:left;margin:5px 0;padding:0;line-height:1.2em;font-weight:400;font-size:14px;height:3pc}.at4-whatsnext .at-whatsnext-content-inner a:link,.at4-whatsnext .at-whatsnext-content-inner a:visited{text-decoration:none;font-weight:400;color:#464646}.at4-whatsnext .at-whatsnext-content-inner a:hover{color:#000}.at4-whatsnext .at-whatsnext-content-inner small{position:absolute;bottom:15px;line-height:10px;font-size:11px;color:#666;cursor:default;text-align:left}.at4-whatsnext .at-whatsnext-content .at-whatsnext-content-img{position:absolute;top:0;left:0;width:90pt;height:90pt;overflow:hidden}.at4-whatsnext .at-whatsnext-content .at-whatsnext-content-img img{position:absolute;top:0;left:0;max-height:none;max-width:none}.at4-whatsnext .at-whatsnext-close-control{position:absolute;top:0;right:0;display:block;width:20px;height:20px;line-height:20px;margin:0 5px 0 0;padding:0;text-indent:-9999em}.at-whatsnext-open-control{position:fixed;right:0;bottom:0;z-index:100020}.at4-whatsnext.ats-dark{background:#262b30}.at4-whatsnext.ats-dark .at-whatsnext-content .at-h3,.at4-whatsnext.ats-dark .at-whatsnext-content a.at4-logo:hover,.at4-whatsnext.ats-dark .at-whatsnext-content-inner a:link,.at4-whatsnext.ats-dark .at-whatsnext-content-inner a:visited{color:#fff}.at4-whatsnext.ats-light{background:#fff}.at4-whatsnext.ats-gray{background:#f2f2f2}.at4-whatsnext.at-whatsnext-nophoto{width:270px}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content-img{display:none}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner{top:15px;right:0;left:20px}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner.addthis_32x32_style{top:0;right:0;left:0;padding:45px 20px 0;font-size:20px}.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner .at4-icon,.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner .at4-icon-fw,.at4-whatsnext.at-whatsnext-nophoto .at-whatsnext-content .at-whatsnext-content-inner .whatsnext-msg{vertical-align:middle}.at-whatsnext-img,.at-whatsnext-img-lnk{position:absolute;left:0}</style><style type="text/css">.at4-whatsnextmobile{position:fixed;bottom:0;right:0;left:0;background:#fff;z-index:9999998;height:170px;font-size:28px}.at4-whatsnextmobile .col-2{height:100%;font-size:1em}.at4-whatsnextmobile .col-2:first-child{max-width:200px;display:inline-block;float:left}.at4-whatsnextmobile .col-2:last-child{position:absolute;left:200px;right:50px;top:0;bottom:0;display:inline-block}.at4-whatsnextmobile .at-whatsnext-content-inner{font-size:1em}.at4-whatsnextmobile .at-whatsnext-content-img img{height:100%;width:100%}.at4-whatsnextmobile .at-close-control{font-size:1em;position:absolute;top:0;right:0;width:50px;height:50px}.at4-whatsnextmobile .at-close-control button{width:100%;height:100%;font-size:1em;font-weight:400;text-decoration:none;opacity:.5;padding:0;cursor:pointer;background:0 0;border:0;-webkit-appearance:none}.at4-whatsnextmobile .at-h3,.at4-whatsnextmobile .at-h6{font-size:1em;margin:0;color:#a1a1a1;margin-left:2.5%;margin-top:25px}.at4-whatsnextmobile .at-h3{font-size:1em;line-height:1em;font-weight:500;height:50%}.at4-whatsnextmobile .at-h3 a{font-size:1em;text-decoration:none}.at4-whatsnextmobile .at-h6{font-size:.8em;line-height:.8em;font-weight:500}.at4-whatsnextmobile .footer{position:absolute;bottom:2px;left:200px;right:0;padding-left:2.5%;font-size:1em;line-height:.6em}.at4-whatsnextmobile .footer small{font-size:.6em;color:#a1a1a1}.at4-whatsnextmobile .footer small:first-child{margin-right:5%;float:left}.at4-whatsnextmobile .footer small:last-child{margin-right:2.5%;float:right}.at4-whatsnextmobile .at-whatsnext-content{height:100%}.at4-whatsnextmobile.ats-dark{background:#262b30;color:#fff}.at4-whatsnextmobile .at-close-control button{color:#bfbfbf}.at4-whatsnextmobile.ats-dark a:link,.at4-whatsnextmobile.ats-dark a:visited{color:#fff}.at4-whatsnextmobile.ats-gray{background:#f2f2f2;color:#262b30}.at4-whatsnextmobile.ats-light{background:#fff;color:#262b30}.at4-whatsnextmobile.ats-dark .footer a:link,.at4-whatsnextmobile.ats-dark .footer a:visited,.at4-whatsnextmobile.ats-gray .footer a:link,.at4-whatsnextmobile.ats-gray .footer a:visited,.at4-whatsnextmobile.ats-light .footer a:link,.at4-whatsnextmobile.ats-light .footer a:visited{color:#a1a1a1}.at4-whatsnextmobile.ats-gray a:link,.at4-whatsnextmobile.ats-gray a:visited,.at4-whatsnextmobile.ats-light a:link,.at4-whatsnextmobile.ats-light a:visited{color:#262b30}@media only screen and (min-device-width:320px) and (max-device-width:480px){.at4-whatsnextmobile{height:85px;font-size:14px}.at4-whatsnextmobile .col-2:first-child{width:75pt}.at4-whatsnextmobile .col-2:last-child{right:25px;left:75pt}.at4-whatsnextmobile .footer{left:75pt}.at4-whatsnextmobile .at-close-control{width:25px;height:25px}.at4-whatsnextmobile .at-h3,.at4-whatsnextmobile .at-h6{margin-top:12.5px}}</style><style type="text/css">.at-custom-mobile-bar{left:0;right:0;width:100%;height:56px;position:fixed;text-align:center;z-index:100020;background:#fff;overflow:hidden;box-shadow:0 0 10px 0 rgba(0,0,0,.2);font:initial;line-height:normal;top:auto;bottom:0}.at-custom-mobile-bar.at-custom-mobile-bar-zindex-hide{z-index:-1!important}.at-custom-mobile-bar.atss-top{top:0;bottom:auto}.at-custom-mobile-bar.atss-bottom{top:auto;bottom:0}.at-custom-mobile-bar .at-custom-mobile-bar-btns{display:inline-block;text-align:center}.at-custom-mobile-bar .at-custom-mobile-bar-counter,.at-custom-mobile-bar .at-share-btn{margin-top:4px}.at-custom-mobile-bar .at-share-btn{display:inline-block;text-decoration:none;transition:none;box-sizing:content-box}.at-custom-mobile-bar .at-custom-mobile-bar-counter{font-family:Helvetica neue,arial;vertical-align:top;margin-left:4px;margin-right:4px;display:inline-block}.at-custom-mobile-bar .at-custom-mobile-bar-count{font-size:26px;line-height:1.25em;color:#222}.at-custom-mobile-bar .at-custom-mobile-bar-text{font-size:9pt;line-height:1.25em;color:#888;letter-spacing:1px}.at-custom-mobile-bar .at-icon-wrapper{text-align:center;height:3pc;width:3pc;margin:0 4px}.at-custom-mobile-bar .at-icon{vertical-align:top;margin:8px;width:2pc;height:2pc}.at-custom-mobile-bar.at-shfs-medium{height:3pc}.at-custom-mobile-bar.at-shfs-medium .at-custom-mobile-bar-counter{margin-top:6px}.at-custom-mobile-bar.at-shfs-medium .at-custom-mobile-bar-count{font-size:18px}.at-custom-mobile-bar.at-shfs-medium .at-custom-mobile-bar-text{font-size:10px}.at-custom-mobile-bar.at-shfs-medium .at-icon-wrapper{height:40px;width:40px}.at-custom-mobile-bar.at-shfs-medium .at-icon{margin:6px;width:28px;height:28px}.at-custom-mobile-bar.at-shfs-small{height:40px}.at-custom-mobile-bar.at-shfs-small .at-custom-mobile-bar-counter{margin-top:3px}.at-custom-mobile-bar.at-shfs-small .at-custom-mobile-bar-count{font-size:1pc}.at-custom-mobile-bar.at-shfs-small .at-custom-mobile-bar-text{font-size:10px}.at-custom-mobile-bar.at-shfs-small .at-icon-wrapper{height:2pc;width:2pc}.at-custom-mobile-bar.at-shfs-small .at-icon{margin:4px;width:24px;height:24px}</style><style type="text/css">.at-custom-sidebar{top:20%;width:58px;position:fixed;text-align:center;z-index:100020;background:#fff;overflow:hidden;box-shadow:0 0 10px 0 rgba(0,0,0,.2);font:initial;line-height:normal;top:auto;bottom:0}.at-custom-sidebar.at-custom-sidebar-zindex-hide{z-index:-1!important}.at-custom-sidebar.atss-left{left:0;right:auto;float:left;border-radius:0 4px 4px 0}.at-custom-sidebar.atss-right{left:auto;right:0;float:right;border-radius:4px 0 0 4px}.at-custom-sidebar .at-custom-sidebar-btns{display:inline-block;text-align:center;padding-top:4px}.at-custom-sidebar .at-custom-sidebar-counter{margin-bottom:8px}.at-custom-sidebar .at-share-btn{display:inline-block;text-decoration:none;transition:none;box-sizing:content-box}.at-custom-sidebar .at-custom-sidebar-counter{font-family:Helvetica neue,arial;vertical-align:top;margin-left:4px;margin-right:4px;display:inline-block}.at-custom-sidebar .at-custom-sidebar-count{font-size:21px;line-height:1.25em;color:#222}.at-custom-sidebar .at-custom-sidebar-text{font-size:10px;line-height:1.25em;color:#888;letter-spacing:1px}.at-custom-sidebar .at-icon-wrapper{text-align:center;margin:0 4px}.at-custom-sidebar .at-icon{vertical-align:top;margin:9px;width:2pc;height:2pc}.at-custom-sidebar .at-icon-wrapper{position:relative}.at-custom-sidebar .at4-share-count,.at-custom-sidebar .at4-share-count-container{line-height:1pc;font-size:10px}.at-custom-sidebar .at4-share-count{text-indent:0;font-family:Arial,Helvetica Neue,Helvetica,sans-serif;font-weight:200;width:100%;height:1pc}.at-custom-sidebar .at4-share-count-anchor .at-icon{margin-top:3px}.at-custom-sidebar .at4-share-count-container{position:absolute;left:0;right:auto;top:auto;bottom:0;width:100%;color:#fff;background:inherit}</style><style type="text/css">.at-image-sharing-mobile-icon{position:absolute;background:#000 url(https://s7.addthis.com/static/44a36d35bafef33aa9455b7d3039a771.png) no-repeat top center;background-color:rgba(0,0,0,.9);background-image:url(https://s7.addthis.com/static/10db525181ee0bbe1a515001be1c7818.svg),none;border-radius:3px;width:50px;height:40px;top:-9999px;left:-9999px}.at-image-sharing-tool{display:block;position:absolute;text-align:center;z-index:9001;background:none;overflow:hidden;top:-9999px;left:-9999px;font:initial;line-height:0}.at-image-sharing-tool.addthis-animated{animation-duration:.15s}.at-image-sharing-tool.at-orientation-vertical .at-share-btn{display:block}.at-image-sharing-tool.at-orientation-horizontal .at-share-btn{display:inline-block}.at-image-sharing-tool.at-image-sharing-tool-size-big .at-icon{width:43px;height:43px}.at-image-sharing-tool.at-image-sharing-tool-size-mobile .at-share-btn{margin:0!important}.at-image-sharing-tool.at-image-sharing-tool-size-mobile .at-icon-wrapper{height:60px;width:100%;border-radius:0!important}.at-image-sharing-tool.at-image-sharing-tool-size-mobile .at-icon{max-width:100%;height:54px!important;width:54px!important}.at-image-sharing-tool .at-custom-shape.at-image-sharing-tool-btns{margin-right:8px;margin-bottom:8px}.at-image-sharing-tool .at-custom-shape .at-share-btn{margin-top:8px;margin-left:8px}.at-image-sharing-tool .at-share-btn{line-height:0;text-decoration:none;transition:none;box-sizing:content-box}.at-image-sharing-tool .at-icon-wrapper{text-align:center;height:100%;width:100%}.at-image-sharing-tool .at-icon{vertical-align:top;width:2pc;height:2pc;margin:3px}</style><style type="text/css">.at-expanding-share-button{box-sizing:border-box;position:fixed;z-index:9999}.at-expanding-share-button[data-position=bottom-right]{bottom:10px;right:10px}.at-expanding-share-button[data-position=bottom-right] .at-expanding-share-button-toggle-bg,.at-expanding-share-button[data-position=bottom-right] .at-expanding-share-button-toggle-btn[data-name]:after,.at-expanding-share-button[data-position=bottom-right] .at-icon-wrapper,.at-expanding-share-button[data-position=bottom-right] [data-name]:after{float:right}.at-expanding-share-button[data-position=bottom-right] [data-name]:after{margin-right:10px}.at-expanding-share-button[data-position=bottom-right] .at-expanding-share-button-toggle-btn[data-name]:after{margin-right:5px}.at-expanding-share-button[data-position=bottom-right] .at-icon-wrapper{margin-right:-3px}.at-expanding-share-button[data-position=bottom-left]{bottom:10px;left:10px}.at-expanding-share-button[data-position=bottom-left] .at-expanding-share-button-toggle-bg,.at-expanding-share-button[data-position=bottom-left] .at-expanding-share-button-toggle-btn[data-name]:after,.at-expanding-share-button[data-position=bottom-left] .at-icon-wrapper,.at-expanding-share-button[data-position=bottom-left] [data-name]:after{float:left}.at-expanding-share-button[data-position=bottom-left] [data-name]:after{margin-left:10px}.at-expanding-share-button[data-position=bottom-left] .at-expanding-share-button-toggle-btn[data-name]:after{margin-left:5px}.at-expanding-share-button *,.at-expanding-share-button :after,.at-expanding-share-button :before{box-sizing:border-box}.at-expanding-share-button .at-expanding-share-button-services-list{display:none;list-style:none;margin:0 5px;overflow:visible;padding:0}.at-expanding-share-button .at-expanding-share-button-services-list&gt;li{display:block;height:45px;position:relative;overflow:visible}.at-expanding-share-button .at-expanding-share-button-toggle-btn,.at-expanding-share-button .at-share-btn{transition:.1s;text-decoration:none}.at-expanding-share-button .at-share-btn{display:block;height:40px;padding:0 3px 0 0}.at-expanding-share-button .at-expanding-share-button-toggle-btn{position:relative;overflow:auto}.at-expanding-share-button .at-expanding-share-button-toggle-btn.at-expanding-share-button-hidden[data-name]:after{display:none}.at-expanding-share-button .at-expanding-share-button-toggle-bg{box-shadow:0 2px 4px 0 rgba(0,0,0,.3);border-radius:50%;position:relative}.at-expanding-share-button .at-expanding-share-button-toggle-bg&gt;span{background-image:url("data:image/svg+xml,%3Csvg%20width%3D%2232px%22%20height%3D%2232px%22%20viewBox%3D%220%200%2032%2032%22%20version%3D%221.1%22%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%3E%3Ctitle%3Eshare%3C%2Ftitle%3E%3Cg%20stroke%3D%22none%22%20stroke-width%3D%221%22%20fill%3D%22none%22%20fill-rule%3D%22evenodd%22%3E%3Cg%20fill%3D%22%23FFFFFF%22%3E%3Cpath%20d%3D%22M26%2C13.4285714%20C26%2C13.6220248%2025.9293162%2C13.7894338%2025.7879464%2C13.9308036%20L20.0736607%2C19.6450893%20C19.932291%2C19.786459%2019.7648819%2C19.8571429%2019.5714286%2C19.8571429%20C19.3779752%2C19.8571429%2019.2105662%2C19.786459%2019.0691964%2C19.6450893%20C18.9278267%2C19.5037195%2018.8571429%2C19.3363105%2018.8571429%2C19.1428571%20L18.8571429%2C16.2857143%20L16.3571429%2C16.2857143%20C15.6279725%2C16.2857143%2014.9750773%2C16.3080355%2014.3984375%2C16.3526786%20C13.8217977%2C16.3973217%2013.2488868%2C16.477306%2012.6796875%2C16.5926339%20C12.1104882%2C16.7079619%2011.6157015%2C16.8660704%2011.1953125%2C17.0669643%20C10.7749235%2C17.2678581%2010.3824423%2C17.5264121%2010.0178571%2C17.8426339%20C9.65327199%2C18.1588557%209.35565592%2C18.534596%209.125%2C18.9698661%20C8.89434408%2C19.4051361%208.71391434%2C19.9203839%208.58370536%2C20.515625%20C8.45349637%2C21.1108661%208.38839286%2C21.7842224%208.38839286%2C22.5357143%20C8.38839286%2C22.9449425%208.40699386%2C23.4025272%208.44419643%2C23.9084821%20C8.44419643%2C23.9531252%208.45349693%2C24.0405499%208.47209821%2C24.1707589%20C8.4906995%2C24.3009679%208.5%2C24.3995532%208.5%2C24.4665179%20C8.5%2C24.5781256%208.46837829%2C24.6711306%208.40513393%2C24.7455357%20C8.34188956%2C24.8199408%208.25446484%2C24.8571429%208.14285714%2C24.8571429%20C8.02380893%2C24.8571429%207.9196433%2C24.7938994%207.83035714%2C24.6674107%20C7.77827355%2C24.6004461%207.72991094%2C24.5186017%207.68526786%2C24.421875%20C7.64062478%2C24.3251483%207.59040206%2C24.2135423%207.53459821%2C24.0870536%20C7.47879436%2C23.9605648%207.43973225%2C23.87128%207.41741071%2C23.8191964%20C6.47246551%2C21.6986501%206%2C20.0208395%206%2C18.7857143%20C6%2C17.3050521%206.19717065%2C16.0662252%206.59151786%2C15.0691964%20C7.79688103%2C12.0706695%2011.0520568%2C10.5714286%2016.3571429%2C10.5714286%20L18.8571429%2C10.5714286%20L18.8571429%2C7.71428571%20C18.8571429%2C7.52083237%2018.9278267%2C7.35342333%2019.0691964%2C7.21205357%20C19.2105662%2C7.07068382%2019.3779752%2C7%2019.5714286%2C7%20C19.7648819%2C7%2019.932291%2C7.07068382%2020.0736607%2C7.21205357%20L25.7879464%2C12.9263393%20C25.9293162%2C13.067709%2026%2C13.2351181%2026%2C13.4285714%20L26%2C13.4285714%20Z%22%3E%3C%2Fpath%3E%3C%2Fg%3E%3C%2Fg%3E%3C%2Fsvg%3E");background-position:center center;background-repeat:no-repeat;transition:transform .4s ease;border-radius:50%;display:block}.at-expanding-share-button .at-icon-wrapper{box-shadow:0 2px 4px 0 rgba(0,0,0,.3);border-radius:50%;display:inline-block;height:40px;line-height:40px;text-align:center;width:40px}.at-expanding-share-button .at-icon{display:inline-block;height:34px;margin:3px 0;vertical-align:top;width:34px}.at-expanding-share-button [data-name]:after{box-shadow:0 2px 4px 0 rgba(0,0,0,.3);transform:translate(0, -50%);transition:.4s;background-color:#fff;border-radius:3px;color:#666;content:attr(data-name);font-family:Helvetica Neue,Helvetica,Arial,sans-serif;font-size:9pt;line-height:9pt;font-weight:500;opacity:0;padding:3px 5px;position:relative;top:20px;white-space:nowrap}.at-expanding-share-button.at-expanding-share-button-show-icons .at-expanding-share-button-services-list{display:block}.at-expanding-share-button.at-expanding-share-button-animate-in .at-expanding-share-button-toggle-bg&gt;span{transform:rotate(270deg);background-image:url("data:image/svg+xml,%3Csvg%20xmlns%3D%22http%3A%2F%2Fwww.w3.org%2F2000%2Fsvg%22%20xmlns%3Axlink%3D%22http%3A%2F%2Fwww.w3.org%2F1999%2Fxlink%22%20viewBox%3D%220%200%2032%2032%22%3E%3Cg%3E%3Cpath%20d%3D%22M18%2014V8h-4v6H8v4h6v6h4v-6h6v-4h-6z%22%20fill-rule%3D%22evenodd%22%20fill%3D%22white%22%3E%3C%2Fpath%3E%3C%2Fg%3E%3C%2Fsvg%3E");background-position:center center;background-repeat:no-repeat}.at-expanding-share-button.at-expanding-share-button-animate-in [data-name]:after{opacity:1}.at-expanding-share-button.at-hide-label [data-name]:after{display:none}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle{height:50px}.at-expanding-share-button.at-expanding-share-button-desktop .at-icon-wrapper:hover{box-shadow:0 2px 5px 0 rgba(0,0,0,.5)}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg{height:50px;line-height:50px;width:50px}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg&gt;span{height:50px;width:50px}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg:after{box-shadow:0 2px 5px 0 rgba(0,0,0,.2);transition:opacity .2s ease;border-radius:50%;content:'';height:100%;opacity:0;position:absolute;top:0;left:0;width:100%}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-bg:hover:after{opacity:1}.at-expanding-share-button.at-expanding-share-button-desktop .at-expanding-share-button-toggle-btn[data-name]:after{top:25px}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-services-list{margin:0}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle-btn,.at-expanding-share-button.at-expanding-share-button-mobile .at-share-btn{outline:0}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle{height:40px;-webkit-tap-highlight-color:transparent}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle-bg,.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-toggle-bg span{height:40px;line-height:40px;width:40px}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-click-flash{transform:scale(0);transition:transform ease,opacity ease-in;background-color:hsla(0,0%,100%,.3);border-radius:50%;height:40px;opacity:1;position:absolute;width:40px;z-index:10000}.at-expanding-share-button.at-expanding-share-button-mobile .at-expanding-share-button-click-flash.at-expanding-share-button-click-flash-animate{transform:scale(1);opacity:0}.at-expanding-share-button.at-expanding-share-button-mobile+.at-expanding-share-button-mobile-overlay{transition:opacity ease;bottom:0;background-color:hsla(0,0%,87%,.7);display:block;height:auto;left:0;opacity:0;position:fixed;right:0;top:0;width:auto;z-index:9998}.at-expanding-share-button.at-expanding-share-button-mobile+.at-expanding-share-button-mobile-overlay.at-expanding-share-button-hidden{height:0;width:0;z-index:-10000}.at-expanding-share-button.at-expanding-share-button-mobile.at-expanding-share-button-animate-in+.at-expanding-share-button-mobile-overlay{transition:opacity ease;opacity:1}</style><style type="text/css">.at-tjin-element .at300b,.at-tjin-element .at300m{display:inline-block;width:auto;padding:0;margin:0 2px 5px;outline-offset:-1px;transition:all .2s ease-in-out}.at-tjin-element .at300b:focus,.at-tjin-element .at300b:hover,.at-tjin-element .at300m:focus,.at-tjin-element .at300m:hover{transform:translateY(-4px)}.at-tjin-element .addthis_tjin_label{display:none}.at-tjin-element .addthis_vertical_style .at300b,.at-tjin-element .addthis_vertical_style .at300m{display:block}.at-tjin-element .addthis_vertical_style .at300b .addthis_tjin_label,.at-tjin-element .addthis_vertical_style .at300b .at-icon-wrapper,.at-tjin-element .addthis_vertical_style .at300m .addthis_tjin_label,.at-tjin-element .addthis_vertical_style .at300m .at-icon-wrapper{display:inline-block;vertical-align:middle;margin-right:5px}.at-tjin-element .addthis_vertical_style .at300b:focus,.at-tjin-element .addthis_vertical_style .at300b:hover,.at-tjin-element .addthis_vertical_style .at300m:focus,.at-tjin-element .addthis_vertical_style .at300m:hover{transform:none}.at-tjin-element .at-tjin-btn{margin:0 5px 5px 0;padding:0;outline-offset:-1px;display:inline-block;box-sizing:content-box;transition:all .2s ease-in-out}.at-tjin-element .at-tjin-btn:focus,.at-tjin-element .at-tjin-btn:hover{transform:translateY(-4px)}.at-tjin-element .at-tjin-title{margin:0 0 15px}</style><style type="text/css">#addthissmartlayerscssready{color:#bada55!important}.addthis-smartlayers,div#at4-follow,div#at4-share,div#at4-thankyou,div#at4-whatsnext{padding:0;margin:0}#at4-follow-label,#at4-share-label,#at4-whatsnext-label,.at4-recommended-label.hidden{padding:0;border:none;background:none;position:absolute;top:0;left:0;height:0;width:0;overflow:hidden;text-indent:-9999em}.addthis-smartlayers .at4-arrow:hover{cursor:pointer}.addthis-smartlayers .at4-arrow:after,.addthis-smartlayers .at4-arrow:before{content:none}a.at4-logo{background:url(data:image/gif;base64,R0lGODlhBwAHAJEAAP9uQf///wAAAAAAACH5BAkKAAIALAAAAAAHAAcAAAILFH6Ge8EBH2MKiQIAOw==) no-repeat left center}.at4-minimal a.at4-logo{background:url(data:image/gif;base64,R0lGODlhBwAHAJEAAP9uQf///wAAAAAAACH5BAkKAAIALAAAAAAHAAcAAAILFH6Ge8EBH2MKiQIAOw==) no-repeat left center!important}button.at4-closebutton{position:absolute;top:0;right:0;padding:0;margin-right:10px;cursor:pointer;background:transparent;border:0;-webkit-appearance:none;font-size:19px;line-height:1;color:#000;text-shadow:0 1px 0 #fff;opacity:.2}button.at4-closebutton:hover{color:#000;text-decoration:none;cursor:pointer;opacity:.5}div.at4-arrow{background-image:url(data:image/png;base64,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);background-repeat:no-repeat;width:20px;height:20px;margin:0;padding:0;overflow:hidden;text-indent:-9999em;text-align:left;cursor:pointer}#at4-recommendedpanel-outer-container .at4-arrow.at-right,div.at4-arrow.at-right{background-position:-20px 0}#at4-recommendedpanel-outer-container .at4-arrow.at-left,div.at4-arrow.at-left{background-position:0 0}div.at4-arrow.at-down{background-position:-60px 0}div.at4-arrow.at-up{background-position:-40px 0}.ats-dark div.at4-arrow.at-right{background-position:-20px -20px}.ats-dark div.at4-arrow.at-left{background-position:0 -20px}.ats-dark div.at4-arrow.at-down{background-position:-60px -20px}.ats-dark div.at4-arrow.at-up{background-position:-40px -20}.at4-opacity-hidden{opacity:0!important}.at4-opacity-visible{opacity:1!important}.at4-visually-hidden{position:absolute;clip:rect(1px,1px,1px,1px);padding:0;border:0;overflow:hidden}.at4-hidden-off-screen,.at4-hidden-off-screen *{position:absolute!important;top:-9999px!important;left:-9999px!important}.at4-show{display:block!important;opacity:1!important}.at4-show-content{opacity:1!important;visibility:visible}.at4-hide{display:none!important;opacity:0!important}.at4-hide-content{opacity:0!important;visibility:hidden}.at4-visible{display:block!important;opacity:0!important}.at-wordpress-hide{display:none!important;opacity:0!important}.addthis-animated{animation-fill-mode:both;animation-timing-function:ease-out;animation-duration:.3s}.slideInDown.addthis-animated,.slideInLeft.addthis-animated,.slideInRight.addthis-animated,.slideInUp.addthis-animated,.slideOutDown.addthis-animated,.slideOutLeft.addthis-animated,.slideOutRight.addthis-animated,.slideOutUp.addthis-animated{animation-duration:.4s}@keyframes fadeIn{0%{opacity:0}to{opacity:1}}.fadeIn{animation-name:fadeIn}@keyframes fadeInUp{0%{opacity:0;transform:translateY(20px)}to{opacity:1;transform:translateY(0)}}.fadeInUp{animation-name:fadeInUp}@keyframes fadeInDown{0%{opacity:0;transform:translateY(-20px)}to{opacity:1;transform:translateY(0)}}.fadeInDown{animation-name:fadeInDown}@keyframes fadeInLeft{0%{opacity:0;transform:translateX(-20px)}to{opacity:1;transform:translateX(0)}}.fadeInLeft{animation-name:fadeInLeft}@keyframes fadeInRight{0%{opacity:0;transform:translateX(20px)}to{opacity:1;transform:translateX(0)}}.fadeInRight{animation-name:fadeInRight}@keyframes fadeOut{0%{opacity:1}to{opacity:0}}.fadeOut{animation-name:fadeOut}@keyframes fadeOutUp{0%{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(-20px)}}.fadeOutUp{animation-name:fadeOutUp}@keyframes fadeOutDown{0%{opacity:1;transform:translateY(0)}to{opacity:0;transform:translateY(20px)}}.fadeOutDown{animation-name:fadeOutDown}@keyframes fadeOutLeft{0%{opacity:1;transform:translateX(0)}to{opacity:0;transform:translateX(-20px)}}.fadeOutLeft{animation-name:fadeOutLeft}@keyframes fadeOutRight{0%{opacity:1;transform:translateX(0)}to{opacity:0;transform:translateX(20px)}}.fadeOutRight{animation-name:fadeOutRight}@keyframes slideInUp{0%{transform:translateY(1500px)}0%,to{opacity:1}to{transform:translateY(0)}}.slideInUp{animation-name:slideInUp}.slideInUp.addthis-animated{animation-duration:.4s}@keyframes slideInDown{0%{transform:translateY(-850px)}0%,to{opacity:1}to{transform:translateY(0)}}.slideInDown{animation-name:slideInDown}@keyframes slideOutUp{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(-250px)}}.slideOutUp{animation-name:slideOutUp}@keyframes slideOutUpFast{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(-1250px)}}#at4m-menu.slideOutUp{animation-name:slideOutUpFast}@keyframes slideOutDown{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(350px)}}.slideOutDown{animation-name:slideOutDown}@keyframes slideOutDownFast{0%{transform:translateY(0)}0%,to{opacity:1}to{transform:translateY(1250px)}}#at4m-menu.slideOutDown{animation-name:slideOutDownFast}@keyframes slideInLeft{0%{opacity:0;transform:translateX(-850px)}to{transform:translateX(0)}}.slideInLeft{animation-name:slideInLeft}@keyframes slideInRight{0%{opacity:0;transform:translateX(1250px)}to{transform:translateX(0)}}.slideInRight{animation-name:slideInRight}@keyframes slideOutLeft{0%{transform:translateX(0)}to{opacity:0;transform:translateX(-350px)}}.slideOutLeft{animation-name:slideOutLeft}@keyframes slideOutRight{0%{transform:translateX(0)}to{opacity:0;transform:translateX(350px)}}.slideOutRight{animation-name:slideOutRight}.at4win{margin:0 auto;background:#fff;border:1px solid #ebeced;width:25pc;box-shadow:0 0 10px rgba(0,0,0,.3);border-radius:8px;font-family:helvetica neue,helvetica,arial,sans-serif;text-align:left;z-index:9999}.at4win .at4win-header{position:relative;border-bottom:1px solid #f2f2f2;background:#fff;height:49px;-webkit-border-top-left-radius:8px;-webkit-border-top-right-radius:8px;-moz-border-radius-topleft:8px;-moz-border-radius-topright:8px;border-top-left-radius:8px;border-top-right-radius:8px;cursor:default}.at4win .at4win-header .at-h3,.at4win .at4win-header h3{height:49px;line-height:49px;margin:0 50px 0 0;padding:1px 0 0;margin-left:20px;font-family:helvetica neue,helvetica,arial,sans-serif;font-size:1pc;font-weight:700;text-shadow:0 1px #fff;color:#333}.at4win .at4win-header .at-h3 img,.at4win .at4win-header h3 img{display:inline-block;margin-right:4px}.at4win .at4win-header .at4-close{display:block;position:absolute;top:0;right:0;background:url("data:image/gif;base64,R0lGODlhFAAUAIABAAAAAP///yH5BAEAAAEALAAAAAAUABQAAAIzBIKpG+YMm5Enpodw1HlCfnkKOIqU1VXk55goVb2hi7Y0q95lfG70uurNaqLgTviyyUoFADs=") no-repeat center center;background-repeat:no-repeat;background-position:center center;border-left:1px solid #d2d2d1;width:49px;height:49px;line-height:49px;overflow:hidden;text-indent:-9999px;text-shadow:none;cursor:pointer;opacity:.5;border:0;transition:opacity .15s ease-in}.at4win .at4win-header .at4-close::-moz-focus-inner{border:0;padding:0}.at4win .at4win-header .at4-close:hover{opacity:1;background-color:#ebeced;border-top-right-radius:7px}.at4win .at4win-content{position:relative;background:#fff;min-height:220px}#at4win-footer{position:relative;background:#fff;border-top:1px solid #d2d2d1;-webkit-border-bottom-right-radius:8px;-webkit-border-bottom-left-radius:8px;-moz-border-radius-bottomright:8px;-moz-border-radius-bottomleft:8px;border-bottom-right-radius:8px;border-bottom-left-radius:8px;height:11px;line-height:11px;padding:5px 20px;font-size:11px;color:#666;-ms-box-sizing:content-box;-o-box-sizing:content-box;box-sizing:content-box}#at4win-footer a{margin-right:10px;text-decoration:none;color:#666}#at4win-footer a:hover{text-decoration:none;color:#000}#at4win-footer a.at4-logo{top:5px;padding-left:10px}#at4win-footer a.at4-privacy{position:absolute;top:5px;right:10px;padding-right:14px}.at4win.ats-dark{border-color:#555;box-shadow:none}.at4win.ats-dark .at4win-header{background:#1b1b1b;-webkit-border-top-left-radius:6px;-webkit-border-top-right-radius:6px;-moz-border-radius-topleft:6px;-moz-border-radius-topright:6px;border-top-left-radius:6px;border-top-right-radius:6px}.at4win.ats-dark .at4win-header .at4-close{background:url("data:image/gif;base64,iVBORw0KGgoAAAANSUhEUgAAABQAAAAUCAYAAACNiR0NAAAABHNCSVQICAgIfAhkiAAAAAlwSFlzAAALEgAACxIB0t1+/AAAABx0RVh0U29mdHdhcmUAQWRvYmUgRmlyZXdvcmtzIENTNui8sowAAAAWdEVYdENyZWF0aW9uIFRpbWUAMTEvMTMvMTKswDp5AAAAd0lEQVQ4jb2VQRLAIAgDE///Z3qqY1FAhalHMCsCIkVEAIAkkVgvp2lDBgYAnAyHkWotLccNrEd4A7X2TqIdqLfnWBAdaF5rJdyJfjtPH5GT37CaGhoVq3nOm/XflUuLUto2pY1d+vRKh0Pp+MrAVtDe2JkvYNQ+jVSEEFmOkggAAAAASUVORK5CYII=") no-repeat center center;background-image:url(https://s7.addthis.com/static/fb08f6d50887bd0caacc86a62bcdcf68.svg),none;border-color:#333}.at4win.ats-dark .at4win-header .at4-close:hover{background-color:#000}.at4win.ats-dark .at4win-header .at-h3,.at4win.ats-dark .at4win-header h3{color:#fff;text-shadow:0 1px #000}.at4win.ats-gray .at4win-header{background:#fff;border-color:#d2d2d1;-webkit-border-top-left-radius:6px;-webkit-border-top-right-radius:6px;-moz-border-radius-topleft:6px;-moz-border-radius-topright:6px;border-top-left-radius:6px;border-top-right-radius:6px}.at4win.ats-gray .at4win-header a.at4-close{border-color:#d2d2d1}.at4win.ats-gray .at4win-header a.at4-close:hover{background-color:#ebeced}.at4win.ats-gray #at4win-footer{border-color:#ebeced}.at4win .clear{clear:both}.at4win ::selection{background:#fe6d4c;color:#fff}.at4win ::-moz-selection{background:#fe6d4c;color:#fff}.at4-icon-fw{display:inline-block;background-repeat:no-repeat;background-position:0 0;margin:0 5px 0 0;overflow:hidden;text-indent:-9999em;cursor:pointer;padding:0;border-radius:50%;-moz-border-radius:50%;-webkit-border-radius:50%}.at44-follow-container a.aticon{height:2pc;margin:0 5px 5px 0}.at44-follow-container .at4-icon-fw{margin:0}</style></head>

<body class="" id="homepage_controller" style="">
<div class="off-canvas-wrap" data-offcanvas="">
<div class="inner-wrap">
<div class="fixed show-for-large-up">
<div class="row menu-align" id="logo-bar">
<div class="small-12 columns">
<div class="cross-journal-container">
Go to
<a href="http://insight.jci.org">JCI Insight</a>
</div>
<a href="/"><img src="/assets/common/jci-spelled-out-white-on-transparent.20160208-f0c39cd1eaee455c46365719769dc2f4859d68368cfa219e5e491c77d472c0f4.png" /></a>
</div>
</div>

<div class="row menu-align" id="journal-bar">
<div class="small-12 columns">
<ul class="inline-list">
<li><a href="/kiosks/about">About</a></li>
<li><a href="/kiosks/editorial-board">Editors</a></li>
<li><a href="/kiosks/about/consulting-editors">Consulting Editors</a></li>
<li><a href="/kiosks/authors">For authors</a></li>
<li><a href="/kiosks/connect">Alerts</a></li>
<li><a href="/kiosks/advertise">Advertising/recruitment</a></li>
<li><a href="/kiosks/subscriptions">Subscribe</a></li>
<li><a href="/kiosks/contact">Contact</a></li>

</ul>
</div>
</div>

<div id="content-bar">
<nav class="top-bar" data-topbar="">

<section class="top-bar-section">
<ul class="left">
<li class="not-click">
<a id="topmenu_current_issue" href="/current">Current Issue</a>
</li>
<li class="not-click">
<a href="/archive">Past Issues</a>
</li>
<li class="has-dropdown not-click">
<a>By specialty</a>
<ul class="dropdown"><li class="title back js-generated"><h5><a href="javascript:void(0)">Back</a></h5></li>
<li><a href="/tags/118">COVID-19</a></li>
<li><a href="/tags/15">Cardiology</a></li>
<li><a href="/tags/21">Gastroenterology</a></li>
<li><a href="/tags/25">Immunology</a></li>
<li><a href="/tags/28">Metabolism</a></li>
<li><a href="/tags/31">Nephrology</a></li>
<li><a href="/tags/32">Neuroscience</a></li>
<li><a href="/tags/33">Oncology</a></li>
<li><a href="/tags/36">Pulmonology</a></li>
<li><a href="/tags/42">Vascular biology</a></li>
<li><a href="/specialties">All ...</a></li>
</ul>
</li>
<li class="has-dropdown not-click">
<a href="/videos">Videos</a>
<ul class="dropdown"><li class="title back js-generated"><h5><a href="javascript:void(0)">Back</a></h5></li><li class="parent-link hide-for-medium-up"><a class="parent-link js-generated" href="/videos">Videos</a></li>
<li><a href="/videos/cgms">Conversations with Giants in Medicine</a></li>
<li><a href="/videos/authors_takes">Author's Takes</a></li>
</ul>
</li>
<li class="has-dropdown not-click">
<a href="/tags/reviews">Reviews</a>
<ul class="dropdown"><li class="title back js-generated"><h5><a href="javascript:void(0)">Back</a></h5></li><li class="parent-link hide-for-medium-up"><a class="parent-link js-generated" href="/tags/reviews">Reviews</a></li>
<li>
<label>Reviews</label>
</li>
<li><a href="/tags/reviews">View all reviews ...</a></li>
<li class="divider"></li>
<li>
<label>Review Series</label>
</li>
<li><a href="/review_series/111">Hypoxia-inducible factors in disease pathophysiology and therapeutics (Oct 2020)</a></li>
<li><a href="/review_series/110">Latency in Infectious Disease (Jul 2020)</a></li>
<li><a href="/review_series/109">Immunotherapy in Hematological Cancers (Apr 2020)</a></li>
<li><a href="/review_series/108">Big Data's Future in Medicine (Feb 2020)</a></li>
<li><a href="/review_series/107">Mechanisms Underlying the Metabolic Syndrome (Oct 2019)</a></li>
<li><a href="/review_series/106">Reparative Immunology (Jul 2019)</a></li>
<li><a href="/review_series/105">Allergy (Apr 2019)</a></li>
<li>
<a href="/review_series">View all review series ...</a>
</li>
</ul>
</li>
<li class="not-click">
<a href="/tags/111">Viewpoint</a>
</li>
<li class="has-dropdown not-click">
<a>Collections</a>
<ul class="dropdown"><li class="title back js-generated"><h5><a href="javascript:void(0)">Back</a></h5></li>
<li><a href="/recently-published">Recently published</a></li>
<li><a href="/in-press-preview">In-Press Preview</a></li>
<li><a href="/tags/44">Commentaries</a></li>
<li><a href="/tags/concise_communications">Concise Communication</a></li>
<li><a href="/tags/56">Editorials</a></li>
<li><a href="/tags/111">Viewpoint</a></li>
<li><a href="/top_articles">Top read articles</a></li>

</ul>
</li>
<li><a href="/tags/3">Clinical Medicine</a></li>
<li class="has-dropdown not-click">
<a href="/this-month">JCI This Month</a>
<ul class="dropdown"><li class="title back js-generated"><h5><a href="javascript:void(0)">Back</a></h5></li><li class="parent-link hide-for-medium-up"><a class="parent-link js-generated" href="/this-month">JCI This Month</a></li>
<li><a href="/this-month/current">Current issue</a></li>
<li><a href="/this-month">Past issues</a></li>
</ul>
</li>
</ul>
<ul class="right">
<li class="has-form">
<div id="search-area">
<form action="/search/results" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓" />
<input type="text" name="q" id="q" value="" placeholder="Search the JCI" />
<input type="image" src="/assets/search-black-867f68b5b717d00fb9c106b8c637cfd33ea8ee8b2ff37a9eaf8cc675abe2fc86.png" value="" />
</form>

</div>
</li>
</ul>
</section></nav>
</div>

</div>
<!--[if gt IE 8]><!--><nav class="tab-bar hide-for-large-up fixed" id="small-navbar">
<section class="left-small">
<a class="left-off-canvas-toggle menu-icon">
<span></span>
</a>
</section>
<section class="middle tab-bar-section">
<h1 class="title"><a href="/"><img width="40" src="/assets/common/jci-only-white-8a7e75c924e8f4e2d61f98952aa688ca36f76c9e55ac7fa58f3a9a33a8cb4236.png" /></a></h1>
</section>
</nav>
<aside class="left-off-canvas-menu">
<ul class="off-canvas-list">
<li>
<label>The Journal of Clinical Investigation</label>
</li>
<li><form action="/search/results" accept-charset="UTF-8" method="get"><input name="utf8" type="hidden" value="✓" />
<div class="row collapse" id="search-div-offcanvas">
<div class="small-8 columns">
<input name="q" placeholder="Search the JCI" type="text" />
</div>
<div class="small-4 columns">
<input type="image" src="/assets/common/search-white-cc4a29c31d1a1a75e19da4c773d8175e78de1ac330be7aa089e7212ec0a7b49e.png" id="search-icon-offcanvas" />
</div>
</div>
</form>

</li>
<li><a id="offcanvas_current_issue" href="/current">Current issue</a></li>
<li><a href="/archive">Past issues</a></li>
<li><a href="/specialties">Specialties</a></li>
<li><a href="/tags/reviews">Reviews</a></li>
<li><a href="/review_series">Review series</a></li>
<li>
<label>Videos</label>
</li>
<li><a href="/videos/cgms">Conversations with Giants in Medicine</a></li>
<li><a href="/videos/authors_takes">Author's Takes</a></li>
<li>
<label>Collections</label>
</li>
<li><a href="/recently-published">Recently published</a></li>
<li><a href="/in-press-preview">In-Press Preview</a></li>
<li><a href="/tags/44">Commentaries</a></li>
<li><a href="/tags/concise_communications">Concise Communication</a></li>
<li><a href="/tags/56">Editorials</a></li>
<li><a href="/tags/111">Viewpoint</a></li>
<li><a href="/top_articles">Top read articles</a></li>

<li>
<label>Journal Details</label>
</li>
<li><a href="/kiosks/about">About</a></li>
<li><a href="/kiosks/editorial-board">Editors</a></li>
<li><a href="/kiosks/about/consulting-editors">Consulting Editors</a></li>
<li><a href="/kiosks/authors">For authors</a></li>
<li><a href="/kiosks/connect">Alerts</a></li>
<li><a href="/kiosks/advertise">Advertising/recruitment</a></li>
<li><a href="/kiosks/subscriptions">Subscribe</a></li>
<li><a href="/kiosks/contact">Contact</a></li>

</ul>
</aside>
<a class="exit-off-canvas"></a><!--<![endif]-->



<!--[if (lt IE 9)]>
<div class='alert-box info' data-alert=''>
Please note that the JCI no longer supports your version of Internet Explorer. We recommend upgrading to the latest version of
<a href="http://windows.microsoft.com/en-us/internet-explorer/download-ie">Internet Explorer</a>,
<a href="https://www.google.com/chrome/browser/desktop/index.html">Google Chrome</a>, or
<a href="https://www.mozilla.org/en-US/firefox/new/">Firefox</a>
<a class='close' href='#'>&times;</a>
</div>
<![endif]-->

<div class="row content-wrapper" style="padding-bottom: 142px;">
<div class="small-12 columns">
<div class="row">
<div class="large-8 large-push-4 medium-7 medium-push-5 columns">


<div class="row panel-padding">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4>
Recently published
<small>- <a title="View more recently published articles" href="/recently-published">More</a></small>
</h4>
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/143120">Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41669-more" href="#">
<div class="article-abstract">
BACKGROUND T cell responses to the common cold coronaviruses have not been well characterized. Preexisting T cell immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been...
</div>
</a>
<span class="article-published-at">
Published September 23, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/3"><span class="label-article-type">
Clinical Medicine
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><a href="/tags/26"><span class="label-specialty">
Infectious disease
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI143120" data-hide-no-mentions="true" data-uuid="b95b2594-981c-624f-580d-a54b376ac9f8"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91135806" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91135806&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;28&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;21&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91135806'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 17" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/17.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/143120/figure/1" ref="group" title="IFN-γ responses to viral peptide pools from HDs and CCPs. The number of SFU from unfractioned PBMCs (A and E) and CD8+ T cell–depleted PBMCs (C and G) and the corresponding stimulation indices (B, D, F, and H) in response to S protein peptide pools from different viruses are shown. The number of SFU (I and K) and the stimulation indices (J and L) from unfractioned PBMCs in response to CEF and SARS-CoV-2 M and N peptide pools are also shown. Arrows indicate HD9. Each data point represents the mean of 3 replicate values. Horizontal bars represent the median. Statistical comparisons were performed using 1-way ANOVA with Geisser-Greenhouse correction and Dunnett’s multiple-comparison test (n = 19–21 for samples from HDs; n = 3–4 for samples from patients with COVID-19). *P = 0.0332, **P = 0.0021, ***P = 0.0002, and ****P &lt; 0.0001.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/143000/143120/small/JCI143120.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41669-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/143120">Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/143120">Text</a></li>
<li><a class="button tiny" href="/articles/view/143120/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>BACKGROUND T cell responses to the common cold coronaviruses have not been well characterized. Preexisting T cell immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has been reported, and a recent study suggested that this immunity was due to cross-recognition of the novel coronavirus by T cells specific for the common cold coronaviruses.METHODS We used the enzyme-linked immunospot (ELISPOT) assay to characterize the T cell responses against peptide pools derived from the spike protein of 3 common cold coronaviruses (HCoV-229E, HCoV-NL63, and HCoV-OC43) and SARS-CoV-2 in 21 healthy donors (HDs) who were seronegative for SARS-CoV-2 and had no known exposure to the virus. An in vitro expansion culture assay was also used to analyze memory T cell responses.RESULTS We found responses to the spike protein of the 3 common cold coronaviruses in many of the donors. We then focused on HCoV-NL63 and detected broad T cell responses to the spike protein and identified 22 targeted peptides. Interestingly, only 1 study participant had a significant response to SARS-CoV-2 spike or nucleocapsid protein in the ELISPOT assay. In vitro expansion studies suggested that T cells specific for the HCoV-NL63 spike protein in this individual could also recognize SARS-CoV-2 spike protein peptide pools.CONCLUSION HDs have circulating T cells specific for the spike proteins of HCoV-NL63, HCoV-229E, and HCoV-OC43. T cell responses to SARS-CoV-2 spike and nucleocapsid proteins were present in only 1 participant and were potentially the result of cross-recognition by T cells specific for the common cold coronaviruses. Further studies are needed to determine whether this cross-recognition influences coronavirus disease 2019 (COVID-19) outcomes.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Bezawit A. Woldemeskel, Abena K. Kwaa, Caroline C. Garliss, Oliver Laeyendecker, Stuart C. Ray, Joel N. Blankson</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/139682">Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41672-more" href="#">
<div class="article-abstract">
Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor...
</div>
</a>
<span class="article-published-at">
Published September 8, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/22"><span class="label-specialty">
Genetics
</span>
</a><a href="/tags/23"><span class="label-specialty">
Hematology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI139682" data-hide-no-mentions="true" data-uuid="f52ab5ad-a3c1-869e-94a1-a3f67579bb2d"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89680346" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89680346&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;70&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;5&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89680346'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 46" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/46.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/139682/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/139000/139682/small/JCI139682.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41672-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/139682">Germ cell tumors and associated hematologic malignancies evolve from a common shared precursor</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/139682">Text</a></li>
<li><a class="button tiny" href="/articles/view/139682/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Germ cell tumors (GCTs) are the most common cancer in men between the ages of 15 and 40. Although most patients are cured, those with disease arising in the mediastinum have distinctly poor outcomes. One in every 17 patients with primary mediastinal nonseminomatous GCTs develop an incurable hematologic malignancy and prior data intriguingly suggest a clonal relationship exists between hematologic malignancies and GCTs in these cases. To date, however, the precise clonal relationship between GCTs and the diverse additional somatic malignancies arising in such individuals have not been determined. Here, we traced the clonal evolution and characterized the genetic features of each neoplasm from a cohort of 15 patients with GCTs and associated hematologic malignancies. We discovered that GCTs and hematologic malignancies developing in such individuals evolved from a common shared precursor, nearly all of which harbored allelically imbalanced p53 and/or RAS pathway mutations. Hematologic malignancies arising in this setting genetically resembled mediastinal GCTs rather than de novo myeloid neoplasms. Our findings argue that this scenario represents a unique clinical syndrome, distinct from de novo GCTs or hematologic malignancies, initiated by an ancestral precursor that gives rise to the parallel evolution of GCTs and blood cancers in these patients.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Justin Taylor, Mark T.A. Donoghue, Caleb Ho, Kseniya Petrova-Drus, Hikmat A. Al-Ahmadie, Samuel A. Funt, Yanming Zhang, Umut Aypar, Pavitra Rao, Shweta S. Chavan, Michael Haddadin, Roni Tamari, Sergio Giralt, Martin S. Tallman, Raajit K. Rampal, Priscilla Baez, Rajya Kappagantula, Satyajit Kosuri, Ahmet Dogan, Satish K. Tickoo, Victor E. Reuter, George J. Bosl, Christine A. Iacobuzio-Donahue, David B. Solit, Barry S. Taylor, Darren R. Feldman, Omar Abdel-Wahab</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/141777">Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41673-more" href="#">
<div class="article-abstract">
BACKGROUND Understanding outcomes and immunologic characteristics of cellular therapy recipients with SARS-CoV-2 is critical to performing these potentially life-saving therapies in the COVID-19...
</div>
</a>
<span class="article-published-at">
Published September 8, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/3"><span class="label-article-type">
Clinical Medicine
</span>
</a><a href="/tags/118"><span class="label-specialty">
COVID-19
</span>
</a><a href="/tags/40"><span class="label-specialty">
Transplantation
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI141777" data-hide-no-mentions="true" data-uuid="96a92831-aa2c-f080-4f49-b53c33cedb1b"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89679244" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89679244&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;119&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;25&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89679244'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 78" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/78.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/141777/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/141000/141777/small/JCI141777.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41673-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/141777">Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/141777">Text</a></li>
<li><a class="button tiny" href="/articles/view/141777/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>BACKGROUND Understanding outcomes and immunologic characteristics of cellular therapy recipients with SARS-CoV-2 is critical to performing these potentially life-saving therapies in the COVID-19 era. In this study of recipients of allogeneic (Allo) and autologous (Auto) hematopoietic cell transplant and CD19-directed chimeric antigen receptor T cell (CAR T) therapy at Memorial Sloan Kettering Cancer Center, we aimed to identify clinical variables associated with COVID-19 severity and assess lymphocyte populations.METHODS We retrospectively investigated patients diagnosed between March 15, 2020, and May 7, 2020. In a subset of patients, lymphocyte immunophenotyping, quantitative real-time PCR from nasopharyngeal swabs, and SARS-CoV-2 antibody status were available.RESULTS We identified 77 patients with SARS-CoV-2 who were recipients of cellular therapy (Allo, 35; Auto, 37; CAR T, 5; median time from cellular therapy, 782 days; IQR, 354–1611 days). Overall survival at 30 days was 78%. Clinical variables significantly associated with the composite endpoint of nonrebreather or higher oxygen requirement and death (n events = 25 of 77) included number of comorbidities (HR 5.41, P = 0.004), infiltrates (HR 3.08, P = 0.032), and neutropenia (HR 1.15, P = 0.04). Worsening graft-versus-host disease was not identified among Allo recipients. Immune profiling revealed reductions and rapid recovery in lymphocyte populations across lymphocyte subsets. Antibody responses were seen in a subset of patients.CONCLUSION In this series of Allo, Auto, and CAR T recipients, we report overall favorable clinical outcomes for patients with COVID-19 without active malignancy and provide preliminary insights into the lymphocyte populations that are key for the antiviral response and immune reconstitution.FUNDING NIH grant P01 CA23766 and NIH/National Cancer Institute grant P30 CA008748.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Gunjan L. Shah, Susan DeWolf, Yeon Joo Lee, Roni Tamari, Parastoo B. Dahi, Jessica A. Lavery, Josel Ruiz, Sean M. Devlin, Christina Cho, Jonathan U. Peled, Ioannis Politikos, Michael Scordo, N. Esther Babady, Tania Jain, Santosha Vardhana, Anthony Daniyan, Craig S. Sauter, Juliet N. Barker, Sergio A. Giralt, Cheryl Goss, Peter Maslak, Tobias M. Hohl, Mini Kamboj, Lakshmi Ramanathan, Marcel R.M. van den Brink, Esperanza Papadopoulos, Genovefa Papanicolaou, Miguel-Angel Perales</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/141206">Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41676-more" href="#">
<div class="article-abstract">
The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the urgent need for assays that detect protective levels of neutralizing antibodies. We studied the...
</div>
</a>
<span class="article-published-at">
Published September 10, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><a href="/tags/26"><span class="label-specialty">
Infectious disease
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI141206" data-hide-no-mentions="true" data-uuid="6ef8f11b-943c-56a7-2314-241cca892840"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;38&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=blogs'&gt;&#10;          Blogged by &lt;b&gt;1&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;20&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=facebook'&gt;&#10;          On &lt;b&gt;1&lt;/b&gt; Facebook pages&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;26&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 293" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/293.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/141206/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/141000/141206/small/JCI141206.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41676-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/141206">Convalescent plasma anti–SARS-CoV-2 spike protein ectodomain and receptor-binding domain IgG correlate with virus neutralization</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/141206">Text</a></li>
<li><a class="button tiny" href="/articles/view/141206/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>The newly emerged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlights the urgent need for assays that detect protective levels of neutralizing antibodies. We studied the relationship among anti-spike ectodomain (anti-ECD), anti–receptor-binding domain (anti-RBD) IgG titers, and SARS-CoV-2 virus neutralization (VN) titers generated by 2 in vitro assays using convalescent plasma samples from 68 patients with COVID-19. We report a strong positive correlation between both plasma anti-RBD and anti-ECD IgG titers and in vitro VN titers. The probability of a VN titer of ≥160, the FDA-recommended level for convalescent plasma used for COVID-19 treatment, was ≥80% when anti-RBD or anti-ECD titers were ≥1:1350. Of all donors, 37% lacked VN titers of ≥160. Dyspnea, hospitalization, and disease severity were significantly associated with higher VN titer. Frequent donation of convalescent plasma did not significantly decrease VN or IgG titers. Analysis of 2814 asymptomatic adults found 73 individuals with anti-ECD IgG titers of ≥1:50 and strong positive correlation with anti-RBD and VN titers. Fourteen of these individuals had VN titers of ≥1:160, and all of them had anti-RBD titers of ≥1:1350. We conclude that anti-RBD or anti-ECD IgG titers can serve as a surrogate for VN titers to identify suitable plasma donors. Plasma anti-RBD or anti-ECD titers of ≥1:1350 may provide critical information about protection against COVID-19 disease.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Eric Salazar, Suresh V. Kuchipudi, Paul A. Christensen, Todd Eagar, Xin Yi, Picheng Zhao, Zhicheng Jin, S. Wesley Long, Randall J. Olsen, Jian Chen, Brian Castillo, Christopher Leveque, Dalton Towers, Jason Lavinder, Jimmy Gollihar, Jose Cardona, Gregory Ippolito, Ruth Nissly, Ian Bird, Denver Greenawalt, Randall M. Rossi, Abhinay Gontu, Sreenidhi Srinivasan, Indira Poojary, Isabella M. Cattadori, Peter J. Hudson, Nicole M. Josleyn, Laura Prugar, Kathleen Huie, Andrew Herbert, David W. Bernard, John M. Dye, Vivek Kapur, James M. Musser</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/145301">Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41681-more" href="#">
<div class="article-abstract">

</div>
</a>
<span class="article-published-at">
Published October 27, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/111"><span class="label-article-type">
Viewpoint
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI145301" data-hide-no-mentions="true" data-uuid="d1b1ce11-cd4c-1687-c8c1-255e1941f8db"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93228172" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93228172&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;35&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;4&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93228172'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 21" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/21.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/145301/figure/1" ref="group" title="Potential mechanisms for inflammatory syndromes associated with SARS-CoV-2. SARS-CoV-2 can trigger a range of inflammatory syndromes across the age spectrum. Compared with children, adults — particularly those with certain preexisting proinflammatory comorbidities — are more likely to develop acute COVID-19–associated hyperinflammatory syndrome within 1 to 2 weeks of exposure to SARS-CoV-2. COVID-19–associated hyperinflammatory syndrome begins with failure of the regulatory immune response to SARS-CoV-2, including abnormal interferon production that drives macrophage hyperactivation. This results in inflammatory cytokine cascades and causes significant damage to multiple organ systems. In contrast, children are more likely to have asymptomatic or mild acute SARS-CoV-2 infection without sequelae. The reason or reasons why children do not commonly develop acute COVID-19–associated hyperinflammatory syndrome remain unknown. However, both children and adults can develop MIS-C/A of unclear etiology weeks after initial asymptomatic or mild SARS-CoV-2 infection. The precise cause of MIS-C/A inflammatory symptoms remains unclear, but may be due to development of abnormal antibody responses that drive systemic hyperinflammation. APC, antigen-presenting cell; ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase; ALC, absolute lymphocyte count; GCSF, granulocyte colony-stimulating factor; IP-10, interferon-γ–induced protein–10; MCP1, monocyte chemotactic protein 1; MIP1α, macrophage inflammatory protein 1α; BNP, brain natriuretic peptide.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/145000/145301/small/JCI145301.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41681-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/145301">Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/145301">Text</a></li>
<li><a class="button tiny" href="/articles/view/145301/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p></p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Jill E. Weatherhead, Eva Clark, Tiphanie P. Vogel, Robert L. Atmar, Prathit A. Kulkarni</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/120288">Inhibition of IRF5 hyperactivation protects from lupus onset and severity</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41684-more" href="#">
<div class="article-abstract">
The transcription factor IFN regulatory factor 5 (IRF5) is a central mediator of innate and adaptive immunity. Genetic variations within IRF5 are associated with a risk of systemic lupus...
</div>
</a>
<span class="article-published-at">
Published September 8, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/13"><span class="label-specialty">
Autoimmunity
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI120288" data-hide-no-mentions="true" data-uuid="a3c8ccb1-bfaa-a812-3435-da832cd60dae"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89748146" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89748146&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;9&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;4&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89748146'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 4" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/4.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/120288/figure/1" ref="group" title="IRF5 is hyperactivated in immune cells from patients with SLE and in NZB/W F1 lupus-prone mice. IRF5 activation was assessed by nuclear localization in CD45+CD14+ monocytes (Mo) (A) and CD45+CD19+ B cells (B) from healthy donors and patients with SLE in the New Jersey cohort using imaging flow cytometry. Data represent the percentage of IRF5 nuclear translocation; circles represent independent donors. (C and D) IRF5 localization determined in monocytes (C) and B cells (D) from healthy donors and patients with SLE in the New York cohort with clinically inactive (score = 0/1) or active (score = 2/3) disease. (E and F) Percentage of IRF5 nuclear translocation in monocytes and B cells from patients with SLE stratified by SLEDAI (E) and dsDNA antibody titers (F). (G–K) Correlation between the percentage of IRF5 translocation in B cells or monocytes and dsDNA titers (G and H) or serum IFN-α levels (J and K) by linear regression analysis. (L and M) IRF5 nuclear translocation in CD11b+ monocytes from cohort 1 (L) and cohort 2 (M) consisting of aging female NZB/W F1 and BALB/c mice. Black circles, NZB/W F1 mice; white circles, BALB/c. n = 3 mice/group/cohort. (N) Inhibition of IRF5 activation (10–21 weeks old) by N5-1 in CD11b+ monocytes. (O and P) Same as in L and M, except in B220+ B cells from cohort 1 (O) and cohort 2 (P). (Q) Same as in N, except inhibition of IRF5 activation is shown in B220+ B cells. (R and S) IRF5 translocation in CD3+CD4+ T cells (R) and CD3+CD8+ T cells (S) from aging female NZB/W F1 and BALB/c mice. n = 6 mice/group. Data represent the mean ± SEM. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, and ****P ≤ 0.0001, by 2-way ANOVA with Bonferroni’s post hoc test.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/120000/120288/small/JCI120288.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41684-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/120288">Inhibition of IRF5 hyperactivation protects from lupus onset and severity</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/120288">Text</a></li>
<li><a class="button tiny" href="/articles/view/120288/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>The transcription factor IFN regulatory factor 5 (IRF5) is a central mediator of innate and adaptive immunity. Genetic variations within IRF5 are associated with a risk of systemic lupus erythematosus (SLE), and mice lacking Irf5 are protected from lupus onset and severity, but how IRF5 functions in the context of SLE disease progression remains unclear. Using the NZB/W F1 model of murine lupus, we show that murine IRF5 becomes hyperactivated before clinical onset. In patients with SLE, IRF5 hyperactivation correlated with dsDNA titers. To test whether IRF5 hyperactivation is a targetable function, we developed inhibitors that are cell permeable, nontoxic, and selectively bind to the inactive IRF5 monomer. Preclinical treatment of NZB/W F1 mice with an inhibitor attenuated lupus pathology by reducing serum antinuclear autoantibodies, dsDNA titers, and the number of circulating plasma cells, which alleviated kidney pathology and improved survival. Clinical treatment of MRL/lpr and pristane-induced lupus mice with an inhibitor led to significant reductions in dsDNA levels and improved survival. In ex vivo human studies, the inhibitor blocked SLE serum–induced IRF5 activation and reversed basal IRF5 hyperactivation in SLE immune cells. We believe this study provides the first in vivo clinical support for treating patients with SLE with an IRF5 inhibitor.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Su Song, Saurav De, Victoria Nelson, Samin Chopra, Margaret LaPan, Kyle Kampta, Shan Sun, Mingzhu He, Cherrie D. Thompson, Dan Li, Tiffany Shih, Natalie Tan, Yousef Al-Abed, Eugenio Capitle, Cynthia Aranow, Meggan Mackay, William L. Clapp, Betsy J. Barnes</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/144115">Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41686-more" href="#">
<div class="article-abstract">
Human coronaviruses (hCoVs) cause severe respiratory illness in the elderly. Age-related impairments in innate immunity and suboptimal virus-specific T cell and antibody responses are believed to...
</div>
</a>
<span class="article-published-at">
Published October 21, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/2"><span class="label-article-type">
Review
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI144115" data-hide-no-mentions="true" data-uuid="f7d8e2c0-88db-55af-1a0d-68bc7b186c93"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;27&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863&amp;tab=facebook'&gt;&#10;          On &lt;b&gt;1&lt;/b&gt; Facebook pages&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;7&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 17" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/17.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/144115/figure/1" ref="group" title="Immune response to respiratory hCoV infection in young and aged individuals. In young hosts, hCoV infection induces an early elevation of IFN-I and IL-12 responses and controlled proinflammatory cytokine/chemokine production, leading to effective adaptive immunity and enhanced virus clearance. In contrast, aged hosts mount reduced and delayed IFN-I and IL-12 responses and excessive proinflammatory cytokine/chemokine responses, leading to excessive inflammation, impaired adaptive immune response, delayed virus clearance, and fatal pneumonia.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/144000/144115/small/JCI144115.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41686-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/144115">Age-related susceptibility to coronavirus infections: role of impaired and dysregulated host immunity</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/144115">Text</a></li>
<li><a class="button tiny" href="/articles/view/144115/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Human coronaviruses (hCoVs) cause severe respiratory illness in the elderly. Age-related impairments in innate immunity and suboptimal virus-specific T cell and antibody responses are believed to cause severe disease upon respiratory virus infections. This phenomenon has recently received increased attention, as elderly patients are at substantially elevated risk for severe COVID-19 disease and experience increased rates of mortality following SARS-CoV-2 infection compared with younger populations. However, the basis for age-related fatal pneumonia following pathogenic hCoVs is not well understood. In this Review, we provide an overview of our current understanding of hCoV-induced fatal pneumonia in the elderly. We describe host immune response to hCoV infections derived from studies of young and aged animal models and discuss the potential role of age-associated increases in sterile inflammation (inflammaging) and virus-induced dysregulated inflammation in causing age-related severe disease. We also highlight the existing gaps in our knowledge about virus replication and host immune responses to hCoV infection in young and aged individuals.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Rudragouda Channappanavar, Stanley Perlman</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/143199">Preferential Gq signaling in diabetes: an electrical switch in incretin action and in diabetes progression?</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41677-more" href="#">
<div class="article-abstract">
Patients with type 2 diabetes (T2D) fail to secrete insulin in response to increased glucose levels that occur with eating. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic...
</div>
</a>
<span class="article-published-at">
Published November 16, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/44"><span class="label-article-type">
Commentary
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI143199" data-hide-no-mentions="true" data-uuid="4c86c76e-2c72-a589-f0a0-8447cc12b3f0"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;4&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;3&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670&amp;tab=facebook'&gt;&#10;          On &lt;b&gt;1&lt;/b&gt; Facebook pages&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 34" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/34.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/143199/figure/1" ref="group" title="Model for T2D progression and treatment. (A) (i) Lean individuals with normal glucose tolerance (NGT) develop increasing obesity (OB), which reduces insulin sensitivity. (ii) Pancreatic β cells respond by reducing KATP current density and increasing excitability/mean intracellular [Ca], which initially results in increased insulin secretion, maintaining normal blood glucose. However, above a certain level (iii), high excitability/intracellular [Ca] paradoxically inhibits insulin secretion itself (indicated by arrow). Impaired glucose tolerance (IGT) then progresses to overt diabetes (DIAB), coupled to an inexorable rise in blood glucose (iv), as the initially compensatory hyperinsulinemia (Hi INS) progresses to hypoinsulinemia (Lo INS). (B) As Oduori et al. (14) show, the same hyperexcitability that drives the switch to low insulin secretion also drives a shift of GPCR coupling from Gs to Gq. Consequently, GLP-1 treatment (acting via Gq) can maintain amplification of insulin secretion and, hence, slow the rise of blood glucose (indicated by arrows), whereas GIP (which does not couple to Gq) would have little to no effect.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/143000/143199/small/JCI143199.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41677-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/143199">Preferential Gq signaling in diabetes: an electrical switch in incretin action and in diabetes progression?</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/143199">Text</a></li>
<li><a class="button tiny" href="/articles/view/143199/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Patients with type 2 diabetes (T2D) fail to secrete insulin in response to increased glucose levels that occur with eating. Glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) are two incretins secreted from gastrointestinal cells that amplify insulin secretion when glucose is high. In this issue of the JCI, Oduori et al. explore the role of ATP-sensitive K+ (KATP) channels in maintaining glucose homeostasis. In persistently depolarized β cells from KATP channel knockout (KO) mice, the researchers revealed a shift in G protein signaling from the Gs family to the Gq family. This shift explains why GLP-1, which signals via Gq, but not GIP, which signals preferentially via Gs, can effectively potentiate secretion in islets from the KATP channel–deficient mice and in other models of KATP deficiency, including diabetic KK-Ay mice. Their results provide one explanation for differential insulinotropic potential of incretins in human T2D and point to a potentially unifying model for T2D progression itself.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Colin G. Nichols, Nathaniel W. York, Maria S. Remedi</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/136057">Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41679-more" href="#">
<div class="article-abstract">
Tertiary lymphoid organs are aggregates of immune and stromal cells including high endothelial venules and lymphatic vessels that resemble secondary lymphoid organs and can be induced at...
</div>
</a>
<span class="article-published-at">
Published November 16, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/40"><span class="label-specialty">
Transplantation
</span>
</a><a href="/tags/42"><span class="label-specialty">
Vascular biology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI136057" data-hide-no-mentions="true" data-uuid="e92e37b4-a3bf-9d0c-0629-c6ceef3dd1f3"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94433054" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94433054&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;8&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94433054'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 5" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/5.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/136057/figure/1" ref="group" title="Induction and maintenance of peripheral tolerance after lung transplantation depend on the presence of the tolerant pulmonary allograft. (A) Kaplan-Meier survival curves of BALB/c hearts that were transplanted into B6 mice that had received BALB/c lungs under perioperative costimulatory blockade at least 30 days prior (●) without (n = 8), (▼) with removal of the tolerant pulmonary allograft 24 hours before cardiac transplantation (early pneumonectomy) (n = 7), and (▲) with removal of the tolerant pulmonary allograft 30 days after cardiac transplantation (late pneumonectomy) (n = 7). Control vs. early pneumonectomy P &lt; 0.001; control vs. late pneumonectomy P &lt; 0.05; early pneumonectomy vs. late pneumonectomy not significant. Histological appearance (H&amp;E) of (B) long-term-surviving BALB/c heart after transplantation into B6 mouse that carries a tolerant BALB/c lung allograft, (C) rejected BALB/c heart after transplantation into B6 mouse in which tolerant BALB/c lung allograft was removed 24 hours before heart transplantation, and (D) rejected BALB/c heart after transplantation into B6 mouse in which tolerant BALB/c lung allograft was removed 30 days after heart transplantation. Verhoeff’s elastin stain of (E) long-term-surviving BALB/c heart after transplantation into B6 mouse that carries a tolerant BALB/c lung allograft, (F) rejected BALB/c heart after transplantation into B6 mouse in which tolerant BALB/c lung allograft was removed 24 hours before heart transplantation, and (G) rejected BALB/c heart after transplantation into B6 mouse in which tolerant BALB/c lung allograft was removed 30 days after heart transplantation. CTRL, control; PNX, pneumonectomy. Scale bars: 100 μm.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/136000/136057/small/JCI136057.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41679-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/136057">Lymphatic drainage from bronchus-associated lymphoid tissue in tolerant lung allografts promotes peripheral tolerance</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/136057">Text</a></li>
<li><a class="button tiny" href="/articles/view/136057/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Tertiary lymphoid organs are aggregates of immune and stromal cells including high endothelial venules and lymphatic vessels that resemble secondary lymphoid organs and can be induced at nonlymphoid sites during inflammation. The function of lymphatic vessels within tertiary lymphoid organs remains poorly understood. During lung transplant tolerance, Foxp3+ cells accumulate in tertiary lymphoid organs that are induced within the pulmonary grafts and are critical for the local downregulation of alloimmune responses. Here, we showed that tolerant lung allografts could induce and maintain tolerance of heterotopic donor-matched hearts through pathways that were dependent on the continued presence of the transplanted lung. Using lung retransplantation, we showed that Foxp3+ cells egressed from tolerant lung allografts via lymphatics and were recruited into donor-matched heart allografts. Indeed, survival of the heart allografts was dependent on lymphatic drainage from the tolerant lung allograft to the periphery. Thus, our work indicates that cellular trafficking from tertiary lymphoid organs regulates immune responses in the periphery. We propose that these findings have important implications for a variety of disease processes that are associated with the induction of tertiary lymphoid organs.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Wenjun Li, Jason M. Gauthier, Alice Y. Tong, Yuriko Terada, Ryuji Higashikubo, Christian C. Frye, Margaret S. Harrison, Kohei Hashimoto, Amit I. Bery, Jon H. Ritter, Ruben G. Nava, Varun Puri, Brian W. Wong, Kory J. Lavine, Ankit Bharat, Alexander S. Krupnick, Andrew E. Gelman, Daniel Kreisel</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/140046">Gs/Gq signaling switch in <b>β</b> cells defines incretin effectiveness in diabetes</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41682-more" href="#">
<div class="article-abstract">
By restoring glucose-regulated insulin secretion, glucagon-like peptide-1–based (GLP-1–based) therapies are becoming increasingly important in diabetes care. Normally, the incretins GLP-1 and...
</div>
</a>
<span class="article-published-at">
Published November 16, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/20"><span class="label-specialty">
Endocrinology
</span>
</a><a href="/tags/28"><span class="label-specialty">
Metabolism
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI140046" data-hide-no-mentions="true" data-uuid="2a65fb2e-509f-bf13-e833-e62cbae3ea8b"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;6&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;30&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311&amp;tab=facebook'&gt;&#10;          On &lt;b&gt;1&lt;/b&gt; Facebook pages&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 65" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/65.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/140046/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/140000/140046/small/JCI140046.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41682-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/140046">Gs/Gq signaling switch in <b>β</b> cells defines incretin effectiveness in diabetes</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/140046">Text</a></li>
<li><a class="button tiny" href="/articles/view/140046/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>By restoring glucose-regulated insulin secretion, glucagon-like peptide-1–based (GLP-1–based) therapies are becoming increasingly important in diabetes care. Normally, the incretins GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) jointly maintain normal blood glucose levels by stimulation of insulin secretion in pancreatic β cells. However, the reason why only GLP-1–based drugs are effective in improving insulin secretion after presentation of diabetes has not been resolved. ATP-sensitive K+ (KATP) channels play a crucial role in coupling the systemic metabolic status to β cell electrical activity for insulin secretion. Here, we have shown that persistent membrane depolarization of β cells due to genetic (β cell–specific Kcnj11–/– mice) or pharmacological (long-term exposure to sulfonylureas) inhibition of the KATP channel led to a switch from Gs to Gq in a major amplifying pathway of insulin secretion. The switch determined the relative insulinotropic effectiveness of GLP-1 and GIP, as GLP-1 can activate both Gq and Gs, while GIP only activates Gs. The findings were corroborated in other models of persistent depolarization: a spontaneous diabetic KK-Ay mouse and nondiabetic human and mouse β cells of pancreatic islets chronically treated with high glucose. Thus, a Gs/Gq signaling switch in β cells exposed to chronic hyperglycemia underlies the differential insulinotropic potential of incretins in diabetes.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Okechi S. Oduori, Naoya Murao, Kenju Shimomura, Harumi Takahashi, Quan Zhang, Haiqiang Dou, Shihomi Sakai, Kohtaro Minami, Belen Chanclon, Claudia Guida, Lakshmi Kothegala, Johan Tolö, Yuko Maejima, Norihide Yokoi, Yasuhiro Minami, Takashi Miki, Patrik Rorsman, Susumu Seino</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/143884">Mediastinal germ cell tumors: many questions and perhaps an answer</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41685-more" href="#">
<div class="article-abstract">
Some germ cell tumors (GCTs) in men develop into hematologic malignancies; however, the clonal origins of such malignancies remain unknown. In this issue of the JCI, Taylor, Donoghue, et al....
</div>
</a>
<span class="article-published-at">
Published November 16, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/44"><span class="label-article-type">
Commentary
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI143884" data-hide-no-mentions="true" data-uuid="bb5cb137-884f-0be7-c3e7-82a82e8fe820"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94656887" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94656887&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;2&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94656887'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 2" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/2.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/143884/figure/1" ref="group" title="Model for the pathogenesis of type I and II germ cell tumors. PGCs give origin to extragonadal GCTs. During embryogenesis (shown here at week seven), early PGCs (PGC1, light blue) migrate from the yolk sac to the genital ridge, and along the midline of the body. Early PGCs undergo apoptosis, unless, very rarely, they are reprogrammed (R) to a primed embryonic stem cell (ESC, orange), the stem cell of type I GCTs, usually benign teratomas. Type I GCTs can also develop in the genital ridge/developing gonads prior to completion of epigenetic reprogramming to late PGCs (PGC2, dark blue). Early PGCs escape apoptosis physiologically when they reach the niches in the genital ridge/developing gonad, and nonphysiologically when they lodge in the surrogate niches in the thymus or in the pineal gland/hypothalamus. In each of these niches, early PGCs can complete epigenetic reprogramming to become late PGCs/gonocytes. In the gonads their normal fate is spermatogenesis in the testis and oogenesis in the ovary. Rarely, late PGCs undergo malignant transformation (T) and form the precursor lesions for seminoma (PLS), a malignant GCT (black). A transformed late PGC/gonocyte may be reprogrammed into an ECC (purple), which is the malignant counterpart of a naive ESC, and becomes the stem cell that gives rise to the various components of a nonseminoma. In the thymus and the pineal gland/hypothalamus, late PGCs undergo apoptosis, unless they are transformed to the precursors of seminomas. Also, in these sites, transformed PGCs may be reprogrammed to ECCs, giving rise to nonseminomas, and in the thymus also hematologic malignancy.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/143000/143884/small/JCI143884.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41685-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/143884">Mediastinal germ cell tumors: many questions and perhaps an answer</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/143884">Text</a></li>
<li><a class="button tiny" href="/articles/view/143884/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Some germ cell tumors (GCTs) in men develop into hematologic malignancies; however, the clonal origins of such malignancies remain unknown. In this issue of the JCI, Taylor, Donoghue, et al. unravel the clonal relationship between primary mediastinal nonseminomas (PMNs) and hematologic somatic-type malignancies (HSTMs). Whole-exome sequencing was used to construct phylogenetic trees of the PMNs and the ensuing HSTM clones. HSTMs were derived from multiple distinct clones not detected within the PMNs. Clones from PMNs and HSTMs shared a common precursor, arguably an embryonal carcinoma cell resulting from a reprogrammed primordial germ cell from the thymus. Mutational and copy number variation analysis of a large cohort of patients with PMNs also demonstrated a high prevalence of TP53 mutations not found in testicular nonseminomas. These data likely explain why patients with PMNs are frequently resistant to platinum-based chemotherapy and provide TP53 mutations as potential targets.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>J. Wolter Oosterhuis, Leendert H.J. Looijenga</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/139681">Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41687-more" href="#">
<div class="article-abstract">
BACKGROUND Kisspeptin is a key regulator of hypothalamic gonadotropin-releasing hormone (GnRH) neurons and is essential for reproductive health. A specific kisspeptin receptor (KISS1R) agonist...
</div>
</a>
<span class="article-published-at">
Published November 16, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/3"><span class="label-article-type">
Clinical Medicine
</span>
</a><a href="/tags/20"><span class="label-specialty">
Endocrinology
</span>
</a><a href="/tags/37"><span class="label-specialty">
Reproductive biology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI139681" data-hide-no-mentions="true" data-uuid="eee8f711-307b-0138-7da6-00ffa46ec58a"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;7&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;12&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 61" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/61.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/139681/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/139000/139681/small/JCI139681.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41687-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/139681">Kisspeptin receptor agonist has therapeutic potential for female reproductive disorders</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/139681">Text</a></li>
<li><a class="button tiny" href="/articles/view/139681/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>BACKGROUND Kisspeptin is a key regulator of hypothalamic gonadotropin-releasing hormone (GnRH) neurons and is essential for reproductive health. A specific kisspeptin receptor (KISS1R) agonist could significantly expand the potential clinical utility of therapeutics targeting the kisspeptin pathway. Herein, we investigate the effects of a KISS1R agonist, MVT-602, in healthy women and in women with reproductive disorders.METHODS We conducted in vivo and in vitro studies to characterize the action of MVT-602 in comparison with native kisspeptin-54 (KP54). We determined the pharmacokinetic and pharmacodynamic properties of MVT-602 (doses 0.01 and 0.03 nmol/kg) versus KP54 (9.6 nmol/kg) in the follicular phase of healthy women (n = 9), and in women with polycystic ovary syndrome (PCOS; n = 6) or hypothalamic amenorrhea (HA; n = 6). Further, we investigated their effects on KISS1R-mediated inositol monophosphate (IP1) and Ca2+ signaling in cell lines and on action potential firing of GnRH neurons in brain slices.RESULTS In healthy women, the amplitude of luteinizing hormone (LH) rise was similar to that after KP54, but peaked later (21.4 vs. 4.7 hours; P = 0.0002), with correspondingly increased AUC of LH exposure (169.0 vs. 38.5 IU∙h/L; P = 0.0058). LH increases following MVT-602 were similar in PCOS and healthy women, but advanced in HA (P = 0.004). In keeping with the clinical data, MVT-602 induced more potent signaling of KISS1R-mediated IP1 accumulation and a longer duration of GnRH neuron firing than KP54 (115 vs. 55 minutes; P = 0.0012).CONCLUSION Taken together, these clinical and mechanistic data identify MVT-602 as having considerable therapeutic potential for the treatment of female reproductive disorders.TRIAL REGISTRATION International Standard Randomised Controlled Trial Number (ISRCTN) Registry, ISRCTN21681316.FUNDING National Institute for Health Research and NIH.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Ali Abbara, Pei Chia Eng, Maria Phylactou, Sophie A. Clarke, Rachel Richardson, Charlene M. Sykes, Chayarndorn Phumsatitpong, Edouard Mills, Manish Modi, Chioma Izzi-Engbeaya, Debbie Papadopoulou, Kate Purugganan, Channa N. Jayasena, Lisa Webber, Rehan Salim, Bryn Owen, Paul Bech, Alexander N. Comninos, Craig A. McArdle, Margaritis Voliotis, Krasimira Tsaneva-Atanasova, Suzanne Moenter, Aylin Hanyaloglu, Waljit S. Dhillo</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12  columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/143466">What are protective antibody responses to pandemic SARS-CoV-2?</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41638-more" href="#">
<div class="article-abstract">
Human antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hold intense interest, with research efforts directed at optimizing antibody-based interventions and...
</div>
</a>
<span class="article-published-at">
Published October 15, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/44"><span class="label-article-type">
Commentary
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI143466" data-hide-no-mentions="true" data-uuid="64f901ea-e858-62c0-dd06-89cf9c1e3df1"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92450955" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92450955&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;4&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;10&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92450955'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 3" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/3.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41638-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/143466">What are protective antibody responses to pandemic SARS-CoV-2?</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/143466">Text</a></li>
<li><a class="button tiny" href="/articles/view/143466/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Human antibody responses to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) hold intense interest, with research efforts directed at optimizing antibody-based interventions and monitoring immune status. By relating individual variations in antibody response to coronavirus disease 2019 (COVID-19) severity, beneficial antiviral immune responses may be identified in detail. In this issue of the JCI, Secchi and collaborators describe antibody response profiles in 509 patients with COVID-19 from Italy during the 2020 pandemic. The research team found that multiple antibody types to multiple SARS-CoV-2 antigens developed over four weeks. Notably, IgG against the spike receptor binding domain (RBD) was predictive of survival and IgA against the viral spike protein (S protein) associated with rapid virologic clearance. These results may help guide selection of convalescent plasma, hyperimmune products, monoclonal antibodies, and vaccine strategies for COVID-19.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Jeffrey P. Henderson</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/140189"><i>BCL11A</i> enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41641-more" href="#">
<div class="article-abstract">
Gene editing of the erythroid-specific BCL11A enhancer in hematopoietic stem and progenitor cells (HSPCs) from patients with sickle cell disease (SCD) induces fetal hemoglobin (HbF) without...
</div>
</a>
<span class="article-published-at">
Published September 8, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/23"><span class="label-specialty">
Hematology
</span>
</a><a href="/tags/40"><span class="label-specialty">
Transplantation
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI140189" data-hide-no-mentions="true" data-uuid="097fc16a-4b43-8171-9589-6d8d8627cf9c"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89690979" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89690979&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;12&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;6&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89690979'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 7" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/7.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/140189/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/140000/140189/small/JCI140189.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41641-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/140189"><i>BCL11A</i> enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/140189">Text</a></li>
<li><a class="button tiny" href="/articles/view/140189/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Gene editing of the erythroid-specific BCL11A enhancer in hematopoietic stem and progenitor cells (HSPCs) from patients with sickle cell disease (SCD) induces fetal hemoglobin (HbF) without detectable toxicity, as assessed by mouse xenotransplant. Here, we evaluated autologous engraftment and HbF induction potential of erythroid-specific BCL11A enhancer–edited HSPCs in 4 nonhuman primates. We used a single guide RNA (sgRNA) with identical human and rhesus target sequences to disrupt a GATA1 binding site at the BCL11A +58 erythroid enhancer. Cas9 protein and sgRNA ribonucleoprotein complex (RNP) was electroporated into rhesus HSPCs, followed by autologous infusion after myeloablation. We found that gene edits persisted in peripheral blood (PB) and bone marrow (BM) for up to 101 weeks similarly for BCL11A enhancer– or control locus–targeted (AAVS1-targeted) cells. Biallelic BCL11A enhancer editing resulted in robust γ-globin induction, with the highest levels observed during stress erythropoiesis. Indels were evenly distributed across PB and BM lineages. Off-target edits were not observed. Nonhomologous end-joining repair alleles were enriched in engrafting HSCs. In summary, we found that edited HSCs can persist for at least 101 weeks after transplant and biallelic-edited HSCs provide substantial HbF levels in PB red blood cells, together supporting further clinical translation of this approach.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Selami Demirci, Jing Zeng, Yuxuan Wu, Naoya Uchida, Anne H. Shen, Danilo Pellin, Jackson Gamer, Morgan Yapundich, Claire Drysdale, Jasmine Bonanno, Aylin C. Bonifacino, Allen E. Krouse, Nathaniel S. Linde, Theresa Engels, Robert E. Donahue, Juan J. Haro-Mora, Alexis Leonard, Tina Nassehi, Kevin Luk, Shaina N. Porter, Cicera R. Lazzarotto, Shengdar Q. Tsai, Mitchell J. Weiss, Shondra M. Pruett-Miller, Scot A. Wolfe, Daniel E. Bauer, John F. Tisdale</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/135665">Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41643-more" href="#">
<div class="article-abstract">
The sodium-phosphate cotransporter NPT2a plays a key role in the reabsorption of filtered phosphate in proximal renal tubules, thereby critically contributing to phosphate homeostasis. Inadequate...
</div>
</a>
<span class="article-published-at">
Published August 27, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/20"><span class="label-specialty">
Endocrinology
</span>
</a><a href="/tags/31"><span class="label-specialty">
Nephrology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI135665" data-hide-no-mentions="true" data-uuid="18bd3dcd-7599-0b16-a040-822c0a188174"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91124905" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91124905&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;3&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91124905'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 2" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/2.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/135665/figure/1" ref="group" title="PF-06869206 inhibits phosphate uptake in primary rat PRT cells. PRT cells were treated with increasing doses of PF-06869206 (30 nM to 30 μM), DMSO vehicle (0 mg/kg PF-06869206), or PFA ( 5 mM, positive control) for 30 minutes. 32P was then added to the cells for 5 minutes, and the cells were rinsed to remove unincorporated 32P. Phosphate uptake by the cells was derived from cell-associated radioactivity measured after cell lysis. Phosphate uptake data are reported as the percentage of vehicle control and shown as the mean ± SEM of cells from 3 animals. P &lt; 0.05, mixed-effects model.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/135000/135665/small/JCI135665.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41643-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/135665">Selective pharmacological inhibition of the sodium-dependent phosphate cotransporter NPT2a promotes phosphate excretion</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/135665">Text</a></li>
<li><a class="button tiny" href="/articles/view/135665/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>The sodium-phosphate cotransporter NPT2a plays a key role in the reabsorption of filtered phosphate in proximal renal tubules, thereby critically contributing to phosphate homeostasis. Inadequate urinary phosphate excretion can lead to severe hyperphosphatemia as in tumoral calcinosis and chronic kidney disease (CKD). Pharmacological inhibition of NPT2a may therefore represent an attractive approach for treating hyperphosphatemic conditions. The NPT2a-selective small-molecule inhibitor PF-06869206 was previously shown to reduce phosphate uptake in human proximal tubular cells in vitro. Here, we investigated the acute and chronic effects of the inhibitor in rodents and report that administration of PF-06869206 was well tolerated and elicited a dose-dependent increase in fractional phosphate excretion. This phosphaturic effect lowered plasma phosphate levels in WT mice and in rats with CKD due to subtotal nephrectomy. PF-06869206 had no effect on Npt2a-null mice, but promoted phosphate excretion and reduced phosphate levels in normophophatemic mice lacking Npt2c and in hyperphosphatemic mice lacking Fgf23 or Galnt3. In CKD rats, once-daily administration of PF-06869206 for 8 weeks induced an unabated acute phosphaturic and hypophosphatemic effect, but had no statistically significant effect on FGF23 or PTH levels. Selective pharmacological inhibition of NPT2a thus holds promise as a therapeutic option for genetic and acquired hyperphosphatemic disorders.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Valerie Clerin, Hiroshi Saito, Kevin J. Filipski, An Hai Nguyen, Jeonifer Garren, Janka Kisucka, Monica Reyes, Harald Jüppner</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/137712">Maintenance DNA methylation is essential for regulatory T cell development and stability of suppressive function</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41646-more" href="#">
<div class="article-abstract">
Tregs require Foxp3 expression and induction of a specific DNA hypomethylation signature during development, after which Tregs persist as a self-renewing population that regulates immune system...
</div>
</a>
<span class="article-published-at">
Published September 8, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/13"><span class="label-specialty">
Autoimmunity
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI137712" data-hide-no-mentions="true" data-uuid="431dbed3-96d4-b323-827d-f80cfaf64312"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;27&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679&amp;tab=reddit'&gt;&#10;          Reddited by &lt;b&gt;1&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;3&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 19" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/19.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/137712/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/137000/137712/small/JCI137712.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41646-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/137712">Maintenance DNA methylation is essential for regulatory T cell development and stability of suppressive function</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/137712">Text</a></li>
<li><a class="button tiny" href="/articles/view/137712/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Tregs require Foxp3 expression and induction of a specific DNA hypomethylation signature during development, after which Tregs persist as a self-renewing population that regulates immune system activation. Whether maintenance DNA methylation is required for Treg lineage development and stability and how methylation patterns are maintained during lineage self-renewal remain unclear. Here, we demonstrate that the epigenetic regulator ubiquitin-like with plant homeodomain and RING finger domains 1 (Uhrf1) is essential for maintenance of methyl-DNA marks that stabilize Treg cellular identity by repressing effector T cell transcriptional programs. Constitutive and induced deficiency of Uhrf1 within Foxp3+ cells resulted in global yet nonuniform loss of DNA methylation, derepression of inflammatory transcriptional programs, destabilization of the Treg lineage, and spontaneous inflammation. These findings support a paradigm in which maintenance DNA methylation is required in distinct regions of the Treg genome for both lineage establishment and stability of identity and suppressive function.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Kathryn A. Helmin, Luisa Morales-Nebreda, Manuel A. Torres Acosta, Kishore R. Anekalla, Shang-Yang Chen, Hiam Abdala-Valencia, Yuliya Politanska, Paul Cheresh, Mahzad Akbarpour, Elizabeth M. Steinert, Samuel E. Weinberg, Benjamin D. Singer</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/125297">Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41649-more" href="#">
<div class="article-abstract">
Chronic viral infections are often established by the exploitation of immune-regulatory mechanisms that result in nonfunctional T cell responses. Viruses that establish persistent infections remain...
</div>
</a>
<span class="article-published-at">
Published September 8, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><a href="/tags/43"><span class="label-specialty">
Virology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI125297" data-hide-no-mentions="true" data-uuid="e2f58365-a56f-2da7-8bd7-c000f02d52be"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;7&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;10&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;2&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 59" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/59.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/125297/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/125000/125297/small/JCI125297.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41649-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/125297">Sphingosine kinase 2 restricts T cell immunopathology but permits viral persistence</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/125297">Text</a></li>
<li><a class="button tiny" href="/articles/view/125297/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Chronic viral infections are often established by the exploitation of immune-regulatory mechanisms that result in nonfunctional T cell responses. Viruses that establish persistent infections remain a serious threat to human health. Sphingosine kinase 2 (SphK2) generates sphingosine 1-phosphate, which is a molecule known to regulate multiple cellular processes. However, little is known about SphK2’s role during the host immune responses to viral infection. Here, we demonstrate that SphK2 functions during lymphocytic choriomeningitis virus Cl 13 (LCMV Cl 13) infection to limit T cell immune pathology, which subsequently aids in the establishment of virus-induced immunosuppression and the resultant viral persistence. The infection of Sphk2-deficient (Sphk2–/–) mice with LCMV Cl 13 led to the development of nephropathy and mortality via T cell–mediated immunopathology. Following LCMV infection, Sphk2–/– CD4+ T cells displayed increased activity and proliferation, and these cells promoted overactive LCMV Cl 13–specific CD8+ T cell responses. Notably, oral instillation of an SphK2-selective inhibitor promoted protective T cell responses and accelerated the termination of LCMV Cl 13 persistence in mice. Thus, SphK2 is indicated as an immunotherapeutic target for the control of persistent viral infections.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Caleb J. Studstill, Curtis J. Pritzl, Young-Jin Seo, Dae Young Kim, Chuan Xia, Jennifer J. Wolf, Ravi Nistala, Madhuvanthi Vijayan, Yong-Bin Cho, Kyung Won Kang, Sang-Myeong Lee, Bumsuk Hahm</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/136105">A GABAergic neural circuit in the ventromedial hypothalamus mediates chronic stress–induced bone loss</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41652-more" href="#">
<div class="article-abstract">
Homeostasis of bone metabolism is regulated by the central nervous system, and mood disorders such as anxiety are associated with bone metabolism abnormalities, yet our understanding of the central...
</div>
</a>
<span class="article-published-at">
Published September 10, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/51"><span class="label-article-type">
Research Article
</span>
</a><a href="/tags/14"><span class="label-specialty">
Bone biology
</span>
</a><a href="/tags/32"><span class="label-specialty">
Neuroscience
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI136105" data-hide-no-mentions="true" data-uuid="720b551b-eff1-93ec-ac06-572eb521f96e"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;9&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;21&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;11&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 84" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/84.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/136105/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/136000/136105/small/JCI136105.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41652-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/136105">A GABAergic neural circuit in the ventromedial hypothalamus mediates chronic stress–induced bone loss</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/136105">Text</a></li>
<li><a class="button tiny" href="/articles/view/136105/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Homeostasis of bone metabolism is regulated by the central nervous system, and mood disorders such as anxiety are associated with bone metabolism abnormalities, yet our understanding of the central neural circuits regulating bone metabolism is limited. Here, we demonstrate that chronic stress in crewmembers resulted in decreased bone density and elevated anxiety in an isolated habitat mimicking a space station. We then used a mouse model to demonstrate that GABAergic neural circuitry in the ventromedial hypothalamus (VMH) mediates chronic stress–induced bone loss. We show that GABAergic inputs in the dorsomedial VMH arise from a specific group of somatostatin neurons in the posterior region of the bed nucleus of the stria terminalis, which is indispensable for stress-induced bone loss and is able to trigger bone loss in the absence of stressors. In addition, the sympathetic system and glutamatergic neurons in the nucleus tractus solitarius were employed to regulate stress-induced bone loss. Our study has therefore identified the central neural mechanism by which chronic stress–induced mood disorders, such as anxiety, influence bone metabolism.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Fan Yang, Yunhui Liu, Shanping Chen, Zhongquan Dai, Dazhi Yang, Dashuang Gao, Jie Shao, Yuyao Wang, Ting Wang, Zhijian Zhang, Lu Zhang, William W. Lu, Yinghui Li, Liping Wang</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/142804">COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41658-more" href="#">
<div class="article-abstract">
BACKGROUND Serological assays are of critical importance to investigate correlates of response and protection in coronavirus disease 2019 (COVID-19), to define previous exposure to severe acute...
</div>
</a>
<span class="article-published-at">
Published September 29, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/3"><span class="label-article-type">
Clinical Medicine
</span>
</a><a href="/tags/118"><span class="label-specialty">
COVID-19
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI142804" data-hide-no-mentions="true" data-uuid="91daefe7-ed45-64cf-c139-3638ff9b81de"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;13&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975&amp;tab=blogs'&gt;&#10;          Blogged by &lt;b&gt;1&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;16&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div class='altmetric-embed readers' style='margin-top: 10px;'&gt;&#10;          &lt;div class='altmetric-embed tip_mendeley'&#10;               style='padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;'&gt;&#10;              &lt;b&gt;14&lt;/b&gt; readers on Mendeley&#10;          &lt;/div&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 123" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/123.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/142804/figure/1" ref="group" title="Flow diagram of patients characterized in the study. All patients included in the study had a confirmed SARS-CoV-2 infection as defined by a positive RT-PCR from a nasal/throat swab and/or signs, symptoms, and radiological findings suggestive of COVID-19 pneumonia.">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/142000/142804/small/JCI142804.f1.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41658-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/142804">COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike receptor binding domain</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/142804">Text</a></li>
<li><a class="button tiny" href="/articles/view/142804/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>BACKGROUND Serological assays are of critical importance to investigate correlates of response and protection in coronavirus disease 2019 (COVID-19), to define previous exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in populations, and to verify the development of an adaptive immune response in infected individuals.METHODS We studied 509 patients confirmed to have COVID-19 from the San Raffaele Hospital of Milan and 480 samples of prepandemic organ donor sera collected in 2010–2012. Using fluid-phase luciferase immune precipitation (LIPS) assays, we characterized IgG, IgM, and IgA antibodies to the spike receptor binding domain (RBD), S1+S2, nucleocapsid, and ORF6 to ORF10 of SARS-CoV-2, to the HCoV-OC43 and HCoV-HKU1 betacoronaviruses spike S2, and the H1N1Ca2009 flu virus hemagglutinin. Sequential samples at 1 and 3 months after hospital discharge were also tested for SARS-CoV-2 RBD antibodies in 95 patients.RESULTS Antibodies developed rapidly against multiple SARS-CoV-2 antigens in 95% of patients by 4 weeks after symptom onset and IgG to the RBD increased until the third month of follow-up. We observed a major synchronous expansion of antibodies to the HCoV-OC43 and HCoV-HKU1 spike S2. A likely coinfection with influenza was neither linked to a more severe presentation of the disease nor to a worse outcome. Of the measured antibody responses, positivity for IgG against the SARS-CoV-2 spike RBD was predictive of survival.CONCLUSION The measurement of antibodies to selected epitopes of SARS-CoV-2 antigens can offer a more accurate assessment of the humoral response in patients and its impact on survival. The presence of partially cross-reactive antibodies with other betacoronaviruses is likely to impact on serological assay specificity and interpretation.TRIAL REGISTRATION COVID-19 Patients Characterization, Biobank, Treatment Response and Outcome Predictor (COVID-BioB). ClinicalTrials.gov identifier: NCT04318366.FUNDING IRCCS Ospedale San Raffaele and Università Vita Salute San Raffaele.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Massimiliano Secchi, Elena Bazzigaluppi, Cristina Brigatti, Ilaria Marzinotto, Cristina Tresoldi, Patrizia Rovere-Querini, Andrea Poli, Antonella Castagna, Gabriella Scarlatti, Alberto Zangrillo, Fabio Ciceri, Lorenzo Piemonti, Vito Lampasona</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/140797">Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41642-more" href="#">
<div class="article-abstract">
BACKGROUND Interpatient differences in the accumulation of methotrexate’s active polyglutamylated metabolites (MTXPGs) in leukemia cells influence its antileukemic effects.METHODS To identify...
</div>
</a>
<span class="article-published-at">
Published November 9, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/3"><span class="label-article-type">
Clinical Medicine
</span>
</a><a href="/tags/23"><span class="label-specialty">
Hematology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI140797" data-hide-no-mentions="true" data-uuid="52fdf4a1-7651-a35b-5711-9983caf9fd8a"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284&amp;tab=news'&gt;&#10;          Picked up by &lt;b&gt;1&lt;/b&gt; news outlets&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;6&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 13" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/13.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
<div class="medium-3 hide-for-small columns">
<a href="https://www.jci.org/articles/view/140797/ga" ref="group" title="Graphical abstract">
<img src="//dm5migu4zj3pb.cloudfront.net/manuscripts/140000/140797/small/JCI140797.ga.gif" />
</a>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41642-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/140797">Pharmacogenomics of intracellular methotrexate polyglutamates in patients’ leukemia cells in vivo</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/140797">Text</a></li>
<li><a class="button tiny" href="/articles/view/140797/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>BACKGROUND Interpatient differences in the accumulation of methotrexate’s active polyglutamylated metabolites (MTXPGs) in leukemia cells influence its antileukemic effects.METHODS To identify genomic and epigenomic and patient variables determining the intracellular accumulation of MTXPGs, we measured intracellular MTXPG levels in acute lymphoblastic leukemia (ALL) cells from 388 newly diagnosed patients after in vivo high-dose methotrexate (HDMTX) (1 g/m2) treatment, defined ALL subtypes, and assessed genomic and epigenomic variants influencing folate pathway genes (mRNA, miRNA, copy number alterations [CNAs], SNPs, single nucleotide variants [SNVs], CpG methylation).RESULTS We documented greater than 100-fold differences in MTXPG levels, which influenced its antileukemic effects (P = 4 × 10–5). Three ALL subtypes had lower MTXPG levels (T cell ALL [T-ALL] and B cell ALL [B-ALL] with the TCF3-PBX1 or ETV6-RUNX1 fusions), and 2 subtypes had higher MTXPG levels (hyperdiploid and BCR-ABL like). The folate pathway genes SLC19A1, ABCC1, ABCC4, FPGS, and MTHFD1 significantly influenced intracellular MTXPG levels (P = 2.9 × 10–3 to 3.7 × 10–8). A multivariable model including the ALL subtype (P = 1.1 × 10–14), the SLC19A1/(ABCC1 + ABCC4) transporter ratio (P = 3.6 × 10–4), the MTX infusion time (P = 1.5 × 10–3), FPGS mRNA expression (P = 2.1 × 10–3), and MTX systemic clearance (P = 4.4 × 10–2) explained 42% of the variation in MTXPG accumulation (P = 1.1 × 10–38). Model simulations indicated that a longer infusion time (24 h vs. 4 h) was superior in achieving higher intracellular MTXPG levels across all subtypes if ALL.CONCLUSIONS These findings provide insights into mechanisms underlying interpatient differences in intracellular accumulation of MTXPG in leukemia cells and its antileukemic effectsFUNDING THE National Cancer Institute (NCI) and the Institute of General Medical Sciences of the NIH, the Basque Government Programa Posdoctoral de Perfeccionamiento de Personal Investigador doctor, and the American Lebanese Syrian Associated Charities (ALSAC).</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Elixabet Lopez-Lopez, Robert J. Autry, Colton Smith, Wenjian Yang, Steven W. Paugh, John C. Panetta, Kristine R. Crews, Erik J. Bonten, Brandon Smart, Deqing Pei, J. Robert McCorkle, Barthelemy Diouf, Kathryn G. Roberts, Lei Shi, Stanley Pounds, Cheng Cheng, Charles G. Mullighan, Ching-Hon Pui, Mary V. Relling, William E. Evans</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />

<h4>
In-Press Preview
<small>- <a title="View more In-Press Preview articles" href="/in-press-preview">More</a></small>
</h4>
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/142468">TREM-1 orchestrates Angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41758-more" href="#">
<div class="article-abstract">
The triggering receptor expressed on myeloid cells-1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our...
</div>
</a>
<span class="article-published-at">
Published December 1, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/106"><span class="label-article-type">
Research
</span>
</a><a href="/tags/113"><span class="label-in-press-preview">
In-Press Preview
</span>
</a><a href="/tags/27"><span class="label-specialty">
Inflammation
</span>
</a><a href="/tags/42"><span class="label-specialty">
Vascular biology
</span>
</a><span class="altmetric-embed altmetric-hidden" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI142468" data-hide-no-mentions="true" data-uuid="d3551e67-2881-e874-2b76-a3942e7c5983"></span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41758-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/142468">TREM-1 orchestrates Angiotensin II-induced monocyte trafficking and promotes experimental abdominal aortic aneurysm</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/142468">Text</a></li>
<li><a class="button tiny" href="/articles/view/142468/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>The triggering receptor expressed on myeloid cells-1 (TREM-1) drives inflammatory responses in several cardiovascular diseases but its role in abdominal aortic aneurysm (AAA) remains unknown. Our objective was to explore the role of TREM-1 in a mouse model of Angiotensin (Ang) II-induced AAA. TREM-1 expression was detected in mouse aortic aneurysm and colocalizes with macrophages. Trem1 gene deletion (Apoe-/-Trem1-/-), as well as TREM-1 pharmacological blockade with LR-12 peptide limited both AAA development and severity. Trem1 gene deletion attenuated the inflammatory response in the aorta, with a reduction of Il1b, Tnfa, Mmp2 and Mmp9 mRNA expression, and led to a decreased macrophage content, due to a reduction of Ly6Chi classical monocyte trafficking. Conversely, antibody-mediated TREM-1 stimulation exacerbated Ly6Chi monocyte aorta infiltration after AngII infusion through CD62L up-regulation and promoted pro-inflammatory signature in the aorta, resulting in worsening AAA severity. AngII infusion stimulated TREM-1 expression and activation on Ly6Chi monocytes through AngII Receptor Type I (AT1R). In human AAA, TREM-1 was detected and TREM1 mRNA expression correlated with SELL mRNA expression. Finally, circulating levels of sTREM-1 were increased in patients with AAA when compared to patients without AAA. In conclusion, TREM-1 is involved in AAA pathophysiology and may represent a promising therapeutic target in human.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Marie Vandestienne, Yujiao Zhang, Icia Santos-Zas, Rida Al-Rifai, Jeremie Joffre, Andreas Giraud, Ludivine Laurans, Bruno Esposito, Florence Pinet, Patrick Bruneval, Juliette Raffort, Fabien Lareyre, Jose Vilar, Amir Boufenzer, Lea Guyonnet, Coralie L. Guerin, Eric Clauser, Jean-Sébastien Silvestre, Sylvie Lang, Laurie Soulat-Dufour, Alain Tedgui, Ziad Mallat, Soraya Taleb, Alexandre Boissonnas, Marc Derive, Giulia Chinetti, Hafid Ait-Oufella</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/136655">The vascular landscape of human cancer</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41763-more" href="#">
<div class="article-abstract">
Tumors depend on a blood supply to deliver oxygen and nutrients, making tumor vasculature an attractive anti-cancer target. However, only a fraction of cancer patients benefits from angiogenesis...
</div>
</a>
<span class="article-published-at">
Published December 1, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/106"><span class="label-article-type">
Research
</span>
</a><a href="/tags/113"><span class="label-in-press-preview">
In-Press Preview
</span>
</a><a href="/tags/12"><span class="label-specialty">
Angiogenesis
</span>
</a><a href="/tags/33"><span class="label-specialty">
Oncology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI136655" data-hide-no-mentions="true" data-uuid="5d020305-d4dd-fa43-83b7-070d13ace940"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=95335433" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=95335433&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;14&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=95335433'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 8" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/8.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41763-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/136655">The vascular landscape of human cancer</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/136655">Text</a></li>
<li><a class="button tiny" href="/articles/view/136655/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Tumors depend on a blood supply to deliver oxygen and nutrients, making tumor vasculature an attractive anti-cancer target. However, only a fraction of cancer patients benefits from angiogenesis inhibitors. Whether anti-angiogenic therapy would be more effective if targeted to individuals with specific tumor characteristics is unknown. To better characterize the tumor vascular environment both within and between cancer types, we developed a standardized metric – the Endothelial Index (EI) – to estimate vascular density in over 10,000 human tumors, corresponding to 31 solid tumor types, from transcriptome data. We then used this index to compare hyper- and hypo-vascular tumors, enabling the classification of human tumors into six vascular microenvironment signatures (VMSs) based on the expression of a panel of 24 vascular hub genes. EI and VMS correlated with known tumor vascular features and were independently associated with prognosis in certain cancer types. Retrospective testing of clinical trial data identified VMS2 classification as a powerful biomarker for response to bevacizumab. Our studies thus provide an unbiased picture of human tumor vasculature which may enable more precise deployment of anti-angiogenesis therapy.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Benjamin M. Kahn, Alfredo Lucas, Rohan Alur, Maximilian D. Wengyn, Gregory W. Schwartz, Jinyang Li, Kathryn Sun, H. Carlo Maurer, Kenneth P. Olive, Robert B. Faryabi, Ben Stanger</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/144450">Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41742-more" href="#">
<div class="article-abstract">
Intellectual and social disabilities are common comorbidities in adolescents and adults with MAGEL2 gene deficiency characterizing the Prader-Willi and Schaaf-Yang neurodevelopmental syndromes. The...
</div>
</a>
<span class="article-published-at">
Published November 24, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/106"><span class="label-article-type">
Research
</span>
</a><a href="/tags/113"><span class="label-in-press-preview">
In-Press Preview
</span>
</a><a href="/tags/32"><span class="label-specialty">
Neuroscience
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI144450" data-hide-no-mentions="true" data-uuid="231d8dd8-b3c6-1dfb-e27d-f1f98dbeb961"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94927422" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94927422&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;11&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94927422'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 5" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/5.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41742-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/144450">Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/144450">Text</a></li>
<li><a class="button tiny" href="/articles/view/144450/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>Intellectual and social disabilities are common comorbidities in adolescents and adults with MAGEL2 gene deficiency characterizing the Prader-Willi and Schaaf-Yang neurodevelopmental syndromes. The cellular and molecular mechanisms underlying the risk for autism in these syndromes are not understood. We ask whether vasopressin functions are altered by MAGEL2 deficiency and whether a treatment with vasopressin can alleviate the disabilities of social behavior. We used Magel2 knockout mice (adult males) combined with optogenetic or pharmacological tools to characterize disease modifications in the vasopressinergic brain system and monitor its impact on neurophysiological and behavioral functions. We find that the activation of vasopressin neurons and its projections in the lateral septum are inappropriate to perform a social habituation/discrimination task. Mechanistically, the lack of vasopressin impedes the deactivation of somatostatin neurons in the lateral septum, which predicts social discrimination deficits. Correction of vasopressin septal content by administration or optogenetic stimulation of projecting axons suppressed the activity of somatostatin neurons and ameliorated social behavior. This preclinical study identifies vasopressin in the lateral septum as a key factor in the pathophysiology.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Amélie M. Borie, Yann Dromard, Gilles Guillon, Aleksandra Olma, Maurice Manning, Françoise Muscatelli, Michel G. Desarmenien, Freddy Jeanneteau</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12 medium-9 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/137001">Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41743-more" href="#">
<div class="article-abstract">
The tumor microenvironment affects the outcome of radiotherapy against head and neck squamous cell carcinoma (HNSCC). We recently found that tolerogenic myeloid cells accumulate in circulation of...
</div>
</a>
<span class="article-published-at">
Published November 24, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/106"><span class="label-article-type">
Research
</span>
</a><a href="/tags/113"><span class="label-in-press-preview">
In-Press Preview
</span>
</a><a href="/tags/25"><span class="label-specialty">
Immunology
</span>
</a><a href="/tags/33"><span class="label-specialty">
Oncology
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI137001" data-hide-no-mentions="true" data-uuid="53dd9c73-a5d7-417e-c4d9-a18818b294af"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94940250" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94940250&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;6&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94940250'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 4" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/4.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41743-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/137001">Myeloid cell-targeted STAT3 inhibition sensitizes head and neck cancers to radiotherapy and T cell-mediated immunity</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/137001">Text</a></li>
<li><a class="button tiny" href="/articles/view/137001/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>The tumor microenvironment affects the outcome of radiotherapy against head and neck squamous cell carcinoma (HNSCC). We recently found that tolerogenic myeloid cells accumulate in circulation of HNSCC patients undergoing radiotherapy. Here, we analyzed tumor-containing lymph nodes biopsies collected from these patients. After two-weeks of radiotherapy, we found an increase in tumor-associated macrophages (TAMs) with activated STAT3, while CD8 T-cells were reduced as detected using multiplex IHC. Gene expression profiling indicated upregulation of M2 macrophage-related genes (CD163, CD206), immunosuppressive mediators (ARG1, LIF, TGFB1) and Th2 cytokines (IL4, IL5) in irradiated tumors. We next validated STAT3 as a potential target in human HNSCC-associated TAMs, using UM-SCC1 xenotransplants in humanized mice. Local injections of myeloid cell-targeted STAT3 antisense oligonucleotide (CpG-STAT3ASO) activated human DCs/macrophages, promoted CD8 T-cell recruitment and thereby arrested UM-SCC1 tumor growth. Furthermore, CpG-STAT3ASO synergized with tumor irradiation against syngeneic HPV+ mEERL and HPV– MOC2 HNSCC tumors in mice, triggering tumor regression and/or extending animal survival. The antitumor immune responses were CD8+ and CD4+ T-cell-dependent and associated with the activation of antigen-presenting cells (DCs/M1 macrophages) and increased CD8+ to regulatory T-cell ratio. Our observations suggest that targeted inhibition of STAT3 in tumor-associated myeloid cells augments the efficacy of radiotherapy against HNSCC.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>Dayson Moreira, Sagus Sampath, Haejung Won, Seok Voon White, Yu-Lin Su, Marice Alcantara, Chongkai Wang, Peter P. Lee, Ellie Maghami, Erminia Massarelli, Marcin Kortylewski</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />
<div class="row">
<div class="small-12  columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="display: inline-block;"><a href="/articles/view/144807">Does common cold coronavirus infection protect against severe SARS-CoV2 disease?</a></h5>
</div>
</div>
<div class="row">
<div class="small-12 columns article-metadata">
<a class="hide-for-small show-more" data-reveal-id="article41746-more" href="#">
<div class="article-abstract">
The coronavirus disease 2019 (COVID 19) pandemic continues to cause morbidity and mortality. Since severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was identified as the cause for COVID...
</div>
</a>
<span class="article-published-at">
Published November 20, 2020
</span>
<div class="row">
<div class="small-12 columns article-links">
</div>
</div>
<div class="row">
<div class="small-12 columns">
<a href="/tags/44"><span class="label-article-type">
Commentary
</span>
</a><a href="/tags/113"><span class="label-in-press-preview">
In-Press Preview
</span>
</a><span class="altmetric-embed" data-badge-popover="bottom" data-badge-type="2" data-doi="10.1172/JCI144807" data-hide-no-mentions="true" data-uuid="cef52b02-f301-00c2-03b8-5251d9045402"><a target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94672921" rel="popover" data-content="&lt;div&gt;    &lt;div style='padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;'&gt;&#10;      &lt;a class='link-to-altmetric-details-tab' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94672921&amp;tab=twitter'&gt;&#10;          Tweeted by &lt;b&gt;67&lt;/b&gt;&#10;      &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&#10;    &lt;div style='margin-top: 10px; text-align: center;'&gt;&#10;        &lt;a class='altmetric_details' target='_self' href='https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94672921'&gt;&#10;            See more details&#10;        &lt;/a&gt;&#10;    &lt;/div&gt;&#10;&lt;/div&gt;" style="display:inline-block;" data-badge-popover="bottom">
        <img alt="Article has an altmetric score of 41" src="https://d1uo4w7k31k5mn.cloudfront.net/v2_hq/41.png" width="88" height="18" style="border:0; margin:0; max-width: none;" />
</a></span>
</div>
</div>
</div>
</div>
</div>
</div>
<div class="reveal-modal xlarge" data-reveal="" id="article41746-more">
<div class="row">
<div class="small-12 columns">
<h4><a href="/articles/view/144807">Does common cold coronavirus infection protect against severe SARS-CoV2 disease?</a></h4>
</div>
<div class="small-12 columns">
<ul class="button-group">
<li><a class="button tiny" href="/articles/view/144807">Text</a></li>
<li><a class="button tiny" href="/articles/view/144807/pdf">PDF</a></li>
</ul>
</div>
<div class="small-12 columns">
<h5>Abstract</h5>
</div>
<div class="small-12 columns">
<p>The coronavirus disease 2019 (COVID 19) pandemic continues to cause morbidity and mortality. Since severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was identified as the cause for COVID 19, some have questioned whether exposure to seasonal common cold coronaviruses (CCCs) could provide tangible protection against SARS-CoV-2 infection or disease. In this issue of the JCI, Sager, et al. examined SARS-CoV-2 infections and outcomes from patients previously tested for CCC as part of a comprehensive respiratory panel using PCR and were segregated into negative (CCC–) or positive (CCC+) exposure. No differences were seen between groups in terms of susceptibility to SARS-CoV-2 infection. However, hospitalized patients with a documented history of CCC+ infection had lower rates of ICU admissions and higher rates of survival than hospitalized CCC– patients. While these findings are associative and not causative, they highlight evidence suggesting that previous CCC+ infection may influence the disease course of SARS-CoV-2 infection.</p>
</div>
<div class="small-12 columns">
<h5>Authors</h5>
</div>
<div class="small-12 columns">
<p>David K. Meyerholz, Stanley Perlman</p>
</div>
</div>
<a class="close-reveal-modal">×</a>
</div>

<hr />

</div>
</div>

</div>
</div>

<div class="row panel-padding">
<div class="small-12 columns">
<h5>View more articles by topic:</h5>
</div>
<div class="small-12 columns">
<div class="row">
<div class="large-4 columns">
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/10">Aging</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/11">AIDS/HIV</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/12">Angiogenesis</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/13">Autoimmunity</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/119">Bone
Biology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/14">Bone biology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/15">Cardiology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/16">Cell biology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/17">Clinical trials</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/118">COVID-19</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/18">Dermatology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/19">Development</a></p>
</div>
</div>
</div>
<div class="large-4 columns">
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/20">Endocrinology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/21">Gastroenterology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/22">Genetics</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/23">Hematology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/24">Hepatology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/25">Immunology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/26">Infectious disease</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/27">Inflammation</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/28">Metabolism</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/29">Microbiology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/30">Muscle biology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/31">Nephrology</a></p>
</div>
</div>
</div>
<div class="large-4 columns">
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/32">Neuroscience</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/33">Oncology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/34">Ophthalmology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/35">Otology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/36">Pulmonology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/37">Reproductive biology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/38">Stem cells</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/39">Therapeutics</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/40">Transplantation</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/41">Vaccines</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/42">Vascular biology</a></p>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<p><a href="/tags/43">Virology</a></p>
</div>
</div>
</div>
</div>

</div>
</div>

</div>
<div class="large-4 large-pull-8 medium-5 medium-pull-7 columns">
<div class="row homepage-panel centered" id="jci-homepage-med-rectangle-left-col-top" style="display: none;" data-google-query-id="CKKk0fXRse0CFZV9fgodNQcElg">
<div class="small-12 columns">
<span class="secondary label">Advertisement</span>
<script>
  try {
    googletag.cmd.push(function () {
      googletag.display('jci-homepage-med-rectangle-left-col-top');
    })
  } catch(e){}
</script>
</div>
<div id="google_ads_iframe_/82117132/jci-homepage-med-rectangle-left-col-top_0__container__" style="border: 0pt none; width: 260px; height: 217px;"></div></div>

<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4>Latest issue: December 1, 2020</h4>
</div>
</div>
<div class="row">
<div class="large-6 small-12 columns">
<div class="row">
<div class="small-12 columns">
<a class="hide-for-small" data-reveal-id="issue-modal" href="#"><img class="cover-img show-more issue-cover" src="//dm5migu4zj3pb.cloudfront.net/volumes/130/12/130-12-cover.jpg" /></a>
<a class="show-for-small" href="/130/12" id="homepage_mobile_cover_image"><img class="cover-img issue-cover" src="//dm5migu4zj3pb.cloudfront.net/volumes/130/12/130-12-cover.jpg" /></a>
</div>
</div>
</div>
<div class="large-6 small-12 columns">
<div class="row">
<div class="small-12 columns">
<h3>
<small>
On the cover:
<br />
<a href="/articles/view/141455"><i>YIPF5</i> mutations linked to neonatal diabetes and ER stress</a>
</small>
</h3>
</div>
<div class="small-12 columns hide-for-small">
<p>
<a class="show-more" data-reveal-id="issue-modal" href="#">
The Journal
<i class="fi-magnifying-glass"></i>
</a>
</p>
</div>
</div>
</div>
</div>
<div class="reveal-modal medium" data-reveal="" id="issue-modal">
<div class="left non-col">
<a id="homepage_medium_modal_issue" href="/130/12"><img class="border" src="//dm5migu4zj3pb.cloudfront.net/volumes/130/12/130-12-cover.jpg" /></a>
</div>
<div class="non-col">
<h4>December 1, 2020, issue</h4>
</div>
<div class="non-col">
<h3>
<small>
On the cover:
<br />
<a href="/articles/view/141455">&lt;i&gt;YIPF5&lt;/i&gt; mutations linked to neonatal diabetes and ER stress</a>
</small>
</h3>
<p>
Neonatal diabetes (NDM) results from single-gene mutations that impair β cell function or negatively impact β cell populations. In this issue of the JCI, <a href="/articles/view/141455">De Franco et al.</a> investigate homozygous mutations in YIPF5 identified in 6 patients with NDM and microcephaly from 5 families. YIPF5-mutant β cells differentiated from genetically engineered human embryonic stem cells (hESCs) displayed proinsulin accumulation, increased ER stress, and impaired C-peptide secretion in the implanted mice, providing a mechanistic explanation for insulin deficiency in affected patients. In addition to characterizing a novel gene underlying NDM with neurological features, the work provides novel insights into biological pathways essential for β cell function. The cover image depicts an hESC-derived islet implanted under the kidney capsule of immunocompromised mice, showing β cells in yellow, α cells in cyan, and nuclei in red. Image credit: Hazem Ibrahim, Jonna Saarimäki-Vire, and Hossam Montaser.

</p>
<p>
</p><ul class="button-group">
<li><a class="tiny button" id="homepage_cover_popup" href="/130/12">View this issue</a></li>
<li><a class="tiny button" href="/archive">View all issues</a></li>
</ul>
<p></p>
</div>
<a class="close-reveal-modal">×</a>
</div>

</div>
</div>
<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4>JCI This Month</h4>
</div>
<div class="small-12 columns">
<a class="show-more" data-reveal-id="impact-modal" href="#">
<p>JCI This Month is a digest of the research, reviews, and other features published each month.</p>
</a>
</div>
<div class="small-12 columns">
<a class="show-more" data-reveal-id="impact-modal" href="#">
JCI This Month
<i class="fi-magnifying-glass"></i>
</a>
</div>
</div>
<div class="reveal-modal medium" data-reveal="" id="impact-modal">
<div class="left non-col">
<a href="/this-month/2020/12"><img class="border" src="//dm5migu4zj3pb.cloudfront.net/impact/cover/103/jci_tm_2020_12.png" /></a>
</div>
<div class="non-col">
<h4>December 2020 JCI This Month</h4>
</div>
<div class="non-col">
<p>JCI This Month is a digest of the research, reviews, and other features published each month.</p>
<p>
</p><ul class="button-group">
<li><a class="tiny button" href="/this-month/2020/12">View this issue</a></li>
<li><a class="tiny button" href="/this-month">View all issues</a></li>
</ul>
<p></p>
</div>
<a class="close-reveal-modal">×</a>
</div>

</div>
</div>
<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="large-12 columns">
<h4>
Review Series
<small> - <a href="/review_series">More</a></small>
</h4>
</div>
</div>
<div class="row">
<div class="large-12 columns">
<h5><a href="/review_series/111">Hypoxia-inducible factors in disease pathophysiology and therapeutics</a></h5>
</div>
<div class="large-12 columns">
<h6>Series edited by Gregg L. Semenza</h6>
</div>
<div class="large-12 columns">
<a class="show-more" data-reveal-id="review-series-modal" href="#">
<p>
Maintaining adequate oxygen levels in the organs and tissues of multicellular organisms is essential to preserving cellular metabolism and bioenergetics. When oxygen levels fall below normal...
</p>
</a>
</div>
</div>
<div class="reveal-modal medium" data-reveal="" id="review-series-modal">
<h4><a href="/review_series/111">Hypoxia-inducible factors in disease pathophysiology and therapeutics</a></h4>
<h5>Series edited by Gregg L. Semenza</h5>
<p>Maintaining adequate oxygen levels in the organs and tissues of multicellular organisms is essential to preserving cellular metabolism and bioenergetics. When oxygen levels fall below normal physiological levels, hypoxia signaling pathways trigger physiological changes meant to evoke adaptive responses at organismal, tissue, and cellular levels. Hypoxia-inducible factors (HIFs) are positioned at the crux of these oxygen-sensing mechanisms, regulating a multitude of transcriptional programs that control angiogenesis, metabolism, immune function, erythropoiesis, and more. In this issue, a review series created by JCI’s deputy editor Gregg Semenza highlights how HIFs contribute to the pathogenesis and treatment of human disease. The reviews describe the hypoxic conditions that drive or exacerbate pathophysiology in diseases ranging from pulmonary hypertension to cancer. Moreover, they highlight HIF-targeting strategies in preclinical and clinical development, discussing their potential to improve the therapeutic outcomes in these diseases.</p>
<p>
</p><ul class="button-group">
<li><a class="tiny button" href="/review_series/111">View this review series</a></li>
<li><a class="tiny button" href="/review_series">View all review series</a></li>
</ul>
<p></p>
<a class="close-reveal-modal">×</a>
</div>

</div>
</div>
<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4>
Latest Reviews
<small> - <a href="/tags/reviews">More</a></small>
</h4>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="line-height: 1.4;"><a href="/articles/view/144115">Age-related susceptibility to Coronavirus infections: role of impaired and dysregulated host immunity</a></h5>
</div>
<div class="small-12 columns article-metadata">
<a style="color:black;" href="/articles/view/144115">Human coronaviruses (hCoVs) cause severe respiratory illness in the elderly. Age-related impairments in innate immunity and sub-optimal virus-specific T cell and antibody responses are believed to...
</a></div>
</div>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h5 class="article-title" style="line-height: 1.4;"><a href="/articles/view/142031">Stem cell therapy for muscular dystrophies</a></h5>
</div>
<div class="small-12 columns article-metadata">
<a style="color:black;" href="/articles/view/142031">Muscular dystrophies are a heterogeneous group of genetic diseases, characterized by progressive degeneration of skeletal and cardiac muscle. Despite the intense investigation of different...
</a></div>
</div>
</div>
</div>
</div>
</div>

<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4 class="notices-signup">Sign up for email alerts</h4>
<form action="https://notices.jci.org/subscribers/new" method="get">
<input name="utm_source" type="hidden" value="jci" />
<input name="utm_medium" type="hidden" value="web" />
<input name="utm_campaign" type="hidden" value="email_signup" />
<input name="utm_content" type="hidden" value="homepage" />
<div class="row">
<div class="small-12 medium-9 columns">
<input name="email_address" placeholder="Your email address" type="text" />
</div>
<div class="small-12 medium-3 columns">
<input class="button tiny orange" type="submit" value="Sign up" />
</div>
</div>
</form>
</div>
</div>

</div>
</div>
<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4>
Author's Take
<small> - <a href="/videos/authors_takes">More</a></small>
</h4>
</div>
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h5><a href="/posts/626">Gs/Gq signaling switch in β cells underlies the potential of incretins in diabetes</a></h5>
</div>
<div class="small-12 columns">
<a href="/posts/626"><p>Persistent depolarization of β-cells leads to Gs to Gq signaling switch, explaining the differential effects of GLP-1 and GIP on insulin secretion in diabetes...</p>
</a></div>
</div>
</div>
</div>
<div class="row">
<div class="small-12 large-10 columns">
<div class="flex-video">
<iframe allowfullscreen="" frameborder="0" height="197" src="//www.youtube.com/embed/R2fm7g63QRw" width="350"></iframe>

</div>
</div>
</div>
</div>
</div>

<div class="row homepage-panel">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h4>
Conversations with Giants in Medicine
<small> - <a href="/videos/cgms">More</a></small>
</h4>
</div>
</div>
<div class="row">
<div class="small-12 columns">
<div class="row">
<div class="small-12 columns">
<h5><a href="/posts/623">JCI's Conversations with Giants in Medicine: C. Ronald Kahn</a></h5>
</div>
<div class="small-12 columns">
<a href="/posts/623"><p>C. Ronald (Ron) Kahn of the Joslin Diabetes Center at Harvard Medical School is a physician-scientist who illuminated much of what we appreciate about the insulin receptor and the means by which it signals.</p>
</a></div>
</div>
</div>
</div>
<div class="row">
<div class="small-12 large-10 columns">
<div class="flex-video">
<iframe allowfullscreen="" frameborder="0" height="197" src="//www.youtube.com/embed/w0A1wQZeDZs" width="350"></iframe>

</div>
</div>
</div>

</div>
</div>

</div>
</div>

</div>
</div>
</div>
<div id="footer">
<div class="row panel-padding">
<div class="small-6 columns">
Follow JCI:
<span id="social-links">
<a onclick="trackOutboundLink('/facebook?ref=footer');" href="/facebook"><img title="Facebook" src="/assets/social/facebook_logo_white-8549cbbdd5755c8d81d1ab2fdea8326c3ec2963a83ad22b73dff80d93b500a47.png" /></a>
<a onclick="trackOutboundLink('/twitter?ref=footer');" href="/twitter"><img title="Twitter" src="/assets/social/twitter_logo_v2-60ea0c72387950663c0b04fc251455a5a04ed832e9291810914f0d9257b5f597.png" /></a>
<a href="/rss"><img title="RSS" src="/assets/social/rss_icon-cd21b1126f247087e91b0bc6c9d4acc3968c4ecb46461efba523e501876818ba.png" /></a>
</span>

<br />
Copyright © 2020
<a href="http://www.the-asci.org">American Society for Clinical Investigation</a>
<br />
ISSN: 0021-9738 (print), 1558-8238 (online)
</div>
<div class="small-6 columns">
<div class="row">
<div class="small-12 columns">
<h4 class="notices-signup">Sign up for email alerts</h4>
<form action="https://notices.jci.org/subscribers/new" method="get">
<input name="utm_source" type="hidden" value="jci" />
<input name="utm_medium" type="hidden" value="web" />
<input name="utm_campaign" type="hidden" value="email_signup" />
<input name="utm_content" type="hidden" value="footer" />
<div class="row">
<div class="small-12 medium-9 columns">
<input name="email_address" placeholder="Your email address" type="text" />
</div>
<div class="small-12 medium-3 columns">
<input class="button tiny orange" type="submit" value="Sign up" />
</div>
</div>
</form>
</div>
</div>

</div>
</div>
</div>

</div>
<!--[if gt IE 8]><!--><script src="/assets/application-b0080efa630f60e2ad71909fdb9e2e47b6644ff7454d1fe90279396c02ef2e8a.js"></script><!--<![endif]-->
<!--[if (lt IE 9)]>
<script src="/assets/ie8/application-56fa2dadb4a7c0b757c9323e2baa810348c2052533f460b704e8627525d49783.js"></script>
<![endif]-->
<script src="//s7.addthis.com/js/300/addthis_widget.js#pubid=ra-4d8389db4b0bb592" async="async"></script>
<script src="//d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" async="async"></script>


<!--[if lt IE 9]>
<script src="/assets/ie8/ie8-b06973a49582971e782acad6ffd4ed088fc75a69416e7b71a48175f8ad303474.js"></script>
<![endif]-->


<div id="_atssh" style="visibility: hidden; height: 1px; width: 1px; position: absolute; top: -9999px; z-index: 100000;"><iframe id="_atssh76" title="AddThis utility frame" style="height: 1px; width: 1px; position: absolute; z-index: 100000; border: 0px; left: 0px; top: 0px;" src="https://s7.addthis.com/static/sh.f48a1a04fe8dbf021b4cda1d.html#rand=0.31462604272510375&amp;iit=1606992594777&amp;tmr=load%3D1606992593625%26core%3D1606992593661%26main%3D1606992594773%26ifr%3D1606992594781&amp;cb=0&amp;cdn=0&amp;md=0&amp;kw=&amp;ab=-&amp;dh=www.jci.org&amp;dr=&amp;du=https%3A%2F%2Fwww.jci.org%2F&amp;href=https%3A%2F%2Fwww.jci.org%2F&amp;dt=JCI%20-%20Welcome&amp;dbg=0&amp;cap=tc%3D0%26ab%3D0&amp;inst=1&amp;jsl=1&amp;prod=undefined&amp;lng=en&amp;ogt=&amp;pc=men&amp;pub=ra-4d8389db4b0bb592&amp;ssl=1&amp;sid=5fc8c2d11a195492&amp;srf=0.01&amp;ver=300&amp;xck=0&amp;xtr=0&amp;og=&amp;csi=undefined&amp;rev=v8.28.8-wp&amp;ct=1&amp;xld=1&amp;xd=1"></iframe></div><style id="service-icons-0"></style><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci143120?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci139682?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci141777?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci141206?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci145301?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci120288?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci144115?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci143199?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci136057?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci140046?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci143884?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci139681?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci143466?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci140189?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci135665?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci137712?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci125297?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci136105?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci142804?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci140797?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci142468?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci136655?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci144450?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci137001?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" src="https://api.altmetric.com/v1/doi/10.1172/jci144807?callback=_altmetric.embed_callback&amp;domain=www.jci.org&amp;key=3c130976ca2b8f2e88f8377633751ba1&amp;cache_until=2-3"></script><script type="text/javascript" id="">"173.10.39.249"==google_tag_manager["GTM-WTNK8H9"].macro(4)||"production"!=google_tag_manager["GTM-WTNK8H9"].macro(5)?dataLayer.push({internal:"true"}):dataLayer.push({internal:"false"});dataLayer.push({event:"ipComplete"});</script>
<div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="96a92831-aa2c-f080-4f49-b53c33cedb1b" id="_altmetric_popover_el_96a92831-aa2c-f080-4f49-b53c33cedb1b" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="96a92831-aa2c-f080-4f49-b53c33cedb1b"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89679244&amp;tab=twitter">
          Tweeted by <b>119</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>25</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89679244">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="d1b1ce11-cd4c-1687-c8c1-255e1941f8db" id="_altmetric_popover_el_d1b1ce11-cd4c-1687-c8c1-255e1941f8db" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="d1b1ce11-cd4c-1687-c8c1-255e1941f8db"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93228172&amp;tab=twitter">
          Tweeted by <b>35</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>4</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93228172">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="b95b2594-981c-624f-580d-a54b376ac9f8" id="_altmetric_popover_el_b95b2594-981c-624f-580d-a54b376ac9f8" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="b95b2594-981c-624f-580d-a54b376ac9f8"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91135806&amp;tab=twitter">
          Tweeted by <b>28</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>21</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91135806">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="a3c8ccb1-bfaa-a812-3435-da832cd60dae" id="_altmetric_popover_el_a3c8ccb1-bfaa-a812-3435-da832cd60dae" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="a3c8ccb1-bfaa-a812-3435-da832cd60dae"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89748146&amp;tab=twitter">
          Tweeted by <b>9</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>4</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89748146">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="f52ab5ad-a3c1-869e-94a1-a3f67579bb2d" id="_altmetric_popover_el_f52ab5ad-a3c1-869e-94a1-a3f67579bb2d" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="f52ab5ad-a3c1-869e-94a1-a3f67579bb2d"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89680346&amp;tab=twitter">
          Tweeted by <b>70</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>5</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89680346">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="6ef8f11b-943c-56a7-2314-241cca892840" id="_altmetric_popover_el_6ef8f11b-943c-56a7-2314-241cca892840" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="6ef8f11b-943c-56a7-2314-241cca892840"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=news">
          Picked up by <b>38</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=blogs">
          Blogged by <b>1</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=twitter">
          Tweeted by <b>20</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480&amp;tab=facebook">
          On <b>1</b> Facebook pages
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>26</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89803480">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="91daefe7-ed45-64cf-c139-3638ff9b81de" id="_altmetric_popover_el_91daefe7-ed45-64cf-c139-3638ff9b81de" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="91daefe7-ed45-64cf-c139-3638ff9b81de"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975&amp;tab=news">
          Picked up by <b>13</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #ffd140;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975&amp;tab=blogs">
          Blogged by <b>1</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975&amp;tab=twitter">
          Tweeted by <b>16</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>14</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91537975">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="64f901ea-e858-62c0-dd06-89cf9c1e3df1" id="_altmetric_popover_el_64f901ea-e858-62c0-dd06-89cf9c1e3df1" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="64f901ea-e858-62c0-dd06-89cf9c1e3df1"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92450955&amp;tab=twitter">
          Tweeted by <b>4</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>10</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92450955">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="231d8dd8-b3c6-1dfb-e27d-f1f98dbeb961" id="_altmetric_popover_el_231d8dd8-b3c6-1dfb-e27d-f1f98dbeb961" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="231d8dd8-b3c6-1dfb-e27d-f1f98dbeb961"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94927422&amp;tab=twitter">
          Tweeted by <b>11</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94927422">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="4c86c76e-2c72-a589-f0a0-8447cc12b3f0" id="_altmetric_popover_el_4c86c76e-2c72-a589-f0a0-8447cc12b3f0" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="4c86c76e-2c72-a589-f0a0-8447cc12b3f0"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670&amp;tab=news">
          Picked up by <b>4</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670&amp;tab=twitter">
          Tweeted by <b>3</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670&amp;tab=facebook">
          On <b>1</b> Facebook pages
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94664670">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="e92e37b4-a3bf-9d0c-0629-c6ceef3dd1f3" id="_altmetric_popover_el_e92e37b4-a3bf-9d0c-0629-c6ceef3dd1f3" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="e92e37b4-a3bf-9d0c-0629-c6ceef3dd1f3"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94433054&amp;tab=twitter">
          Tweeted by <b>8</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94433054">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="eee8f711-307b-0138-7da6-00ffa46ec58a" id="_altmetric_popover_el_eee8f711-307b-0138-7da6-00ffa46ec58a" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="eee8f711-307b-0138-7da6-00ffa46ec58a"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808&amp;tab=news">
          Picked up by <b>7</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808&amp;tab=twitter">
          Tweeted by <b>12</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408808">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="2a65fb2e-509f-bf13-e833-e62cbae3ea8b" id="_altmetric_popover_el_2a65fb2e-509f-bf13-e833-e62cbae3ea8b" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="2a65fb2e-509f-bf13-e833-e62cbae3ea8b"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311&amp;tab=news">
          Picked up by <b>6</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311&amp;tab=twitter">
          Tweeted by <b>30</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311&amp;tab=facebook">
          On <b>1</b> Facebook pages
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94408311">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="5d020305-d4dd-fa43-83b7-070d13ace940" id="_altmetric_popover_el_5d020305-d4dd-fa43-83b7-070d13ace940" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="5d020305-d4dd-fa43-83b7-070d13ace940"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=95335433&amp;tab=twitter">
          Tweeted by <b>14</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=95335433">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="cef52b02-f301-00c2-03b8-5251d9045402" id="_altmetric_popover_el_cef52b02-f301-00c2-03b8-5251d9045402" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="cef52b02-f301-00c2-03b8-5251d9045402"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94672921&amp;tab=twitter">
          Tweeted by <b>67</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94672921">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="bb5cb137-884f-0be7-c3e7-82a82e8fe820" id="_altmetric_popover_el_bb5cb137-884f-0be7-c3e7-82a82e8fe820" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="bb5cb137-884f-0be7-c3e7-82a82e8fe820"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94656887&amp;tab=twitter">
          Tweeted by <b>2</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94656887">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="53dd9c73-a5d7-417e-c4d9-a18818b294af" id="_altmetric_popover_el_53dd9c73-a5d7-417e-c4d9-a18818b294af" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="53dd9c73-a5d7-417e-c4d9-a18818b294af"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94940250&amp;tab=twitter">
          Tweeted by <b>6</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=94940250">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="e2f58365-a56f-2da7-8bd7-c000f02d52be" id="_altmetric_popover_el_e2f58365-a56f-2da7-8bd7-c000f02d52be" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="e2f58365-a56f-2da7-8bd7-c000f02d52be"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396&amp;tab=news">
          Picked up by <b>7</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396&amp;tab=twitter">
          Tweeted by <b>10</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>2</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89764396">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="18bd3dcd-7599-0b16-a040-822c0a188174" id="_altmetric_popover_el_18bd3dcd-7599-0b16-a040-822c0a188174" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="18bd3dcd-7599-0b16-a040-822c0a188174"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91124905&amp;tab=twitter">
          Tweeted by <b>3</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=91124905">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="f7d8e2c0-88db-55af-1a0d-68bc7b186c93" id="_altmetric_popover_el_f7d8e2c0-88db-55af-1a0d-68bc7b186c93" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="f7d8e2c0-88db-55af-1a0d-68bc7b186c93"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863&amp;tab=twitter">
          Tweeted by <b>27</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #2445bd;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863&amp;tab=facebook">
          On <b>1</b> Facebook pages
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>7</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=92817863">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="431dbed3-96d4-b323-827d-f80cfaf64312" id="_altmetric_popover_el_431dbed3-96d4-b323-827d-f80cfaf64312" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="431dbed3-96d4-b323-827d-f80cfaf64312"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679&amp;tab=twitter">
          Tweeted by <b>27</b>
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #D5E8F0;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679&amp;tab=reddit">
          Reddited by <b>1</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>3</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89674679">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="097fc16a-4b43-8171-9589-6d8d8627cf9c" id="_altmetric_popover_el_097fc16a-4b43-8171-9589-6d8d8627cf9c" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="097fc16a-4b43-8171-9589-6d8d8627cf9c"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89690979&amp;tab=twitter">
          Tweeted by <b>12</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>6</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89690979">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="52fdf4a1-7651-a35b-5711-9983caf9fd8a" id="_altmetric_popover_el_52fdf4a1-7651-a35b-5711-9983caf9fd8a" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="52fdf4a1-7651-a35b-5711-9983caf9fd8a"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284&amp;tab=news">
          Picked up by <b>1</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284&amp;tab=twitter">
          Tweeted by <b>6</b>
      </a>
    </div>

    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=93979284">
            See more details
        </a>
    </div>
</div></div></div></div></div><div class="altmetric-embed altmetric-popover altmetric-bottom" data-uuid="720b551b-eff1-93ec-ac06-572eb521f96e" id="_altmetric_popover_el_720b551b-eff1-93ec-ac06-572eb521f96e" style="margin: 0px; display: none;"><div class="altmetric_container"><div class="altmetric_arrow altmetric-bottom"></div><div class="altmetric-embed altmetric-popover-inner altmetric-floating altmetric-bottom" data-uuid="720b551b-eff1-93ec-ac06-572eb521f96e"><div class="altmetric-embed altmetric-popover-content altmetric-floating"><div>    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #FF0000;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503&amp;tab=news">
          Picked up by <b>9</b> news outlets
      </a>
    </div>
    <div style="padding-left: 10px; line-height:18px; border-left: 16px solid #74CFED;">
      <a class="link-to-altmetric-details-tab" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503&amp;tab=twitter">
          Tweeted by <b>21</b>
      </a>
    </div>

    <div class="altmetric-embed readers" style="margin-top: 10px;">
          <div class="altmetric-embed tip_mendeley" style="padding-left: 10px; line-height:18px; border-left: 16px solid #A60000;">
              <b>11</b> readers on Mendeley
          </div>
    </div>
    <div style="margin-top: 10px; text-align: center;">
        <a class="altmetric_details" target="_self" href="https://www.altmetric.com/details.php?domain=www.jci.org&amp;citation_id=89907503">
            See more details
        </a>
    </div>
</div></div></div></div></div><iframe src="https://tpc.googlesyndication.com/sodar/sodar2/219/runner.html" width="0" height="0" style="display: none;"></iframe></body></html>